Drug Interactions Your Doctor Isn't Checking: The Evidence Nobody Joins Up
Polypharmacy affects 30% of over-65s. Most GPs have seven minutes and no interaction-checking protocol beyond the basics. Statins and thyroid medication. PPIs and magnesium depletion. Beta-blockers masking hypoglycaemia. The combinations that compound harm — mapped from published evidence.
Bryan Johnson's Blueprint: What $2M/Year Actually Buys — and What's Free
100+ interventions dissected against published evidence. Gene therapy, rapamycin, plasma exchange, follistatin — and why 80% of the benefit comes from sleep, exercise, and nutrition that costs nothing.
Bile Acid Signalling: The System Connecting Your Liver, Gut, Thyroid & Metabolism
FXR and TGR5 activation. TUDCA as the molecular chaperone. Why cholestyramine wrecks fat-soluble vitamins. The bile-thyroid-gut axis nobody is monitoring — and the compounds that restore it.
The HPA Axis: Why Your Cortisol, Thyroid & Sex Hormones Are All Connected
Chronic stress doesn't just cause fatigue. It suppresses TSH, converts T4 to reverse T3, tanks progesterone, raises SHBG, and depletes pregnenolone. One axis, five hormone systems, zero specialists looking at the whole picture.
Methylene Blue: The Mitochondrial Electron Bypass
Alternative electron carrier that cycles between Complex I and Complex III, bypassing the sites that generate reactive oxygen species. Gonzalez-Lima (UT Austin): increased cytochrome c oxidase activity in human brain tissue. Telch et al. (2014): double-blind RCT showed enhanced fear extinction memory at 260mg single dose. Hormetic dose response — 0.5–4mg/kg therapeutic, higher doses reverse the effect entirely. Critical interaction almost nobody flags: potent MAO-A inhibitor. Combining with SSRIs risks serotonin syndrome — potentially lethal.
Berberine: Metformin's Botanical Mirror
Inhibits mitochondrial Complex I → activates AMPK through the same upstream mechanism as metformin. Yin et al. (2008): 84 type 2 diabetic patients, 500mg three times daily — HbA1c dropped from 9.5% to 7.5%, statistically equivalent to metformin. 2024 meta-analysis: 46 RCTs, 4,000+ patients confirmed equivalent glucose-lowering efficacy. Lipid effects rival statins: 29% total cholesterol reduction, 35% triglycerides via LDLR upregulation and PCSK9 suppression. Dihydroberberine: 5x oral bioavailability, fewer GI side effects. Caution: inhibits CYP3A4, CYP2D6, and P-glycoprotein — significant drug interaction potential.
TUDCA: Chemical Chaperone for ER Stress
Tauroursodeoxycholic acid — a hydrophilic bile acid that acts as a chemical chaperone, stabilising protein folding in the endoplasmic reticulum. Crosses the blood-brain barrier. Dionísio et al. (2015): 500mg/kg in APP/PS1 mice reduced amyloid-beta deposition, glial activation, and synaptic loss. Human trial (Kars et al., Diabetes 2010): 1750mg/day improved hepatic and muscle insulin sensitivity ~30%. Mechanisms: inhibits caspase-12, stabilises mitochondrial membranes, activates Akt/GSK3β survival pathway. Clinical doses: 250–1500mg daily.
Calcium D-Glucarate: Blocking Toxin Reabsorption
Inhibits beta-glucuronidase — the bacterial enzyme that deconjugates Phase II metabolites in the gut, allowing cleared oestrogen, bilirubin, and environmental toxins to re-enter circulation. Converts to D-glucaro-1,4-lactone, which directly suppresses enzyme activity. Walaszek et al.: demonstrated reduced beta-glucuronidase activity and lower circulating oestrogen in animal models. Relevant for oestrogen-dominant conditions, sluggish bile flow, and anyone on medications cleared through glucuronidation. Typical dose: 500–1500mg daily with meals.
Creatine: Beyond the Gym
Phosphocreatine donates phosphate groups to regenerate ATP from ADP — the most direct energy buffer in human physiology. Brain stores 5–6mM creatine; supplementation increases brain creatine ~8–10%. Rae et al. (2003): 5g/day for 6 weeks significantly improved working memory and processing speed. McMorris et al.: enhanced cognitive performance under sleep deprivation. 700+ published studies. One of the most cost-effective interventions in existence. Does convert to DHT via 5-alpha reductase — relevant for hair loss susceptibility. Monohydrate is the only form with robust evidence.
Selenium: The Thyroid's Non-Negotiable
Selenocysteine is the catalytic residue in all three deiodinase enzymes (D1, D2, D3) that convert T4 to T3. Without selenium, you cannot activate thyroid hormone regardless of how much levothyroxine you take. Mazokopakis et al. (2007): 200mcg selenomethionine reduced TPO antibodies by 21% in Hashimoto's patients. Also required for glutathione peroxidase — the enzyme that protects the thyroid from the hydrogen peroxide generated during hormone synthesis. Brazil nuts: 1–2 daily provides ~100–200mcg. Excess above 400mcg is toxic — narrow therapeutic window.
Magnesium: Form Determines Function
Cofactor in 600+ enzymatic reactions. The form dictates tissue distribution. Glycinate: highest bioavailability, calming (glycine is inhibitory neurotransmitter), best for sleep/anxiety/muscle. Threonate (Magtein): only form shown to cross BBB and raise brain magnesium — Bhatt et al. (2020): improved executive function. Taurate: cardiovascular affinity, stabilises cell membranes, blood pressure support. Oxide: 4% absorption, essentially a laxative. Citrate: decent bioavailability, can loosen stools. RBC magnesium is the correct test — serum magnesium reflects only 1% of total body stores.
Lion's Mane: NGF Through Your Gut
Hericium erinaceus contains hericenones (fruiting body) and erinacines (mycelium) — the only known dietary compounds that stimulate nerve growth factor (NGF) synthesis. Mori et al. (2009): 3g/day for 16 weeks significantly improved cognitive function in mild cognitive impairment patients; gains reversed after discontinuation. Erinacine A crosses the BBB. Dual-extracted (hot water + ethanol) fruiting body provides both beta-glucans for immune function and hericenones for NGF. Mycelium-on-grain products are mostly starch. Source matters enormously.
NAD+ Precursors: NMN vs NR vs Niacin
NAD+ declines ~50% between ages 40 and 60. Three routes to restore it: NMN bypasses the NAMPT bottleneck, converting directly via NMNAT; NR enters through equilibrative nucleoside transporters then phosphorylates to NMN; niacin (vitamin B3) feeds the Preiss-Handler pathway at 1/50th the cost. Yoshino et al. (2021): 250mg NMN improved muscle insulin sensitivity in prediabetic women. Martens et al. (2018): NR raised NAD+ 60% in healthy older adults. Niacin: proven cardiovascular benefits since the 1950s, flush indicates prostaglandin release. The expensive option isn't always the most evidence-backed.
Probiotics: Strain-Specific or Useless
Lactobacillus rhamnosus GG is not interchangeable with Lactobacillus rhamnosus HN001 — different clinical evidence, different mechanisms. Most commercial probiotics are underdosed strains with no published trials. Key distinctions: L. reuteri DSM 17938 for histamine modulation, Saccharomyces boulardii for antibiotic-associated diarrhoea (yeast, so antibiotics can't kill it), VSL#3 for ulcerative colitis (the only formulation with IBD trial data). Histamine-producing strains (L. casei, L. bulgaricus) can worsen mast cell patients. CFU count means nothing without strain specificity.
Butyrate: Fuel for Your Gut Lining
Colonocytes derive 70% of their energy from butyrate — a short-chain fatty acid produced by bacterial fermentation of fibre. Without adequate butyrate, the gut epithelium literally starves. Activates PPAR-gamma, suppresses NF-κB, strengthens tight junctions. Tributyrin (glycerol-bound butyrate) survives stomach acid better than sodium butyrate. Fibre sources matter: resistant starch and pectin produce more butyrate than cellulose. Low-carb and carnivore diets can crash butyrate production — one mechanism behind the constipation many experience.
Milk Thistle: What the Evidence Actually Shows
Silymarin — a complex of flavonolignans, principally silibinin — stabilises hepatocyte membranes and upregulates glutathione synthesis. Ferenci et al. (1989): randomised trial in alcoholic cirrhosis showed significant survival benefit (58% vs 39% at 4 years). BUT: most commercial preparations have poor bioavailability. Phytosomal forms (Siliphos/Meriva) show 4.6x higher plasma silibinin. Evidence is strongest for toxic liver injury and alcoholic disease; weaker for NAFLD alone. Often stacked with NAC (glutathione precursor) and phosphatidylcholine (membrane repair). Not a general "detox" supplement — a targeted hepatoprotectant.
Vitamin D3: The Hormone Misclassified as a Vitamin
Secosteroid hormone synthesised from 7-dehydrocholesterol via UVB radiation. Regulates 1,000+ genes via the vitamin D receptor (VDR) expressed in almost every tissue. Pilz et al. (2011): supplementation significantly raised testosterone in men who were deficient. Requires co-factors: K2 (MK-7) activates osteocalcin and matrix GLA protein to direct calcium to bone; magnesium activates 25-hydroxylase and 1-alpha-hydroxylase conversion enzymes; boron reduces urinary excretion. Serum 25(OH)D target: 40–60 ng/mL (100–150 nmol/L). Most UK adults are deficient October–March.
Melatonin: Far More Than a Sleep Supplement
Synthesised from serotonin in the pineal gland, but also produced in 400x greater quantities in the gut. Potent mitochondrial antioxidant — scavenges hydroxyl radicals in the mitochondrial matrix where other antioxidants can't reach. Reiter et al.: demonstrated anti-cancer properties via oncostatic, anti-angiogenic, and immune-modulatory mechanisms. Physiological dose for sleep: 0.3–0.5mg (most products are 10–60x too high). High doses suppress endogenous production and cause morning grogginess. Extended-release mimics natural 6-hour secretion curve better than immediate-release.
Glycine: Deep Sleep Through Temperature
Inhibitory neurotransmitter that reduces core body temperature via peripheral vasodilation — the trigger for sleep onset. Bannai et al. (2012): 3g before bed significantly improved subjective sleep quality and reduced daytime sleepiness in individuals with restricted sleep. Activates NMDA receptors in the suprachiasmatic nucleus, accelerating circadian clock resetting. Also the primary amino acid in collagen synthesis and a precursor for glutathione (glycine + cysteine + glutamate). Cheapest and safest sleep intervention available. 3g dose is consistent across studies.
Choline: The Brain's Building Block Most People Lack
Precursor to acetylcholine (learning, memory, muscle control) and phosphatidylcholine (every cell membrane). 90% of the population doesn't meet adequate intake. Alpha-GPC: 40% choline by weight, crosses BBB, directly raises brain acetylcholine. Traini et al. (2013): improved memory in animal models of vascular dementia. CDP-choline (citicoline): donates both choline and cytidine (converts to uridine → RNA synthesis). Eggs: best dietary source (147mg/egg). Genetic variants in PEMT gene (common in women) increase choline requirements. Low choline → fatty liver independent of alcohol.
This research is what I publish. A private engagement applies it to your specific case.
Your diagnosis. Your medications. Your history. Structured intelligence delivered in 72 hours — not generic advice from a 15-minute appointment.
Codeine & CYP2D6: The Genetic Lottery
Codeine is a prodrug — pharmacologically inert until CYP2D6 converts it to morphine. 10% of Caucasians are ultra-rapid metabolisers: they convert codeine to morphine at unpredictable, potentially dangerous rates. 7% are poor metabolisers: codeine does literally nothing. Your GP prescribes the same dose to both. Pharmacogenomic testing costs ~£150 and tells you which category you fall into — yet it's almost never ordered before prescribing. Meanwhile, codeine-containing OTC products are available without any genetic screening.
Central Sensitisation: When Your Nervous System Becomes the Problem
After sustained nociceptive input, dorsal horn neurons upregulate NMDA receptors, lower firing thresholds, and expand receptive fields — wind-up. Touch becomes painful (allodynia). Mild pain becomes severe (hyperalgesia). The tissue heals but the pain persists because the central nervous system has remodelled. Fibromyalgia, chronic post-surgical pain, and many "unexplained" chronic pain conditions are nociplastic — generated by altered neural processing, not ongoing tissue damage. Treating them with anti-inflammatories misses the mechanism entirely.
NSAIDs: The True Cost of Daily Use
COX-1 inhibition strips the prostaglandin barrier that protects gastric mucosa — 15,000+ NSAID-related hospitalisations annually in the UK for GI bleeding alone. COX-2 inhibition raises cardiovascular risk: Bhala et al. (2013, Lancet meta-analysis): high-dose diclofenac increased major vascular events by ~30%. NSAIDs also alter the gut microbiome, reduce renal blood flow (dangerous if dehydrated or on ACE inhibitors), and may impair tendon/bone healing by suppressing the inflammatory cascade that initiates tissue repair. Topical NSAIDs achieve local tissue concentrations with 5–10% systemic absorption.
Gabapentinoids: The Cognitive Price of Pain Control
Gabapentin and pregabalin bind alpha-2-delta subunits of voltage-gated calcium channels, reducing neurotransmitter release at excitatory synapses. Effective for neuropathic pain — but the same mechanism suppresses synaptic transmission needed for memory consolidation, word retrieval, and executive function. Evins et al.: documented dose-dependent cognitive impairment. Physical dependence develops faster than most prescribers acknowledge. Withdrawal — anxiety, insomnia, seizure risk — can exceed benzodiazepine withdrawal in severity. Taper protocols measured in months, not weeks.
PEA: Endocannabinoid Pain Relief Without Cannabis
Palmitoylethanolamide — an endogenous fatty acid amide that activates PPAR-alpha, downregulates mast cell degranulation, and modulates endocannabinoid tone without binding CB1/CB2 directly. Hesselink et al.: reviewed 3,000+ patients across multiple trials — significant pain reduction in neuropathic, inflammatory, and pelvic pain with no reported side effects or drug interactions. Micronised form (PEA-um) has 3–4x better absorption than standard powder. 600mg twice daily for 2–3 months is the studied protocol. Works through resolution of neuroinflammation rather than blocking pain signals.
Low-Dose Naltrexone: Blocking Glial Activation
At 50mg, naltrexone blocks opioid receptors (addiction treatment). At 1.5–4.5mg, it transiently blocks opioid receptors for ~6 hours, triggering endorphin upregulation, AND directly antagonises TLR4 on glial cells, reducing CNS neuroinflammation. Younger et al. (2014): 4.5mg/day reduced fibromyalgia pain by 28.8% vs placebo. Published trials in Crohn's disease, MS, chronic pain. Costs ~£20/month from compounding pharmacies. Not patentable, so no pharma company will fund phase III trials. Your GP has probably never heard of it.
T4 to T3 Conversion: Where Thyroid Treatment Fails
Levothyroxine is T4 — the storage form. Your body must convert it to T3 (the active form) via deiodinase enzymes. D1 and D2 activate T4→T3; D3 inactivates it to reverse T3. This conversion requires selenium, zinc, iron, and cortisol. Chronic stress upregulates D3 (more reverse T3). Inflammation inhibits D1. Gut dysbiosis impairs the 20% of T4→T3 conversion that happens in the gut. Result: TSH looks "normal," T4 is adequate, but free T3 is low and the patient is still symptomatic. Most GPs only test TSH.
Iodine: Essential but Dangerous in Autoimmune Thyroid
Required for thyroid hormone synthesis — thyroglobulin is iodinated by thyroid peroxidase to produce T3 and T4. Deficiency causes goitre and hypothyroidism. But in Hashimoto's patients, excess iodine can trigger the Wolff-Chaikoff effect: acute inhibition of organification, paradoxically worsening hypothyroidism. Worse: iodine loading in the presence of TPO antibodies increases oxidative damage to thyroid tissue, accelerating autoimmune destruction. Supplementing before confirming antibody status is reckless. Test TPO and TG antibodies first. Always.
Zinc & Copper: The Ratio That Controls Both
Zinc is cofactor for 300+ enzymes including deiodinases (T4→T3), 5-alpha reductase (testosterone→DHT), and superoxide dismutase. But zinc supplementation depletes copper via metallothionein competition. Copper deficiency causes anaemia that looks like iron deficiency (but doesn't respond to iron), neutropenia, and neurological deterioration. Optimal ratio: 10:1 to 15:1 zinc:copper. Test both. If supplementing zinc above 30mg daily for more than 8 weeks, add 1–2mg copper. Most multivitamins get this ratio wrong.
Iron: The Most Mismanaged Deficiency in the NHS
Ferritin below 30 is deficient — but the NHS range starts at 13. Women with ferritin of 15 are told they're "normal" while experiencing fatigue, hair loss, restless legs, and impaired thyroid function (iron is required for thyroid peroxidase activity). Ferrous sulphate — the standard NHS prescription — causes constipation and nausea in ~30% of patients, leading to non-compliance. Iron bisglycinate: equivalent absorption, 80% fewer GI side effects. Take with vitamin C (enhances non-haem absorption 2–3x), away from tea/coffee/calcium (all inhibit absorption). Every-other-day dosing may improve absorption via hepcidin cycling.
Boron: The Forgotten Mineral
Reduces urinary excretion of calcium and magnesium — meaning your other mineral supplements work better. Naghii et al. (2011): 10mg/day for one week increased free testosterone 28% and reduced oestradiol 39% in healthy men. Inhibits SHBG, freeing bound hormones. Required for vitamin D metabolism — boron-deficient subjects showed impaired vitamin D status regardless of supplementation. Also inhibits the enzyme that degrades hyaluronic acid, supporting joint health. 3–10mg daily. Found in avocados, almonds, prunes. Almost never tested clinically. Almost nobody supplements it.
NAC & Glutathione: Your Liver's Emergency System
N-acetyl cysteine provides the rate-limiting substrate (cysteine) for glutathione synthesis — the body's most abundant intracellular antioxidant. Glutathione conjugates Phase II toxins, regenerates vitamins C and E, and protects mitochondrial DNA. Hospitals use IV NAC for paracetamol overdose because it restores hepatic glutathione before the toxic metabolite NAPQI destroys the liver. Oral NAC: 600–1800mg daily. Liposomal glutathione bypasses the digestion issue with standard oral glutathione (broken into amino acids in the gut). Glycine and selenium are also required for glutathione synthesis — NAC alone isn't enough.
Oestrogen Clearance: When the Liver Can't Keep Up
Oestrogen is metabolised through three pathways: 2-OH (protective), 4-OH (DNA-damaging), and 16-OH (proliferative). Phase I hydroxylation (CYP1A1, CYP1B1) determines which pathway dominates. Phase II conjugation (glucuronidation, sulphation, methylation) clears the metabolites. DIM shifts Phase I toward the 2-OH pathway. Calcium D-glucarate prevents Phase II deconjugation. COMT methylation (requires magnesium, B12, folate) clears catechol oestrogens. If any step is impaired — slow COMT genetics, low magnesium, gut dysbiosis reactivating oestrogen via beta-glucuronidase — oestrogen recirculates. The whole pathway has to work.
Bile Insufficiency: The Hidden Driver of a Dozen Symptoms
Bile emulsifies fats, carries conjugated toxins out of the body, is antimicrobial in the small intestine, and regulates its own synthesis via FXR (farnesoid X receptor). Low bile output causes: fat-soluble vitamin deficiency (A, D, E, K) despite supplementation, bloating after fatty meals, pale/floating stools, SIBO (loss of antimicrobial control), oestrogen recirculation, and elevated LDL (bile acid synthesis is a primary cholesterol disposal pathway). Ox bile supplementation: 125–500mg with fatty meals. Bitters (gentian, artichoke) stimulate cholecystokinin release. TUDCA improves bile hydrophilicity.
Mycotoxin & Biotoxin Binders: Evidence vs Marketing
Mould exposure produces mycotoxins (ochratoxin A, aflatoxin, trichothecenes) that are lipophilic — stored in fat, recirculated through bile. Binder strategy: cholestyramine (prescription, strongest evidence — Shoemaker protocol), activated charcoal (broad-spectrum, take away from all medications), bentonite clay (aflatoxin-specific binding well-documented in agricultural literature), modified citrus pectin (gentler, some evidence for heavy metals). All binders reduce medication absorption — dose 2 hours away from everything. Without fixing the source of exposure, binders are a holding pattern, not a solution.
Testosterone: What the Lab Range Hides
NHS "normal" range: 8.6–29 nmol/L. A 35-year-old man at 9 nmol/L is technically "normal" but functionally hypogonadal — fatigue, loss of libido, reduced muscle mass, cognitive fog, depression. Free testosterone matters more than total: SHBG binds testosterone, making it unavailable. Obesity, insulin resistance, ageing, and certain medications elevate SHBG. Testing total testosterone alone misses men who are symptomatic. Optimal free testosterone: 0.3–0.5 nmol/L. Natural optimisation before TRT: sleep, zinc, D3, body composition, stress reduction. TRT is replacement, not enhancement — and it's a commitment, not a course.
Cortisol: The Hormone That Controls Everything Else
Cortisol should peak at ~8am (waking) and decline to its nadir by ~11pm. When the HPA axis is dysregulated by chronic stress, this curve flattens — cortisol stays elevated at night (insomnia) and fails to rise adequately in the morning (can't wake up). Elevated cortisol: upregulates deiodinase D3 (thyroid → reverse T3), suppresses gonadotropins (testosterone and oestrogen drop), increases intestinal permeability, impairs hippocampal memory consolidation, and drives visceral fat storage. Dutch Test or 4-point salivary cortisol maps the curve. Single-point serum cortisol tells you almost nothing.
Ashwagandha: What the Clinical Trials Actually Measured
KSM-66 (full-spectrum root extract): Chandrasekhar et al. (2012): 300mg twice daily reduced serum cortisol by 27.9% vs placebo over 60 days. Wankhede et al. (2015): significant increases in testosterone, muscle mass, and strength in resistance-trained men. Sensoril (root + leaf): higher withanolide content, more sedating, better for anxiety/sleep. Thyroid effect: Sharma et al. (2018): 600mg/day raised T3 and T4 in subclinical hypothyroid patients — meaning it's contraindicated in hyperthyroidism. Not a generic "stress supplement." Two different extracts with different profiles. Dose and extract matter.
Taking multiple medications or supplements? I check what nobody else is checking.
Every combination checked. Every conflict flagged. A clear verdict on what's working, what's not, and what could safely come off. Written report for your GP. From £800.
SIBO: Why Your Bloating Never Resolves
Small intestinal bacterial overgrowth — bacteria colonising a space that should be relatively sterile. Hydrogen-dominant: diarrhoea, rapid bloating. Methane-dominant (now called IMO): constipation, methane directly slows intestinal transit by 59% (Pimentel et al.). Lactulose breath test is standard but 60% sensitivity — false negatives are common. Underlying causes almost never addressed: low bile (antimicrobial), impaired migrating motor complex (MMC — the "housekeeper wave" between meals), proton pump inhibitors reducing gastric acid barrier, ileocecal valve dysfunction. Rifaximin kills bacteria. But without fixing the cause, recurrence rate exceeds 40% at 9 months.
Histamine Intolerance: Not an Allergy
Diamine oxidase (DAO) in the gut epithelium degrades ingested histamine. When DAO is insufficient — genetic variants, gut inflammation, or medications that block DAO (NSAIDs, certain antibiotics, alcohol) — dietary histamine accumulates. Symptoms mimic allergy: flushing, headaches, hives, nasal congestion, diarrhoea, rapid heart rate. Fermented foods (wine, aged cheese, sauerkraut) are the worst triggers. DAO supplementation before meals can help. But the real question: why is DAO low? Gut inflammation, SIBO, and nutrient deficiencies (B6, copper, vitamin C are DAO cofactors) are the upstream targets.
L-Glutamine: Intestinal Fuel, Not Just a Gym Supplement
Primary metabolic fuel for enterocytes — small intestinal cells consume glutamine at higher rates than any other amino acid. Promotes tight junction protein expression (claudins, occludins), directly addressing intestinal permeability. Zhou et al. (2018): glutamine supplementation significantly reduced intestinal permeability markers in critically ill patients. Effective dose for gut repair: 5–20g daily, divided, away from meals for better absorption. ICU evidence is strongest. Outpatient IBS evidence is more mixed but mechanistically sound. Cheap, safe, and foundational in most gut repair protocols before adding more exotic interventions.
Digestive Enzymes & HCl: When Your Stomach Isn't Acid Enough
Hypochlorhydria (low stomach acid) produces symptoms identical to hyperacidity — bloating, reflux, undigested food. PPIs worsen it. Low acid → impaired pepsin activation → undigested protein → bacterial fermentation → gas and bloating. Betaine HCl challenge: take 650mg with a protein meal; burning = sufficient acid, nothing = likely deficient. Pancreatic enzyme insufficiency: lipase deficit causes fat malabsorption (steatorrhoea, fat-soluble vitamin deficiency). Faecal elastase-1 test confirms pancreatic output. Enzyme supplementation with meals — not between meals — targets digestive support specifically.
Sleep Architecture: Why Eight Hours Can Still Leave You Broken
Sleep isn't one state — it's a precise sequence. NREM Stage 3 (slow-wave/deep sleep) dominates the first half of the night: this is when growth hormone pulses, glymphatic clearance removes amyloid-beta from the brain, and memory consolidation begins. REM dominates the second half: emotional processing, procedural memory, creativity. Alcohol suppresses REM. Cannabis suppresses both REM and deep sleep. Melatonin at high doses can fragment architecture. Eight hours of disrupted architecture is worse than six hours of intact cycling. Sleep trackers measure time, not quality — polysomnography is the only true measurement.
The Evidence-Based Sleep Stack
Magnesium glycinate (400mg): glycine lowers core temperature, magnesium modulates GABA receptors. L-theanine (200mg): increases alpha brain waves, promotes relaxation without sedation — Nobre et al. (2008). Apigenin (50mg): binds benzodiazepine site on GABA-A receptors — the mechanism in chamomile that actually works. Glycine (3g): additional temperature drop, published sleep benefit. Tart cherry extract: contains small amounts of natural melatonin plus procyanidins that inhibit tryptophan degradation. This stack targets four different mechanisms. Compare with pharmaceutical sedatives that target one — and suppress sleep architecture in the process.
Light Timing: The Free Intervention Nobody Prioritises
Melanopsin-containing intrinsically photosensitive retinal ganglion cells (ipRGCs) send light signals directly to the suprachiasmatic nucleus, setting the circadian master clock. Morning bright light (10,000+ lux, i.e. outdoor daylight) within 30–60 minutes of waking: advances melatonin onset that evening, amplifies cortisol awakening response, and entrains the 24-hour cortisol curve. Evening blue light (screens at 450–480nm) delays melatonin onset by 90+ minutes. The intervention: 10 minutes of outdoor morning light and blue-blocking glasses after sunset. Zero cost. Larger effect size than most sleep supplements.
Photobiomodulation: Mechanism, Dose, and Evidence
Red (630–670nm) and near-infrared (810–850nm) photons are absorbed by cytochrome c oxidase — Complex IV of the mitochondrial electron transport chain. Mechanism: photodissociation of inhibitory nitric oxide from the CuB centre, restoring electron flow → increased ATP synthesis, transient ROS signalling, NO release. Biphasic dose response (Arndt-Schulz curve): too little does nothing, too much inhibits. Hamblin (Harvard): published 400+ papers on PBM. Gonzalez-Lima (UT Austin): transcranial PBM improved sustained attention and working memory. Power density (mW/cm²) and energy density (J/cm²) are the variables that matter — most consumer devices underdose.
Near-Infrared for Thyroid: The Brazilian Studies
Höfling et al. (2010, 2013): randomised, placebo-controlled trials applying 830nm NIR directly to the thyroid gland in Hashimoto's patients. Results: 47% of patients reduced levothyroxine requirement; some discontinued entirely. Mechanism: anti-inflammatory modulation, improved thyroid microcirculation, reduction in TPO antibodies. The thyroid is superficial enough for NIR to reach directly through the skin. Treatment protocol: 830nm, 50mW/cm², 707J per session, 10 sessions over 5 weeks. These results have been replicated but remain outside mainstream endocrinology guidelines — most endocrinologists have never heard of them.
Cold Exposure: Norepinephrine, Not Willpower
Cold water immersion (14°C or below) increases plasma norepinephrine 200–300% — the largest natural stimulus for this neurotransmitter. Norepinephrine: vasoconstriction, attention, mood elevation, and the mechanism behind cold's anti-inflammatory effect (reduces inflammatory cytokines). Brown adipose tissue activation: cold is the primary stimulus for BAT thermogenesis, increasing metabolic rate. Minimum effective dose: 11 minutes total per week of deliberate cold exposure (Søberg et al., 2021). End on cold (not hot) to retain the norepinephrine/metabolic benefit. Post-exercise: delays recovery if done within 4 hours — impairs the inflammatory signalling needed for adaptation.
Sauna: Cardiovascular Protection Through Heat Stress
Laukkanen et al. (2015): 20-year Finnish study, 2,315 men — 4–7 sauna sessions per week reduced cardiovascular mortality by 50% and all-cause mortality by 40% compared to once weekly. Mechanism: heat stress → heat shock protein expression (HSP70, HSP90) → protein quality control, reduced protein aggregation. Also: NO-mediated vasodilation, plasma volume expansion (mimics mild exercise), growth hormone pulse (up to 16x with repeated exposure per Léppaluoto). Infrared saunas: lower air temperature, deeper tissue penetration, may be better tolerated. Minimum: 80°C for 20 minutes, or 57°C infrared for 30 minutes.
BPC-157: Gastric Pentadecapeptide for Tissue Repair
A 15-amino-acid peptide derived from human gastric juice. Accelerates angiogenesis (VEGF upregulation), promotes tendon-to-bone healing, and modulates the NO system. Sikiric et al.: over 100 published papers demonstrating accelerated healing of muscle, tendon, ligament, gut, and nerve tissue in animal models. Mechanism: upregulates growth hormone receptor expression in injured tissue, promotes reticulin and collagen formation. Oral dosing (250–500mcg BID) targets gut specifically. Subcutaneous injection near injury site for musculoskeletal. No completed human RCTs — all evidence is preclinical. Regulatory status: research compound, not approved for human use.
Dihexa: 10 Million Times More Potent Than BDNF
N-hexanoic-Tyr-Ile-(6) aminohexanoic amide — developed at Washington State University. Agonist of the HGF/c-Met receptor, driving synaptogenesis and dendritic spine formation. Published finding: 10⁷ (10 million) times more potent than BDNF at promoting new synaptic connections. Reversed scopolamine-induced cognitive deficits in rats at 0.05mg/kg (Benoist et al., 2014). The concern: HGF/c-Met pathway is implicated in tumour progression and metastasis. Long-term safety in humans: completely unknown. No human trials. Research compound status. The most powerful cognitive peptide identified — and the one with the most significant unresolved safety question.
GHK-Cu: The Copper Peptide That Resets Gene Expression
Glycyl-L-histidyl-L-lysine with copper. Naturally occurring in human plasma — concentrations decline with age (200ng/mL at 20 to 80ng/mL at 60). Pickart et al.: GHK-Cu modulates expression of 4,000+ human genes, shifting the pattern toward a younger expression profile. Upregulates collagen I, III, and elastin synthesis. Promotes angiogenesis and nerve outgrowth. Published wound healing acceleration in human skin. Topical: 1–2% for skin remodelling and hair regrowth. Subcutaneous: systemic anti-ageing protocol (not FDA-approved). One of the best-characterised peptides with human-relevant data.
Thymosin Alpha-1: Immune Intelligence, Not Immune Stimulation
28-amino-acid peptide originally isolated from thymic tissue. Enhances dendritic cell maturation, increases T-cell and NK cell activity, and modulates toll-like receptors (TLR2, TLR9). Approved in 35+ countries for hepatitis B and C, and as adjunct in cancer immunotherapy. Garaci et al.: published improvement in immune reconstitution during chemotherapy. Key distinction: immunomodulatory, not immunostimulatory — it restores balanced immune function rather than simply amplifying it. Relevant for chronic viral infections, immunosuppressed states, and potentially as adjunct during cancer treatment. 1.6mg subcutaneous, twice weekly is the standard clinical dose.
Sarcopenia: The Silent Epidemic After 40
Muscle mass declines 3–8% per decade after 30 — accelerating after 60. Sarcopenia is the leading predictor of fall risk, fracture, loss of independence, and all-cause mortality in older adults. Anabolic resistance: ageing muscle requires a higher leucine threshold to activate mTOR. Solution: 2.5–3g leucine per meal (equivalent to 30–40g protein per meal). Resistance training is the only intervention that directly reverses sarcopenia — not walking, not yoga, not stretching. Morton et al. (2018): protein dose-response meta-analysis confirmed 1.6g/kg/day as optimal for muscle protein synthesis. Most over-60s eat half this.
Collagen Peptides: More Than Skin Deep
Hydrolysed collagen provides glycine, proline, and hydroxyproline — the specific amino acids underrepresented in muscle-meat-dominant diets. Shaw et al. (2017, AJCN): 15g collagen peptides with 50mg vitamin C taken 60 minutes before exercise doubled collagen synthesis markers in ligament tissue. Type I: skin, bone, tendons. Type II: cartilage (UC-II is undenatured, works via immune tolerance at 40mg/day — different mechanism than hydrolysed). Type III: blood vessels, organs. Effective dose for joints/tendons: 10–15g hydrolysed collagen daily. For cartilage: 40mg UC-II. They're not interchangeable — different products, different mechanisms.
Omega-3: The Dose Most People Get Wrong
EPA and DHA are precursors to resolvins, protectins, and maresins — specialised pro-resolving mediators (SPMs) that actively terminate inflammation (unlike NSAIDs, which merely suppress it). Omega-3 Index (EPA+DHA as % of red blood cell membranes): target 8–12%. Most Westerners: 3–4%. Effective anti-inflammatory dose: 2–4g combined EPA/DHA daily — most capsules contain 300mg, meaning 7–13 capsules/day. Liquid fish oil is more practical. EPA-dominant for inflammation (mood, joints). DHA-dominant for brain structure and neurological conditions. IFOS-certified for heavy metal testing. Rancid fish oil is pro-inflammatory — smell it before you take it.
Blood Sugar: The Metabolic Foundation Everything Else Sits On
Chronic postprandial glucose spikes → repeated insulin surges → progressive insulin resistance → metabolic syndrome → type 2 diabetes. But the damage starts decades before diagnosis. Continuous glucose monitors (CGMs) reveal that "healthy" foods spike some individuals dramatically — genetic variation in amylase production means identical meals produce different glucose responses. Hall et al.: demonstrated significant interindividual variation in glycaemic response to standardised meals. Practical interventions: eat protein/fat before carbohydrates (reduces spike 30–40%), walk 10 minutes post-meal, vinegar (1 tbsp in water before meals reduces glucose AUC ~30%).
Food Sensitivity Testing: What's Real and What's Not
IgE testing: genuine allergy — immediate, potentially anaphylactic. Validated, clinically meaningful. IgG testing (sold by functional medicine labs for £200+): measures prior exposure to food, not pathological sensitivity. The presence of IgG to a food means your immune system has encountered it — which is normal. Most IgG food sensitivity panels are not evidence-based. Gold standard: 30-day elimination of suspected triggers, systematic reintroduction one food at a time, symptom journaling. Autoimmune Protocol (AIP): removes grains, dairy, eggs, nuts, seeds, nightshades for 30–60 days. Labour-intensive but the most reliable identification method available.
Electrolytes: Why Water Isn't Enough
Insulin promotes renal sodium retention. Low-carb, ketogenic, or fasting protocols drop insulin → sodium excretion → potassium and magnesium follow. Symptoms attributed to "keto flu" are primarily electrolyte depletion: headache, fatigue, cramps, dizziness, heart palpitations. Requirements increase under these protocols: sodium 3–5g/day, potassium 3.5–4.7g/day, magnesium 400–600mg/day. Most commercial electrolyte products are underdosed sugar water. Adequate potassium alone (from food: avocado, potatoes, salmon, spinach) reduces blood pressure as effectively as cutting sodium. LMNT, Drip Drop, or DIY (salt + potassium chloride + magnesium) are the functional options.
Intermittent Fasting: What It Actually Does (And Doesn't)
16:8 restricts feeding window → reduces total caloric intake (the actual mechanism of weight loss, not "metabolic switching"). Autophagy: genuine cellular recycling pathway activated by nutrient deprivation, but significant autophagy requires 24–48+ hours of fasting in humans — not the 16 hours most protocols use. mTOR suppression during fasting allows cellular cleanup; protein intake at refeeding reactivates mTOR for rebuilding. Risk: compressed feeding windows make hitting 1.6g/kg protein difficult, especially for older adults already at risk of sarcopenia. For muscle preservation: if fasting, front-load protein at first meal (40–50g). Fasting is a tool, not an identity.
Vitamin D in Children: The Deficiency Nobody Checks
PHE recommends all UK children supplement D3 year-round. Compliance: minimal. Deficiency in children impairs bone mineralisation (rickets at extreme, poor bone density at moderate), immune development, and is associated with increased respiratory infections. Martineau et al. (2017, BMJ): vitamin D supplementation reduced respiratory tract infections, with strongest effect in those with baseline deficiency. Dosing: 400IU (0–12 months), 600–1000IU (1–12 years). Liquid D3 drops easiest for young children. Test 25(OH)D annually — especially in darker-skinned children in northern latitudes where melanin reduces cutaneous synthesis by up to 90%.
Children's Microbiome: First 1,000 Days Shape Everything
Vaginal birth seeds the infant gut with Lactobacillus and Prevotella. C-section: colonised with skin and hospital flora instead — different trajectory for the first 2+ years. Breastmilk: contains 200+ human milk oligosaccharides (HMOs) that selectively feed Bifidobacterium infantis. Early antibiotic courses (before age 2) are associated with increased rates of asthma, allergies, and obesity in prospective cohort studies. If C-section or formula-fed: infant-specific probiotics (B. infantis EVC001) partially restore the trajectory. The window for microbiome establishment is finite — interventions after age 3 have diminishing returns on immune programming.
ADHD & Nutritional Deficiencies: What to Test Before Medicating
Iron (ferritin): Konofal et al. (2008): 84% of ADHD children had ferritin below 30 vs 18% of controls. Iron is cofactor for tyrosine hydroxylase — the rate-limiting enzyme in dopamine synthesis. Zinc: cofactor for dopamine transporter function. Magnesium: deficiency correlates with hyperactivity and inattention. Omega-3 (EPA): meta-analyses show modest but significant improvement in attention with EPA-dominant supplementation. None of this means "supplements cure ADHD." It means nutritional deficiencies that worsen ADHD symptoms are treatable and should be screened before or alongside stimulant medication. Blood tests first. Always.
Alcohol: The Evidence Has Shifted
The "J-curve" (moderate drinking is protective) was a statistical artefact — sick-quitter bias. Stockwell et al. (2023, JAMA Network Open): after correcting for confounders, no level of alcohol consumption showed cardiovascular benefit. Mechanisms of harm: acetaldehyde (Group 1 carcinogen) damages DNA directly. Alcohol suppresses REM sleep architecture. Increases aromatase activity (testosterone → oestrogen). Disrupts gut barrier integrity within hours. Depletes B vitamins, zinc, and magnesium. Increases breast cancer risk by 7–10% per drink per day (Chen et al., 2011, 1.3 million women). The dose that is "safe" according to current evidence: zero.
Mould Illness: The Exposure Your GP Won't Consider
Chronic Inflammatory Response Syndrome (CIRS): a multi-system illness triggered by biotoxin exposure in genetically susceptible individuals (HLA-DR haplotypes — ~25% of the population). Symptoms overlap with chronic fatigue, fibromyalgia, and "medically unexplained" presentations: fatigue, brain fog, joint pain, light sensitivity, shortness of breath. Shoemaker et al.: published diagnostic criteria including VCS (visual contrast sensitivity) testing, HLA typing, and inflammatory markers (C4a, TGF-β1, MMP-9, MSH). The trigger: water-damaged buildings producing mycotoxins, endotoxins, and inflammagens. No amount of supplementation resolves symptoms while exposure continues. Test the environment first.
Blue Light & Screens: Circadian Disruption, Not Radiation
The legitimate concern with screens isn't "radiation" — it's circadian disruption. Screens emit 450–480nm blue light that suppresses melatonin via melanopsin receptors more effectively than any other visible wavelength. Chang et al. (2015, PNAS): iPad use before bed delayed melatonin onset by 90 minutes, reduced REM sleep, and impaired next-morning alertness. The fix isn't "EMF-blocking stickers" (pseudoscience). It's blue-blocking glasses (amber/red-tinted, blocking below 500nm) after sunset, Night Shift/f.lux settings, and keeping phones out of the bedroom. Address the mechanism that's actually established.
Sitting Disease: Exercise Doesn't Cancel 8 Hours in a Chair
Ekelund et al. (2016, Lancet, 1 million participants): 60–75 minutes of moderate exercise daily was required to eliminate the increased mortality risk from sitting 8+ hours. NEAT (non-exercise activity thermogenesis) — fidgeting, standing, walking to the kitchen — accounts for 200–900 kcal/day variation between individuals. Sitting reduces lipoprotein lipase activity (fat metabolism) within minutes. Interrupting sitting every 30 minutes with 2–3 minutes of light activity reduces postprandial glucose and insulin responses (Dunstan et al., 2012). Standing desks, walking meetings, and movement snacks matter more than an evening gym session bracketed by 10 hours of sitting.
Something is wrong and nobody is listening? I've been there.
I research your symptoms against published literature, identify what should have been investigated, and draft the clinical correspondence that gets you in front of the right specialist. From £1,500.
The Blood Panel Your GP Won't Run (And Why You Need It)
Standard NHS bloods: FBC, U&E, LFT, HbA1c, lipids, TSH. What's missing: free T3, reverse T3 (thyroid conversion), fasting insulin (insulin resistance precedes HbA1c elevation by years), ferritin (NHS range starts at 13, optimal >50), vitamin D 25(OH)D, RBC magnesium (not serum), homocysteine (methylation, cardiovascular), hs-CRP (systemic inflammation), DHEA-S (adrenal function), sex hormone panel (free testosterone, SHBG, oestradiol). Optimal ranges differ from "normal" ranges — NHS ranges include the unhealthy population in the reference distribution. Functional medicine ranges: narrower, symptom-correlated.
Fasting Insulin: The Test That Catches Diabetes 10 Years Early
HbA1c rises after glucose regulation has failed. Fasting insulin rises first — years to a decade before glucose becomes abnormal. HOMA-IR (fasting insulin × fasting glucose ÷ 22.5): optimal <1.0, insulin resistance begins >2.0, significant at >3.0. By the time HbA1c hits 42 (prediabetes), the pancreas has been compensating with hyperinsulinaemia for years. Elevated fasting insulin — with normal glucose — is the earliest detectable marker of metabolic dysfunction. It's also associated with increased cancer risk (hyperinsulinaemia promotes IGF-1 and cell proliferation). The test costs £15 privately. The NHS almost never runs it.
Full Thyroid Panel: What TSH Alone Misses
TSH is a pituitary hormone, not a thyroid hormone. It tells you what the brain is requesting, not what the body is receiving. A "normal" TSH with low free T3 means conversion is impaired — and the patient is symptomatic. Full panel: TSH (optimal 0.5–2.0, not the NHS range of 0.3–5.5), free T4, free T3 (the active hormone), reverse T3 (inactive — elevated by stress, inflammation), TPO antibodies (Hashimoto's), TG antibodies (often elevated when TPO is normal — misses autoimmune thyroid disease if not tested). Thyroid UK recommends testing all six. Most NHS GPs will only order TSH, occasionally adding free T4 if TSH is abnormal.
Autoimmune Disease: Three Factors, Not Just "Bad Luck"
Fasano's triad: genetic susceptibility + increased intestinal permeability + environmental trigger = autoimmune disease. All three are required. Coeliac disease proved the model — gluten triggers zonulin release → increased permeability → gliadin reaches lamina propria → immune activation in HLA-DQ2/DQ8 carriers. Molecular mimicry: microbial peptides structurally resembling self-antigens cross-activate autoreactive T-cells. Removing the trigger (when identifiable) and restoring barrier integrity can modulate disease activity. This framework now extends to type 1 diabetes, rheumatoid arthritis, MS, and Hashimoto's. The gut is the starting point, not just a bystander.
Hashimoto's: It's an Immune Disease, Not a Thyroid Problem
90% of hypothyroidism in the UK is autoimmune (Hashimoto's). Levothyroxine replaces the hormone but doesn't address the immune attack destroying the gland. TPO antibodies fluctuate with triggers: gluten cross-reactivity (tissue transglutaminase shares epitopes with thyroid tissue), selenium deficiency (required for glutathione peroxidase that protects thyroid from H2O2), vitamin D deficiency (immune modulation), and gut permeability (Fasano's triad). Approach: replace the hormone AND address the autoimmunity — gluten removal, selenium 200mcg, vitamin D optimisation, gut barrier repair. Monitoring: TPO antibodies trend, not just TSH.
ME/CFS: Post-Viral Mitochondrial Dysfunction
Post-exertional malaise (PEM) — the hallmark symptom — suggests an energy production deficit that cannot meet demand. Myhill et al. (2009): measured mitochondrial function in CFS patients — found significant impairment in ATP production, substrate transport, and recycling efficiency. Fluge et al.: identified amino acid deficiency patterns consistent with impaired pyruvate dehydrogenase. Immune findings: persistent low-grade immune activation, reduced NK cell cytotoxicity, elevated inflammatory cytokines. ME/CFS is not psychological. It is a multi-system neuroimmune condition with measurable biological markers. Activity pacing, not graded exercise, is the appropriate management framework.
IBS: The Diagnosis of Exclusion That Stops Investigation
IBS is a symptom pattern, not a mechanism. The label often terminates investigation rather than beginning it. Potential underlying mechanisms: SIBO (up to 78% of IBS patients test positive — Pimentel et al.), bile acid malabsorption (up to 30% of IBS-D — SeHCAT scan confirms), visceral hypersensitivity (central sensitisation of enteric nervous system), post-infectious gut dysfunction (PI-IBS after gastroenteritis), histamine intolerance, and food chemical sensitivity. Low-FODMAP diet treats symptoms effectively (Halmos et al., 2014: 75% response rate) but doesn't address the mechanism. Finding the mechanism means finding the treatment.
Modafinil: The Wakefulness Agent Masquerading as a Nootropic
Binds the dopamine transporter (DAT) with modest affinity — increasing extracellular dopamine without the surge pattern of amphetamines. Also activates orexin/hypocretin neurons (the system absent in narcolepsy). Prescribed for narcolepsy and shift work disorder. Off-label: cognitive enhancement in healthy adults — Battleday & Brem (2015, European Neuropsychopharmacology): meta-analysis found improvement in executive function and learning for complex tasks. Half-life: 12–15 hours (armodafinil is the R-enantiomer, longer duration). Reduces efficacy of hormonal contraception (CYP3A4 induction). Not a substitute for sleep — it masks sleep debt without resolving it.
Activated Charcoal: Powerful Binder With a Critical Caveat
Massive surface area (~3,000 m²/g) non-selectively adsorbs organic compounds in the GI tract. Hospital use: first-line treatment for acute poisoning within 1 hour of ingestion. Functional use: binding mycotoxins, bacterial endotoxins, and bile-bound toxins during detoxification protocols. The caveat: it binds medications, supplements, and nutrients with equal efficiency. Minimum 2-hour separation from everything — oral contraceptives, thyroid medication, blood pressure meds. Will render co-administered drugs ineffective. Short-term, targeted use with proper timing. Not a daily "detox" supplement.
DIM: Shifting Oestrogen Toward the Safer Pathway
Diindolylmethane — the stable metabolite of indole-3-carbinol (from cruciferous vegetables). Upregulates CYP1A1/CYP1A2 (the 2-hydroxylation pathway) and downregulates CYP1B1 (the 4-hydroxylation pathway) of oestrogen metabolism. 2-OH oestrogen: weakly oestrogenic, protective. 4-OH oestrogen: forms quinones that directly damage DNA — implicated in oestrogen-receptor-positive breast cancer. Dosage: 100–200mg BioResponse DIM (microencapsulated for absorption). Can lower total oestrogen — which is therapeutic in dominance but problematic in already-low-oestrogen states (postmenopausal women, some athletes). Test hormones before supplementing.
L-Theanine: Alert Relaxation Without Sedation
Amino acid from Camellia sinensis (green tea) that crosses the BBB and increases alpha brain wave activity — the frequency associated with calm, focused attention. Nobre et al. (2008): 50mg increased alpha activity within 40 minutes. Enhances GABA, serotonin, and dopamine without the sedation of GABAergic drugs. Synergistic with caffeine: Owen et al. (2008): L-theanine + caffeine improved both speed and accuracy on attention-switching tasks better than either alone. Dose: 100–200mg. No tolerance, no withdrawal, no known adverse effects. The reason matcha produces "calm energy" while coffee produces anxiety — theanine counterbalances caffeine's cortisol spike.
Hyperbaric Oxygen: Mechanisms Beyond Wound Healing
Breathing 100% O₂ at 1.5–3.0 ATA increases dissolved plasma oxygen 10–15x — reaching tissues beyond red blood cell delivery. Established: accelerates wound healing (diabetic ulcers, radiation injury). Emerging: Hadanny et al. (2020): 60 HBOT sessions improved cognitive function in post-stroke patients, with MRI-confirmed neuroplasticity. Mobilises stem cells from bone marrow. Upregulates VEGF (angiogenesis) and Nrf2 (antioxidant response). Published TBI and concussion data accumulating. Protocols: 1.5 ATA for mild applications, 2.0–2.4 ATA for wounds and neurological. Mild HBOT (1.3 ATA, non-prescription chambers) has weaker evidence but lower risk.
Ehlers-Danlos & the MCAS-POTS Triad
Hypermobile EDS (hEDS) is the most common heritable connective tissue disorder — yet average time to diagnosis exceeds 10 years. The triad: hEDS + Mast Cell Activation Syndrome (MCAS) + Postural Orthostatic Tachycardia Syndrome (POTS) co-occur at rates far exceeding chance. Mechanism: defective collagen in blood vessel walls → poor venous return → compensatory tachycardia (POTS). Defective connective tissue in GI tract → visceral hypermobility, gastroparesis. Mast cell dysfunction may relate to altered connective tissue mast cell anchoring. Each condition is frequently diagnosed in isolation. Recognising the triad changes management entirely.
Long COVID: The Emerging Mechanisms
Four leading hypotheses, not mutually exclusive: viral persistence (spike protein detected in tissue months post-infection), microclots (Pretorius et al.: fibrin amyloid microclots trapping inflammatory molecules), autoimmunity (molecular mimicry generating autoantibodies to G-protein coupled receptors), and gut reservoir (persistent viral shedding in GI tract). Overlap with ME/CFS is substantial — both share PEM, autonomic dysfunction, and immune dysregulation. Treatment landscape: antivirals (if persistence), anticoagulation (if microclots confirmed), immunomodulation (LDN, stellate ganglion block for dysautonomia). No single protocol — the mechanism varies by patient. Testing determines treatment.
Tongkat Ali: The Testosterone Data Worth Knowing
Eurycoma longifolia — Southeast Asian botanical with human trial data. Talbott et al. (2013): 200mg daily for 4 weeks — cortisol decreased 16%, testosterone increased 37% in moderately stressed adults. Mechanism: eurycomanone inhibits aromatase and phosphodiesterase, and may reduce SHBG freeing bound testosterone. Ismail et al. (2012): improved semen parameters in idiopathic male infertility. Hot-water-extracted root (100:1 or 200:1 standardised extracts) is the studied form. Effective dose: 200–400mg/day. Not comparable to TRT in magnitude, but one of the few botanicals with consistent human testosterone data. Quality varies enormously — heavy metal contamination is a documented issue in unregulated products.
Alpha-Lipoic Acid: The Universal Antioxidant
Both fat- and water-soluble — active in every cellular compartment. Regenerates vitamins C and E, CoQ10, and glutathione — the only antioxidant that recycles all other major antioxidants. Ziegler et al. (ALADIN study): 600mg IV ALA significantly improved diabetic neuropathy symptoms. R-lipoic acid (the natural enantiomer) is 10–12x more bioavailable than racemic ALA. Also chelates heavy metals (mercury, lead, arsenic) — Cutler protocol uses low-dose ALA on a round-the-clock schedule for redistribution-free chelation. Dose: 300–600mg R-ALA. Na-R-ALA (sodium salt) is the most stable supplemental form. Take away from meals for best absorption.
Three specialists, two GPs, a pharmacist — and none of them know what the others are doing.
I audit your entire care plan: what's working, what's redundant, what's actively harmful. One complete picture. One written report. From £2,000.
Sulforaphane: The Most Potent Natural Nrf2 Activator Known
Derived from glucoraphanin in broccoli sprouts via myrosinase enzyme (released when crushed/chewed). The most potent dietary activator of the Nrf2 pathway — the master regulator of Phase II detoxification and antioxidant gene expression. Upregulates glutathione S-transferase, NAD(P)H quinone oxidoreductase, and heme oxygenase-1. Simultaneously suppresses NF-κB (anti-inflammatory). Singh et al. (2014): sulforaphane-rich broccoli sprout extract improved autistic behavioural markers in a double-blind RCT. Fahey et al.: 3-day-old broccoli sprouts contain 20–100x more glucoraphanin than mature broccoli. Cooking destroys myrosinase — eat raw or supplement with added myrosinase enzyme.
Curcumin: Potent Molecule, Terrible Bioavailability
Inhibits NF-κB, COX-2, LOX, TNF-α, IL-1β, and IL-6 — hitting more inflammatory targets than any single pharmaceutical. The problem: standard curcumin has <1% oral bioavailability — it's glucuronidated and eliminated before reaching systemic circulation. Solutions: piperine (BioPerine) inhibits glucuronidation, increasing absorption 2,000% (Shoba et al., 1998). Meriva (phospholipid complex): 29x absorption. Longvida: designed for BBB penetration, cognitive applications. Theracurmin: nanoparticle, 27x absorption. Each formulation has different tissue distribution. Standard turmeric capsules at any dose: essentially placebo for systemic inflammation. The delivery system IS the product.
CoQ10: Essential If You're on a Statin
Coenzyme Q10 shuttles electrons from Complex I/II to Complex III in the mitochondrial electron transport chain — without it, ATP production collapses. Statins inhibit HMG-CoA reductase, blocking cholesterol synthesis. But CoQ10 shares the same biosynthetic pathway (mevalonate) — statins reduce CoQ10 by 40% within weeks. Statin myopathy (muscle pain, weakness) maps directly to mitochondrial CoQ10 depletion. Ubiquinol (reduced form): 3–6x better absorption than ubiquinone in adults over 40, whose conversion capacity declines. Dose: 100–300mg ubiquinol. Also critical for egg quality — Bentov et al.: CoQ10 supplementation improved ovarian response in IVF patients over 35.
Quercetin: Mast Cell Stabiliser, Senolytic, Zinc Ionophore
Flavonoid with three distinct clinical applications. First: mast cell stabilisation — inhibits histamine release from mast cells at source (not blocking receptors like antihistamines). Superior to cromolyn sodium in some models. Second: senolytic — in combination with dasatinib, clears senescent cells (Kirkland et al., 2019, Nature Medicine: first human senolytic trial showed reduced senescent cell burden). Third: zinc ionophore — facilitates zinc entry into cells, enhancing intracellular zinc's antiviral activity. Bioavailability is poor; phytosomal forms (Quercefit) show 20x improvement. Dose: 500–1000mg, ideally phytosomal. Inhibits CYP3A4 — check drug interactions.
Black Seed Oil: 1,400 Years of Use, Now the Mechanisms
Nigella sativa — "the remedy for everything except death" in the Hadith. Active compound thymoquinone: inhibits NF-κB, scavenges superoxide via quinone reductase cycling, and modulates T-helper cell balance (Th1/Th2). Bamosa et al. (2010): 2g/day for 12 weeks reduced HbA1c in type 2 diabetics as adjunct therapy. Nikakhlagh et al. (2011): reduced nasal mucosal congestion, itching, and sneezing in allergic rhinitis — matching antihistamine efficacy. Animal data suggests thyroid-protective effects via reduced TPO antibody production. CO2-extracted oil standardised to thymoquinone content is the quality marker. Dose: 1–3 teaspoons cold-pressed oil or 500–1000mg capsules.
Taurine: The Amino Acid That Calms Everything
Conditionally essential amino acid — the most abundant free amino acid in excitable tissues (heart, brain, retina). Activates GABA-A receptors (inhibitory), stabilises cell membranes via osmoregulation, and conjugates bile acids (taurocholate). Singh et al. (Science, 2023): taurine supplementation extended healthy lifespan in mice by 10–12%, with improvements in bone density, muscle strength, immune function, and metabolic markers. Enhances magnesium retention — the taurate form of magnesium exploits this for cardiovascular benefit. Depleted by alcohol, stress, and ageing. Energy drinks contain 1000mg — that's actually doing something useful, surrounded by garbage. Dose: 1–3g daily.
D-Mannose: The Sugar That Stops UTIs
Simple sugar that's barely metabolised — excreted through urine. E. coli (cause of 80–90% of UTIs) adheres to bladder epithelium via FimH lectin that binds mannose residues. Oral D-mannose floods the urinary tract, saturating these binding sites — E. coli binds the free mannose instead and is flushed out during urination. Kranjčec et al. (2014): 2g daily was as effective as prophylactic nitrofurantoin in preventing recurrent UTIs, with significantly fewer side effects. Cranberry extract (proanthocyanidins) works via a different mechanism — blocking P-fimbriae adhesion. They're complementary, not interchangeable. Dose: 2g in water at first sign, repeated every 2–3 hours for acute; 1–2g daily for prevention.
Resveratrol: The Sirtuin Activator That Overpromised
Stilbenoid polyphenol from grape skins that activates SIRT1 — a NAD+-dependent deacetylase linked to caloric restriction mimicry. Baur et al. (2006, Nature): resveratrol improved survival in obese mice on high-fat diets. The problem: human bioavailability is abysmal (~1% reaches circulation), rapidly conjugated to glucuronide and sulphate metabolites. Mega-dosing causes GI disturbance. Trans-resveratrol is the active isomer. Pterostilbene: a methylated analogue with 80% oral bioavailability vs resveratrol's 1% — same SIRT1 activation, actually reaches target tissues. If sirtuin activation is the goal, pterostilbene or NMN (provides the NAD+ substrate SIRT1 requires) may be more logical choices. The red wine narrative was always marketing, not science.
PCOS: It's an Insulin Problem Wearing a Hormone Mask
70–80% of PCOS patients have insulin resistance — even lean ones. Elevated insulin directly stimulates ovarian theca cells to produce excess androgens. It also reduces SHBG (more free testosterone) and disrupts GnRH pulsatility (anovulation). Treating the androgens without treating the insulin is like mopping the floor while the tap runs. Myo-inositol (4g/day) + D-chiro-inositol (110mg) in 40:1 ratio: Unfer et al. (2012): restored ovulation in 65% of PCOS patients, improved insulin sensitivity. Berberine: head-to-head with metformin in PCOS trials showed equivalent metabolic improvement. Low-GI diet reduces fasting insulin more than low-calorie alone. The weight loss is a consequence of fixing the insulin, not the other way around.
Progesterone: The Calming Hormone Nobody Tests
Progesterone metabolises to allopregnanolone — a potent positive allosteric modulator of GABA-A receptors. It's literally a neurosteroid anxiolytic. Low progesterone: anxiety, insomnia, PMS, luteal phase defects, and relative oestrogen dominance even when oestrogen is normal. The ratio matters — not just absolute levels. Causes of low progesterone: chronic stress (cortisol steals pregnenolone — the "pregnenolone steal"), anovulatory cycles, hypothyroidism, insufficient luteal phase, and perimenopause (progesterone drops first, years before oestrogen). Day 21 serum progesterone test confirms ovulation and luteal adequacy. Vitex (chasteberry): Zamani et al. (2012): improved luteal phase progesterone and reduced PMS in multiple RCTs. Bioidentical progesterone (micronised) is the replacement form — NOT synthetic progestins, which have different receptor profiles.
Pregnenolone & DHEA: Upstream of Everything
Pregnenolone — synthesised from cholesterol — is the mother hormone: precursor to progesterone, DHEA, cortisol, testosterone, and oestrogen. DHEA is the most abundant circulating steroid, peaking at 25 and declining 2–3% per year. DHEA-S (the sulphated storage form) below age-appropriate ranges correlates with immune decline, reduced bone density, cognitive impairment, and depression. Morales et al. (1994): 50mg DHEA daily for 6 months improved well-being, energy, and immune markers in ageing adults. Pregnenolone: direct precursor to both the stress pathway (cortisol) and the sex hormone pathway. Under chronic stress, flux shifts toward cortisol — the "pregnenolone steal." Testing DHEA-S alongside cortisol reveals adrenal reserve. Supplementation is hormone replacement — requires monitoring, not guesswork.
T4 Monotherapy vs Combination: The Debate Your Endocrinologist Won't Have
15–20% of hypothyroid patients remain symptomatic on levothyroxine (T4) alone despite "normal" TSH. Wiersinga et al.: identified DIO2 polymorphism (Thr92Ala) present in 16% of the population — reduces intracellular T4→T3 conversion in brain and muscle. These patients may benefit from combination T4+T3 therapy. Options: synthetic T3 (liothyronine) added to T4, or natural desiccated thyroid (NDT — T4, T3, T2, T1, calcitonin in physiological ratios). Hoang et al. (2013): 49% of patients preferred NDT over levothyroxine, with significant weight loss and no adverse effects. Most NHS endocrinologists refuse to prescribe T3 — citing cost (£250/month UK vs £5 in Europe) and guidelines that don't account for DIO2 polymorphism. Private prescribers fill the gap.
Breathwork: Vagal Tone, CO2 Tolerance, and HRV
Slow breathing (4–6 breaths/minute) activates the baroreflex → vagal efferent output → parasympathetic dominance. Measurable: heart rate variability (HRV) increases — the single best biomarker of autonomic resilience. Physiological sigh (double inhale + extended exhale): fastest real-time anxiety reduction — Huberman et al. (2023, Cell Reports Medicine): one 5-minute session of cyclic sighing outperformed mindfulness meditation for mood and anxiety reduction. CO2 tolerance: the urge to breathe is driven by CO2, not oxygen deficit. Buteyko method trains tolerance to higher CO2, improving ventilatory efficiency and reducing hyperventilation-pattern breathing. Box breathing (4-4-4-4): used by Navy SEALs for acute stress regulation. All free. All publishable mechanisms.
Transcutaneous Vagus Nerve Stimulation: Hacking the Inflammatory Reflex
The vagus nerve's cholinergic anti-inflammatory pathway: vagal efferents → acetylcholine release → alpha-7 nicotinic receptors on macrophages → NF-κB suppression → reduced TNF-α, IL-1β, IL-6. Tracey (2002, Nature): described this as the "inflammatory reflex." tVNS: non-invasive electrical stimulation of the auricular branch of the vagus nerve (ABVN) at the tragus or cymba conchae. FDA-cleared for migraine and cluster headache (gammaCore). Lerman et al.: reduced TNF and sympathetic tone. Devices: gammaCore (prescription), Nemos/Parasym (consumer). 25Hz, 250μs pulse width, 1mA — 15 minutes twice daily is the studied protocol. Contraindicated: active implants, carotid atherosclerosis.
Grounding: Published Physiology, Not Just Wellness Woo
Direct skin contact with the Earth's surface transfers free electrons into the body — the Earth's surface carries a negative charge (~-200V gradient in fair weather). Chevalier et al. (2012): grounding during sleep normalised cortisol diurnal rhythm. Oschman et al. (2015): demonstrated reduced blood viscosity (zeta potential improvement) — relevant to cardiovascular risk. Proposed mechanism: mobile electrons neutralise reactive oxygen species, functioning as an external antioxidant source. Brown et al. (2015): documented reduced inflammation markers and improved wound healing. The research is real but limited — small sample sizes, few RCTs. Indoor grounding: conductive mats, sheets connected to the earth pin of a grounded outlet. 30 minutes barefoot on grass or soil is the simplest protocol.
Bacopa Monnieri: Slow-Build Cognitive Enhancement
Bacosides A and B modulate serotonin, acetylcholine, and dopamine — and upregulate tryptophan hydroxylase (TPH2) and serotonin transporter (SERT) expression. Stough et al. (2001): 300mg daily for 12 weeks significantly improved speed of visual information processing, learning rate, and memory consolidation. Key distinction: effects take 8–12 weeks to manifest — not acute. Works by enhancing dendritic arborization and synaptic communication over time. Some individuals report lethargy and GI upset (serotonergic mechanism). Fat-soluble — take with meals containing fat. Standardised to 50% bacosides (Bacognize, Synapsa, KeenMind are studied extracts). Best suited as a daily foundation compound, not an on-demand nootropic.
Phosphatidylserine: Cortisol Buffer for the Ageing Brain
Phospholipid concentrated in the inner leaflet of neuronal cell membranes — critical for membrane fluidity, signal transduction, and neurotransmitter release. Declines with age. Monteleone et al. (1992): 800mg/day blunted cortisol response to exercise-induced stress. Kato-Kataoka et al. (2010): 100mg soy-derived PS improved memory and cognitive function in elderly with mild cognitive impairment. FDA permits a qualified health claim for PS and cognitive decline. Also facilitates apoptotic signalling (flip to outer membrane = "eat me" signal for macrophages) — relevant to immune clearance. Dose: 100–300mg daily. Soy-derived has replaced bovine-derived (BSE concerns). Synergistic with omega-3 — DHA is the fatty acid most concentrated in neuronal PS.
Caffeine: Pharmacogenomics of the World's Most Used Drug
Adenosine A1/A2A receptor antagonist — blocks the "tiredness signal," doesn't create energy. Half-life: 3–7 hours, but CYP1A2 polymorphism creates two populations. Fast metabolisers (CYP1A2*1A): clear caffeine quickly, associated with reduced cardiovascular risk from coffee. Slow metabolisers (CYP1A2*1F): clear slowly, coffee may increase MI risk (Cornelis et al., 2006). If caffeine after 12pm disrupts your sleep, you're likely a slow metaboliser. Tolerance develops to the alerting effect within 7–12 days of daily use — you're then consuming caffeine to return to your un-caffeinated baseline, not to enhance above it. Withdrawal: headache onset 12–24 hours, peaks at 48 hours, resolves in 7–9 days. Cycling (5 days on, 2 off) partially preserves sensitivity.
Endometriosis: Average 7.5 Years to Diagnosis
Endometrial-like tissue growing outside the uterus — generating its own oestrogen via local aromatase expression, independent of ovarian production. This means systemic hormonal suppression (the pill, GnRH agonists) often fails to fully control it. Diagnosis: laparoscopy with histological confirmation — imaging misses peritoneal disease. Treatment: excision surgery (not ablation — ablation burns the surface but leaves deeper disease). Average diagnostic delay in the UK: 7.5 years. Symptoms normalised as "bad periods" by clinicians who don't investigate. Affects ~10% of reproductive-age women. Associated with: infertility, bladder and bowel involvement, chronic fatigue, and autoimmune comorbidities at 2–3x population rates. Oestrogen management (DIM, calcium D-glucarate, liver support) is adjunctive — not curative. Surgery is the definitive treatment.
Osteoporosis: Calcium Alone Makes It Worse
Bone is living tissue — osteoclasts resorb, osteoblasts build. After 35, resorption gradually outpaces formation. Calcium supplementation without K2 drives calcium into arterial walls (Bolland et al., 2010, BMJ: calcium supplements without K2 increased cardiovascular events by 30%). The complete framework: vitamin D3 (calcium absorption), K2 MK-7 (directs calcium to bone via osteocalcin activation), magnesium (bone crystal structure), boron (reduces calcium excretion), collagen (type I — the structural protein bone mineralises onto), and weight-bearing exercise (mechanical loading signals osteoblast activation via Wnt pathway). Bisphosphonates: reduce fracture risk but suppress ALL bone turnover — including repair of microdamage. Long-term use (>5 years) paradoxically increases atypical fracture risk. DEXA scan: T-score, not just "normal/abnormal."
Migraine: Mitochondrial Dysfunction, Not Just a Headache
Cortical spreading depression (CSD) — a wave of neuronal depolarisation followed by suppression — underlies aura and may trigger the trigeminal pain cascade. Mitochondrial dysfunction is central: migraine brains show reduced mitochondrial membrane potential and impaired oxidative phosphorylation. Evidence-based nutraceuticals: magnesium (400–600mg — Peikert et al., 1996: reduced migraine frequency 41.6%), riboflavin/B2 (400mg — Schoenen et al., 1998: 50% reduction in attacks via Complex I support), CoQ10 (300mg — Sándor et al., 2005: significant frequency reduction). All three target mitochondrial energy production. CGRP monoclonal antibodies (erenumab, fremanezumab) are the pharmaceutical breakthrough — but at £5,000/year, the mitochondrial approach is first-line for many patients.
Post-Cholecystectomy: What Nobody Tells You After Gallbladder Removal
Without a gallbladder, bile drips continuously into the duodenum instead of being stored and released on demand. Consequences: inability to concentrate bile for fat-heavy meals (malabsorption, bloating, steatorrhoea), bile acid diarrhoea (continuous bile irritating the colon — affects up to 40% of post-cholecystectomy patients), fat-soluble vitamin deficiency (A, D, E, K) despite supplementation, and impaired clearance of conjugated toxins/oestrogen. Management: ox bile supplementation (500mg before meals containing fat), smaller more frequent meals, bile acid sequestrant (cholestyramine) if diarrhoea persists, fat-soluble vitamins in emulsified/liposomal forms for better absorption. Most surgeons mention none of this. The gallbladder was removed because it was "just a storage organ." It wasn't.
Homocysteine: The Cardiovascular Marker That Predicts Dementia
Homocysteine is a toxic intermediate in methionine metabolism — remethylated to methionine (requires B12 and folate) or transsulphurated to cysteine (requires B6). When these pathways are impaired — B12 deficiency, folate deficiency, or MTHFR polymorphism (C677T: 10–15% of population are homozygous, reducing enzyme activity 70%) — homocysteine accumulates. Elevated homocysteine (>10 μmol/L): independent risk factor for cardiovascular disease, stroke, and Alzheimer's. Smith et al. (OPTIMA trial, 2010): B12 + B6 + folate supplementation slowed brain atrophy by 30% in MCI patients with elevated homocysteine. The test costs £30 privately. Optimal: <8 μmol/L. Most GPs have never ordered it.
hs-CRP: The Inflammation Number That Predicts Everything
High-sensitivity C-reactive protein — produced by the liver in response to IL-6. Standard CRP detects infection/acute inflammation. hs-CRP measures low-grade chronic inflammation: the driver of atherosclerosis, insulin resistance, neurodegeneration, and cancer progression. Ridker et al. (JUPITER trial): hs-CRP was a stronger predictor of cardiovascular events than LDL cholesterol. Optimal: <0.5 mg/L. Moderate risk: 1–3 mg/L. High: >3 mg/L. If elevated chronically: investigate gut permeability, visceral adiposity, periodontal disease, occult infection, autoimmunity. Omega-3, curcumin, and addressing the root cause lower hs-CRP. Statins lower it too — part of their benefit may be anti-inflammatory rather than lipid-lowering (the CANTOS trial confirmed this).
Triglyceride-to-HDL Ratio: The Cheapest Metabolic Assessment
Fasting triglycerides divided by HDL. In mg/dL: optimal <1.0, concerning >2.0, insulin resistance likely >3.5. In mmol/L: divide result by 2.3 for equivalent. This single ratio correlates with small dense LDL particles (the atherogenic subtype), insulin resistance, visceral adiposity, and cardiovascular risk better than total cholesterol or LDL alone. McLaughlin et al. (2005): TG/HDL ratio >3.0 identified insulin resistance with 64% sensitivity and 68% specificity — comparable to HOMA-IR. Both are on standard NHS lipid panels. Nobody calculates the ratio. Waist-to-height ratio (WHtR): <0.5 = healthy. Combine TG/HDL with WHtR and fasting insulin — three data points that reveal metabolic health more accurately than BMI ever could.
Vitamin A: The Nutrient You're Probably Not Getting
Preformed retinol (liver, egg yolks, dairy) is active immediately. Beta-carotene (carrots, sweet potato) must be converted via BCO1 enzyme — but 45% of the population carries BCO1 polymorphisms that reduce conversion by 30–70%. These individuals cannot meet vitamin A needs from plant sources alone. Retinol is essential for: immune function (T-cell differentiation), thyroid hormone production (regulates TSH gene), skin integrity (retinoids), and vision (rhodopsin synthesis). Toxicity occurs above 10,000 IU/day chronically — but deficiency is more common than toxicity in UK adults, especially those avoiding liver and on low-fat diets. Cod liver oil: the traditional solution providing retinol, D3, and EPA/DHA in a single source. One tablespoon: ~4,500 IU retinol, ~450 IU D3, ~1g EPA+DHA.
B Vitamins: Form Determines Whether They Work
Cyanocobalamin (B12): synthetic, requires hepatic conversion, contains cyanide (trivial but unnecessary). Methylcobalamin and adenosylcobalamin: the two active coenzyme forms — used directly without conversion. Folic acid: synthetic, requires DHFR enzyme to convert to methylfolate. With MTHFR C677T polymorphism, this conversion is impaired — unmetabolised folic acid accumulates, paradoxically blocking folate receptors. Methylfolate (5-MTHF) bypasses this entirely. B6: pyridoxine is the common form; pyridoxal-5'-phosphate (P5P) is active. High-dose pyridoxine (>200mg) without conversion can paradoxically cause the neuropathy it's supposed to prevent. Thiamine (B1) deficiency: more common than recognised — Lonsdale: subclinical B1 deficiency from high-carbohydrate diets contributes to chronic fatigue and autonomic dysfunction. Benfotiamine: fat-soluble B1 with 5x bioavailability.
Oral Health: The Systemic Disease Your Doctor Ignores
Porphyromonas gingivalis (periodontal pathogen) has been found in Alzheimer's brain tissue — Dominy et al. (2019, Science Advances) identified gingipains (its toxic proteases) in 96% of AD brain samples. Periodontal disease increases cardiovascular risk by 20–50% (Tonetti et al., 2007, NEJM). Mechanism: chronic low-grade bacteraemia from inflamed gums → systemic inflammation → endothelial dysfunction, atherosclerotic plaque destabilisation. Oral microbiome dysbiosis also drives nitric oxide depletion (oral bacteria reduce dietary nitrate to nitrite — antiseptic mouthwash kills these bacteria and raises blood pressure). Root canals can harbour anaerobic bacteria indefinitely. Dental health isn't separate from systemic health — it's a primary driver of it.
Statins: The Numbers Behind the Prescription
For primary prevention (no prior cardiovascular event): NNT (number needed to treat) = 104 over 5 years — meaning 104 people take statins for 5 years to prevent 1 cardiovascular event (Abramson et al., 2013). For secondary prevention (prior heart attack/stroke): NNT drops to ~30 — genuinely life-saving. The distinction matters. Side effects: myopathy in 10–15% (via CoQ10 depletion), new-onset diabetes in 1 per 255 patients, cognitive complaints. Statins block HMG-CoA reductase — which also synthesises CoQ10, dolichol (cell membrane repair), and vitamin K2 (via mevalonate pathway). Mediterranean diet (PREDIMED trial, 2013): reduced cardiovascular events by 30% — comparable to statins, without the side effects. CoQ10 supplementation should be standard with every statin prescription. It almost never is.
PPIs: The 8-Week Drug Prescribed for Decades
Proton pump inhibitors (omeprazole, lansoprazole) were approved for 8-week courses. Millions take them for years. Long-term consequences: B12 deficiency (acid required for B12 liberation from food), magnesium depletion (FDA warning 2011), calcium malabsorption → increased fracture risk (Yang et al., 2006: 44% increased hip fracture risk with >1 year use), SIBO (gastric acid is the primary barrier to small intestinal colonisation), and Clostridium difficile infection (2–3x increased risk). Rebound acid hypersecretion on withdrawal perpetuates the cycle — gastrin upregulation means stopping PPIs causes worse reflux than before starting. Taper over 4–8 weeks, not abrupt discontinuation. H2 blockers (famotidine) as step-down. Address the cause: often hiatal hernia, SIBO, or hypochlorhydria misdiagnosed as hyperacidity.
The Pill: Nutrient Depletions Nobody Discloses
Combined oral contraceptives deplete: B6 (cofactor for serotonin and dopamine synthesis — mechanism behind pill-related depression), B12, folate (critical if pregnancy follows discontinuation), zinc, magnesium, selenium, and vitamin C. Palmery et al. (2013): documented these depletions systematically. The pill also raises SHBG — sometimes permanently — reducing free testosterone and contributing to low libido that persists after discontinuation ("post-pill syndrome"). Increases CRP (inflammatory marker) and alters bile composition (increased gallstone risk). Raises copper via ceruloplasmin elevation, potentially displacing zinc. None of these effects appear on the patient information leaflet as actionable items. At minimum: B-complex, magnesium, zinc, and selenium should accompany any OCP prescription. They never do.
How the NHS Loses Patients: The Architecture of Delay
GP appointment: 10 minutes. Referral: 2-week wait pathway (suspected cancer) or 18-week RTT (everything else — currently breached for 7.5+ million patients). But the clock doesn't start until the referral is made — and GPs are incentivised to investigate conservatively before referring. Between "patient presents" and "specialist sees them," an average of 3–5 decision points exist where the pathway stalls: GP decides to "watch and wait," referral sits in administrative queue, triage downgrades urgency, appointment is booked months out, patient DNA's because the letter arrived late. Patient choice: legal right to choose any provider with an NHS contract. NHS e-Referral Service shows wait times by provider. Most patients don't know this exists. The system isn't designed to lose you — but it isn't designed to find you either.
Rare Diseases: 3.5 Million UK Patients, Average 5 Years to Diagnosis
There are 7,000+ rare diseases — but collectively they affect 1 in 17 people. "Rare" doesn't mean uncommon. Average diagnostic delay: 5 years. Average number of misdiagnoses before correct one: 3. 80% are genetic. 95% have no approved treatment. The knowledge gap: most GPs will never see a specific rare disease in their career. The patient often becomes the world expert on their own condition. Diagnostic approach: phenotype-driven genomic testing (whole exome/genome sequencing), specialist centres (often only 1–2 in the UK per condition), patient registries, and orphan drug access programs. Genetic Alliance UK, NORD, and Orphanet are the navigation tools. If standard investigations return "normal" but symptoms are real and progressive, genomic evaluation should be pursued — not psychological referral.
HbA1c: Why It Lies in Specific Populations
Glycated haemoglobin reflects average blood glucose over ~90 days (red blood cell lifespan). But anything that alters RBC lifespan distorts the reading. Iron deficiency anaemia: prolonged RBC lifespan → falsely elevated HbA1c (patient appears more diabetic than they are). Haemolytic conditions, recent blood loss, or EPO therapy: shortened RBC lifespan → falsely low HbA1c (true diabetes missed). Haemoglobin variants (HbS, HbC, HbE — common in African, Mediterranean, and Southeast Asian populations): can interfere with assay methods. Fructosamine: alternative that reflects 2–3 week glucose average, unaffected by RBC turnover. If HbA1c doesn't match the clinical picture — especially in anaemic patients — question the test, not the patient.
Apple Cider Vinegar: Separating the Three Things It Does From the Fifty It Doesn't
What's published: Johnston et al. (2004): 20ml ACV with a high-carb meal reduced postprandial glucose by 34% in insulin-resistant subjects. Mechanism: acetic acid delays gastric emptying and inhibits disaccharidase enzymes (slower carbohydrate absorption). May support stomach acid in hypochlorhydric patients (additive acid, not stimulatory). Petsiou et al. (2014): modest effect on satiety and caloric intake. What's NOT published: "detoxification," "alkalising the body" (it's an acid), cancer prevention, weight loss independent of caloric deficit, or "dissolving fat." The evidence supports three applications: blunting glucose spikes (1–2 tbsp diluted before carb-heavy meals), supporting low stomach acid, and mild appetite suppression. Everything else is marketing.
Sunscreen, Vitamin D, and Skin Cancer: The Nuance Nobody Offers
UVB (280–315nm): causes sunburn AND triggers vitamin D synthesis. UVA (315–400nm): penetrates deeper, drives photoageing and melanoma. Most sunscreens primarily block UVB — preventing both burns AND vitamin D synthesis while allowing melanoma-associated UVA through. Mineral sunscreens (zinc oxide, titanium dioxide): broad-spectrum physical blockers, sit on skin surface. Chemical sunscreens (oxybenzone, octinoxate): absorbed systemically — detected in blood at levels exceeding FDA safety thresholds (Matta et al., JAMA, 2019). Oxybenzone: endocrine-disrupting, oestrogenic activity in vitro. The balanced approach: moderate unprotected sun exposure (10–20 minutes midday, depending on skin type) for vitamin D synthesis, then mineral sunscreen for extended exposure. Supplement D3 in winter regardless. Neither "always wear SPF50" nor "sunscreen is toxic" captures the evidence accurately.
CBD: What the Evidence Supports vs What's Being Sold
Strong evidence: Epidiolex (pharmaceutical-grade CBD) — FDA-approved for Dravet and Lennox-Gastaut syndromes (severe epilepsy). Doses: 5–20mg/kg/day. Moderate evidence: anxiety (Zuardi et al., 2017: 300mg acute dose reduced anxiety during simulated public speaking; Linares et al.: inverted U-shaped dose response — 300mg effective, 150mg and 600mg were not). Weak-to-speculative evidence: chronic pain (most positive studies used CBD+THC combinations, not CBD alone), anti-inflammatory effects (in vitro, limited human data at consumer doses). The market problem: products vary 10-fold from label claim (Bonn-Miller et al., 2017: only 31% of products tested within 10% of labelled CBD content). Effective doses for anxiety: 25–300mg. Most consumer products: 5–25mg. Bioavailability oral: ~6–19%. Sublingual oil absorbs better than capsules. Full-spectrum (with trace THC and other cannabinoids) outperforms isolate for most applications — the "entourage effect."
Protein Quality: Leucine Threshold, Not Just Grams
Muscle protein synthesis (MPS) is triggered by leucine reaching a threshold concentration — approximately 2.5–3g leucine per meal. This is the molecular switch for mTOR activation. Whey: fastest absorption, ~11% leucine content, 25g whey provides ~2.75g leucine — hits threshold. Casein: slower, sustained aminoacidaemia (better before sleep). Plant proteins: pea is best studied, but lower leucine density — need ~40g pea protein to match 25g whey's leucine. Combining sources improves amino acid profile. The "anabolic window" (must eat within 30 minutes of training): mostly myth for anyone eating adequate daily protein. Schoenfeld et al. (2013, meta-analysis): total daily protein intake matters far more than timing. Target: 1.6–2.2g/kg/day distributed across 3–4 meals, each hitting the leucine threshold.
OTC Sleep Aids: The Anticholinergic Dementia Risk
Diphenhydramine (Nytol, Benadryl) and doxylamine (NightNurse) are first-generation antihistamines — they cross the BBB and block muscarinic acetylcholine receptors. Acetylcholine is essential for memory consolidation and REM sleep. Gray et al. (JAMA Internal Medicine, 2015): cumulative anticholinergic use over 3+ years increased dementia risk by 54% in a dose-response relationship. These drugs don't promote restorative sleep — they induce sedation while suppressing the architecture that makes sleep restorative. Sold without any warning about cognitive risk. The irony: people take them to sleep better, but the sleep they get is neurologically degraded. Short-term use following bereavement or acute crisis is reasonable. Nightly use is a slow cognitive erosion that nobody discloses at the pharmacy counter.
H. pylori: The Infection Behind Ulcers, Reflux, and B12 Deficiency
Helicobacter pylori colonises 50% of the global population. Most are asymptomatic — but in susceptible individuals: chronic gastritis, peptic ulcers (Marshall & Warren, Nobel Prize 2005), impaired acid production (B12 and iron malabsorption), and increased gastric cancer risk (WHO Group 1 carcinogen). Standard triple therapy: PPI + clarithromycin + amoxicillin for 14 days. Resistance is rising — global clarithromycin resistance exceeds 20%. Bismuth quadruple therapy is now preferred in high-resistance areas. Adjunctive: Saccharomyces boulardii (reduces antibiotic side effects and improves eradication rate), mastic gum (Lalioti et al.: bactericidal against H. pylori strains in vitro, including clarithromycin-resistant), lactoferrin. Breath test confirms eradication 4 weeks post-treatment. Stool antigen is the alternative. Serological IgG remains positive long after eradication — useless for confirming cure.
Meditation: Structural Brain Changes in 8 Weeks
Hölzel et al. (2011, Psychiatry Research: Neuroimaging): 8 weeks of mindfulness-based stress reduction (MBSR) increased grey matter density in the hippocampus (memory), posterior cingulate (self-awareness), temporo-parietal junction (empathy), and cerebellum. Amygdala grey matter decreased — correlating with reduced stress scores. Lutz et al.: experienced meditators show reduced default mode network (DMN) activity — the "mind-wandering" network associated with rumination and anxiety. Measurable: HRV increases, cortisol decreases, telomere length preservation (Epel et al.). Not "relaxation" — active neural remodelling. 20 minutes daily is the minimum studied dose for structural change. Vipassana and MBSR have the strongest neuroimaging evidence. Meditation apps show inconsistent protocols — standardised practice matters.
Spore-Based Probiotics: Why They Survive When Others Don't
Bacillus species (B. subtilis, B. coagulans, B. clausii) form endospores — dormant structures that survive stomach acid, bile, and shelf storage without refrigeration. Germinate in the small intestine and function as transient colonisers. McFarlin et al. (2017): Bacillus subtilis HU58 reduced serum endotoxin (LPS) by 42% and triglycerides by 24% in 30 days — suggesting improved gut barrier function. Bacillus coagulans GBI-30,6086: published trials in IBS, showing significant improvement in bloating, pain, and stool consistency. Key advantage over Lactobacillus/Bifidobacterium: guaranteed viability at point of consumption. Disadvantage: transient, not colonising — requires ongoing supplementation. MegaSporeBiotic: the most-studied multi-strain spore product. Dose: 1–2 capsules daily with food.
Seed Cycling: Mechanistically Plausible, Clinically Unproven
The protocol: days 1–14 (follicular phase) — 1 tbsp each ground flaxseed + pumpkin seeds. Days 15–28 (luteal phase) — 1 tbsp each sesame + sunflower seeds. Proposed mechanism: flax lignans modulate oestrogen via SHBG and enterolactone production. Pumpkin seeds provide zinc (progesterone cofactor). Sesame lignans may support progesterone. Sunflower seeds provide selenium and vitamin E. The honest assessment: each individual component has published evidence for hormonal effects. The specific protocol of cycling them by menstrual phase has zero RCTs. It's mechanistically reasonable, inexpensive, and nutritionally beneficial regardless. But claiming it "balances hormones" overstates the evidence. Eat seeds. They're good for you. Don't expect them to replace progesterone therapy if you're genuinely deficient.
Glutathione: Why Most Oral Forms Don't Work
Glutathione (GSH) is a tripeptide — gamma-glutamyl-cysteinyl-glycine. The body's most abundant intracellular antioxidant. Oral reduced glutathione is hydrolysed to its constituent amino acids in the gut — you absorb cysteine, glycine, and glutamate, not intact glutathione. Solutions: liposomal glutathione (phospholipid encapsulation protects from digestion — Sinha et al., 2018: 40% increase in blood GSH after 1 month). S-acetyl glutathione: acetyl group protects the sulfhydryl bond through digestion, deacetylated intracellularly. NAC: provides the rate-limiting precursor (cysteine), letting the body synthesise its own GSH. Cheapest and most evidence-backed approach. IV glutathione: direct delivery, bypasses absorption — used clinically for Parkinson's (pilot data). For most people: NAC (600–1800mg) + glycine (3g) + selenium (200mcg) = the raw materials to let your body do what it does naturally.
TENS: Gate Control Theory in a £25 Device
Transcutaneous electrical nerve stimulation activates large-diameter Aβ afferent fibres — which inhibit pain transmission in the dorsal horn (gate control theory, Melzack & Wall, 1965). High-frequency TENS (80–120Hz): segmental inhibition, rapid onset, works during application. Low-frequency TENS (2–4Hz): triggers endogenous opioid release (endorphins, enkephalins) — slower onset, longer-lasting effect. Vance et al. (2014, Pain): meta-analysis confirmed significant analgesic effect vs sham in musculoskeletal pain. Electrode placement matters — on dermatome, near but not on the pain site. Habituation occurs within 30–45 minutes — alternating frequencies prevents it. One of the most cost-effective, zero-side-effect pain interventions available. NHS physiotherapists prescribe them; GPs almost never mention them.
Zinc Carnosine: Targeted Gut Lining Repair
Zinc-L-carnosine (Polaprezinc) — a chelate that dissociates slowly in the stomach, adhering to ulcer sites and areas of mucosal damage. Unlike zinc supplements taken for systemic zinc status, zinc carnosine delivers zinc directly to damaged gastric and intestinal epithelium. Mahmood et al. (2007, Gut): increased villus height and gut barrier integrity by 50% in a human intestinal permeability study (lactulose-mannitol test). Also: reduces H. pylori colonisation (adjunctive to eradication therapy), stabilises mast cells in gut mucosa, and accelerates NSAID-damaged mucosal recovery. Dose: 75mg (containing 16mg zinc + 59mg carnosine) twice daily between meals. Japanese prescription medication (Promac) for peptic ulcers — available OTC elsewhere. Different product than zinc picolinate or zinc glycinate — the carnosine chelate IS the mechanism.
Xenoestrogens: The Endocrine Disruptors in Your Daily Routine
Synthetic compounds that bind oestrogen receptors: BPA (plastics, thermal receipts, can linings), phthalates (fragrances, flexible plastics, personal care products), parabens (cosmetics, shampoo), atrazine (herbicide in water supply), and organochlorine pesticides. These accumulate in adipose tissue and activate ERα/ERβ at concentrations found in human blood. Swan et al. (2017): phthalate exposure correlated with declining sperm counts — 52% reduction in Western men since 1973. BPA: linked to insulin resistance, obesity, and breast cancer in epidemiological studies. "BPA-free" products often substitute BPS or BPF — structurally similar, equally oestrogenic. Practical reduction: glass/stainless steel containers, fragrance-free personal care, filtered water, organic produce for the Dirty Dozen, and never microwaving plastic. The dose makes the poison — but when exposure is constant and cumulative, "low dose" stops being reassuring.
The Cortisol Awakening Response: Why Your Morning Routine Matters More Than Your Evening One
Within 30–60 minutes of waking, cortisol should surge 50–75% above overnight baseline — the cortisol awakening response (CAR). This spike: consolidates hippocampal memory, activates the immune system, mobilises energy, and sets the circadian cortisol curve for the entire day. Blunted CAR: associated with chronic fatigue, burnout, depression, PTSD, and autoimmune conditions (Fries et al., 2009). Amplified CAR: associated with chronic psychosocial stress and anxiety. What amplifies healthy CAR: morning bright light (10,000+ lux within 30 min of waking), brief cold exposure, movement, protein-containing breakfast. What blunts it: staying in dim indoor light, scrolling phone in bed, skipping breakfast, chronic sleep restriction. Your morning dictates your biochemistry for the next 16 hours. Most people optimise the wrong end of the day.
Children's health. Your own preventive care. Your parents' NHS coordination. All joined up.
One dedicated health intelligence function for the entire family. Monthly briefing. Nothing falling through the cracks. Retainers from £2,000/month.
Sperm Counts Have Halved Since 1973 — and the Decline Is Accelerating
Levine et al. (2017, Human Reproduction Update, 185 studies, 42,935 men): sperm concentration dropped from 99 million/mL to 47.1 million/mL — a 52.4% decline at −1.4% per year. Their 2022 update (223 studies): the annual rate of decrease doubled post-2000 to −2.64%. Environmental drivers: phthalates downregulate INSL3 and CYP11a1 (inhibiting testosterone biosynthesis), BPA disrupts the HPG axis as a xenoestrogen. Adams et al. (2014): mobile phone exposure reduced sperm motility by 8.1%. Swiss military study (2023, n=2,886): dose-response relationship between phone use and sperm concentration. Harvard underwear study: boxers produced 25% higher sperm concentration than tight underwear. Heat, plastics, pesticides, and EMF — the assault is cumulative and constant.
Male Fertility Supplements: What the RCTs Actually Show
CoQ10 has the strongest evidence. 2024 meta-analysis (~900 subjects, 7+ RCTs): +13.38 million sperm count, +7.26% motility, +1.96% morphology at 200–300mg/day for 3–6 months. Ashwagandha KSM-66 (Ambiye 2013, n=46): 167% sperm count increase, 53% volume increase — but small and manufacturer-funded. L-carnitine (2025 meta-analysis, 14 RCTs, n=1,453): +6.85 million concentration, +10.41% motility — but the large MOXI trial found NO improvement in pregnancy rates. Selenium (100–300µg/day): consistent improvements across three RCTs. The landmark FAZST trial (Schisterman 2020, JAMA, n=2,370) — the largest ever — found ZERO improvement with zinc + folic acid. The biggest trial destroyed the most popular supplement recommendation.
TRT Is Effectively a Male Contraceptive — Here Are the Alternatives
Exogenous testosterone suppresses GnRH → collapses intratesticular testosterone from ~600–1,200 ng/mL to <20 ng/mL. Patel et al. (2019): TRT induces azoospermia in ~65% of normospermic men within 4 months. Recovery after cessation: median 110 days, but 30% cannot achieve adequate counts even after 12 months with hCG rescue. Fertility-preserving alternatives: clomiphene citrate 25–50mg daily (2025 meta-analysis, 10 RCTs, n=819): +273.76 ng/dL testosterone while maintaining spermatogenesis. Enclomiphene (purified trans-isomer): Kaminetsky 2013 (n=124) — raised testosterone while maintaining 75–334 million/mL sperm, whereas topical testosterone drove ALL subjects below 20 million/mL. hCG (1,500–3,000 IU 2–3x/week): spermatogenesis restoration rates 44–100%.
Varicocele: The Most Common Treatable Cause of Male Infertility
Affects 15% of all men and 21–40% of infertile men. Retrograde venous blood flow elevates intratesticular temperature by 0.5–1°C, increasing oxidative stress, reducing local testosterone. 2024 meta-analysis (351 articles, ~32,000 patients): repair significantly improves every semen parameter. Agarwal retrospective (304 patients): sperm count increased 53% by 3 months post-repair, total motile count rose 2.5-fold. Natural conception rates: 32.9% after varicocelectomy vs 13.9% observation only (RCT, 145 couples). Microsurgical subinguinal approach: lowest complication and recurrence rates. Most men don't know they have one — diagnosis requires standing physical examination and scrotal ultrasound with Valsalva. If you're subfertile, this should be assessed before any supplement protocol.
Egg Quality Is a Mitochondrial Problem — and It's Addressable
The human oocyte contains ~100,000 mitochondria and 50,000–500,000 mtDNA copies — the most mitochondria-dense cell in the body. No mtDNA replication occurs until the blastocyst stage, meaning every division relies on the mother's original mitochondrial supply. Ben-Meir et al. (2015, Aging Cell): oocyte aging features decreased oxidative phosphorylation, reduced ATP, and diminished CoQ10-synthesising enzyme expression. CoQ10 supplementation in aged mice restored mitochondrial function to young-mouse levels. Human data: Xu et al. (2018, Peking University, n=169): CoQ10 600mg/day pretreatment yielded more retrieved oocytes and 67.49% fertilisation rate. Florou 2020 meta-analysis (5 RCTs): clinical pregnancy rates 28.8% vs 14.1% (OR 2.44, p=0.006). Start 2–3 months before IVF. Ubiquinol form preferred for women over 35.
AMH: Powerful for IVF Prediction, Misleading for Natural Fertility
Anti-Müllerian hormone reflects the remaining follicular pool. Normal ranges: ~3.0–4.0 ng/mL at age 25, declining to <0.5 ng/mL by 45, with up to 80% variation between same-age women. The critical finding: JAMA 2017 (Steiner et al., n=750) — women with low AMH did NOT have significantly lower chances of natural conception. AMH predicts IVF stimulation response, not actual fertility. A woman with low AMH may have fewer eggs retrieved during IVF but each egg can be perfectly healthy. Vitamin D supplementation in deficient women can increase AMH by 10–30% — the AMH gene promoter contains a vitamin D response element. Don't let a single AMH number define your fertility — it's one data point, not a verdict.
DHEA for Diminished Ovarian Reserve: Promising Data, Imperfect Evidence
Pioneered by Gleicher and Barad at the Center for Human Reproduction, New York. DHEA 75mg/day (25mg TID) as androgen precursor: stimulates granulosa cell proliferation and amplifies FSH responsiveness. Their data: clinical pregnancy rates rose from 11.3% to 23.3%, AMH improved ~60% over follow-up. But the critical caveat: they attempted two RCTs — both terminated because patients refused randomisation to placebo. A 2023 meta-analysis found that in the RCT subgroup specifically, DHEA did NOT significantly improve live birth rate, though non-RCT results were favourable. The honest assessment: biologically plausible, clinically promising, but definitively proven? Not yet. Worth discussing with your reproductive endocrinologist if ovarian reserve is diminished. Minimum 6–8 weeks before IVF cycle.
IVF Support Protocols: Myo-Inositol, Melatonin, and What the Evidence Shows
Myo-inositol (4g/day): second messenger for FSH and insulin signalling. Sadeghpour 2022 (double-blind RCT, n=70): significantly higher total oocytes, MII oocytes, and clinical pregnancy rates with 2 months supplementation. However, 2023 international PCOS guidelines cite limited evidence, and Palomba 2025 states evidence does NOT support myo-inositol as stand-alone treatment. Melatonin (3mg/day): follicular fluid antioxidant. Tamura 2008 (n=115 prior IVF failures): fertilisation rates ~50% melatonin vs ~22.8% placebo. The 2025 meta-analysis (9 RCTs, 1,235 participants): improved clinical pregnancy rates (OR 1.59). But the largest double-blind RCT (Fernando 2018) found NO significant differences despite 9-fold increase in follicular fluid melatonin. Start the stack 2–3 months pre-cycle: CoQ10 600mg, myo-inositol 4g, melatonin 3mg, vitamin D to replete.
Age-Related Fertility Decline: The Actual Biology, Not Just 'Your Clock Is Ticking'
PGT-A data (Franasiak 2014, 15,169 biopsies): euploid embryo rates decline from 73% at age <35 to just 5% at ages 43–44. But even when euploid embryos are selected, age still affects outcomes: Reig et al. (2020, 8,175 transfers) — live birth rates 62.5% at <35 declining to 52.2% at 41–42 — proving cytoplasmic quality deteriorates independently of chromosome errors. The molecular mechanisms: cohesin proteins (loaded during fetal life, never replenished) degrade over decades — Lister et al. 2010. Meiotic spindle assembly defects correlate with mitochondrial dysfunction. Accumulated epigenetic damage. The consistent success of donor eggs from young women to older recipients confirms: it's the egg, not the uterus. Mitochondrial support, antioxidant protection, and toxin avoidance are the modifiable factors.
Perimenopause Is an Estrogen Storm — Not a Simple Decline
The 5–10 year transition (typically mid-40s) is characterised by erratic estrogen surges, not steady decline. Estrogen levels may be 20–30% HIGHER than premenopausal baseline in early transition as declining inhibin B removes pituitary suppression and FSH rises. Progesterone declines first as ovulation becomes inconsistent — creating relative estrogen dominance. "LOOP events" (Luteal Out-Of-Phase events, Santoro et al.) cause follicles to grow during the previous luteal phase, compressing and overlapping cycles. Up to 80% experience vasomotor symptoms. Mood disruption is driven by estrogen variability, not absolute level. Dr. Lisa Mosconi (Weill Cornell) demonstrated via PET imaging that perimenopausal women show decreased cerebral glucose metabolism — the brain is a primary estrogen target organ. This is not "just ageing." It's a specific, identifiable hormonal disruption with targeted solutions.
HRT: The WHI Study Was Flawed — Here's What the Evidence Actually Shows
The Women's Health Initiative ($725M, n=27,500) used oral conjugated equine estrogen + synthetic progestin in women averaging age 63 — 78% with pre-existing conditions. Participants started HRT >10 years after menopause (opposite of typical use), used synthetic hormones, administered orally. Critically underreported: the estrogen-only arm showed REDUCED breast cancer incidence and mortality. The "timing hypothesis" is now supported: starting HRT within 10 years of menopause onset may be cardioprotective. Transdermal estradiol shows NO increased VTE risk (RR ~1.0) vs oral estrogen's doubled risk. Micronized progesterone does not increase breast cancer risk for up to 5 years (Stute 2018), unlike synthetic MPA used in WHI. NAMS, ACOG, and the Endocrine Society all recommend HRT as the most effective therapy for menopausal symptoms in women under 60.
Iron Deficiency: Medicine's Most Overlooked Epidemic in Women
Affects 15–50% of active/exercising females (Parks 2017). Spanish cohort (322 women ages 20–50): 44.1% had iron deficiency WITHOUT anaemia. Lancet Haematology (2024) systematic review argued that historical ferritin reference intervals are confounded by including "apparently healthy" individuals with undiagnosed deficiency — structurally underdiagnosing the most affected population. Clinical threshold: ferritin <30 ng/mL identifies deficiency with high sensitivity; sports medicine experts advocate 50µg/L for optimal performance. Iron-deficient women present with: diffuse hair loss (55.9%), nail alterations (38.2%), pica (32.4%), restless legs (20.6%), alongside fatigue, brain fog, exercise intolerance. Treatment with ferrous sulfate for 8 weeks: ferritin increases correlate with reduced cognitive errors (r=−0.40, p=0.034). Your GP says your ferritin of 15 is "normal." It isn't.
Breast Health: Iodine, DIM, and Oestrogen Metabolism
Ghent et al. (1993, 1,365 women with fibrocystic breast disease over 4,813 woman-years): molecular iodine (I₂) — 75% of women reported symptom improvement and pain-free breasts. Japanese women consume ~25× more dietary iodine and have lower breast cancer rates. However, one study found iodine can stimulate ER-α signalling in breast cancer cells in vitro — nuance matters. DIM (diindolylmethane, 100–200mg/day) shifts estrogen metabolism from the pro-tumorigenic 16α-hydroxylation pathway toward the protective 2-hydroxylation pathway. Zeligs et al. (2020, 23 BRCA carriers, 100mg/day for 1 year): significant decreases in breast density by MRI. DIM is the primary active metabolite of I3C from cruciferous vegetables — pharmacokinetic data confirms DIM is the only detectable circulating product after oral I3C. Bioavailable (absorption-enhanced) form essential — Reed 2008 pharmacokinetics.
Hormonal Acne: The Insulin-Androgen Cascade Nobody Explains
The mechanism: insulin/IGF-1 stimulate ovarian androgen production while reducing SHBG → increased free testosterone → 5α-reductase converts to DHT at the skin → sebaceous gland stimulation → excess sebum → C. acnes proliferation → inflammation. Conventional dermatology prescribes retinoids and antibiotics. Functional approach targets the cascade upstream. Grant 2010 (RCT, n=42 PCOS women): spearmint tea twice daily significantly reduced androgen levels and improved skin. Berberine (500–1,000mg/day) acts as an insulin sensitiser comparable to metformin. Zinc (30mg/day, Brandt 2013): comparable to minocycline at 12 weeks with fewer side effects. DIM (100–200mg/day): shifts estrogen metabolism toward 2-OH pathway. Low-glycaemic diet (Smith 2007, n=43, 12 weeks): significant reduction in total lesion count and inflammatory lesions. The skin is downstream — treat the hormones and the insulin, not just the surface.
Your Menstrual Cycle Is a Vital Sign — ACOG Agrees
ACOG Committee Opinion No. 651 (2015, reaffirmed 2021) formally designates the menstrual cycle as a vital sign — alongside blood pressure, pulse, temperature, and respiration. Irregular cycles aren't just inconvenient. Nurses' Health Study (82,439 women): irregular cycles associated with CHD risk RR 1.67. UK Biobank (58,056 women, 11.8-year follow-up): irregular cycles carry 19% higher CVD risk, short cycles (≤21 days) carry 29% higher CVD risk. Cycle length outside 21–35 days, absent periods, heavy bleeding, and severe pain all signal underlying pathology — PCOS, thyroid dysfunction, hypothalamic amenorrhoea, endometriosis. Every woman should track cycle length, flow characteristics, and symptoms. An absent period is not a convenience — it's a red flag for bone density, cardiovascular health, and metabolic function. The cycle tells you more than most blood tests.
ADHD Subtypes: Different Neurochemistry, Different Treatment Needs
Three presentations: predominantly inattentive (ADHD-PI, most common in adults and females), predominantly hyperactive-impulsive, and combined (70% of childhood clinical cases). DSM-5 changed "subtypes" to "presentations" because Lahey et al. (2005, 8-year study): 37% of Combined and 50% of Inattentive children shifted presentations over time. Volkow et al. (2009, JAMA, PET study, 53 ADHD adults vs 44 controls): significantly lower DAT and D2/D3 receptor availability in the dopamine reward pathway. The 2010 secondary analysis directly linked D2/D3 receptors in the nucleus accumbens with motivation scores (r=0.39, p<0.008) — the first direct evidence connecting dopamine reward deficits with ADHD motivational impairment. Arnsten (2006) established the inverted U-shaped curve for prefrontal cortex catecholamine signalling — too little OR too much impairs executive function.
ADHD Nutritional Interventions: Iron, Omega-3, Zinc, and the Evidence
Iron is the most compelling finding. Konofal et al. (2004, Archives of Pediatrics): mean ferritin 23 ng/mL in ADHD children vs 44 ng/mL controls (p<0.001), 84% of ADHD children had ferritin <30 vs 18% controls. Follow-up RCT (Konofal 2008, n=23, 80mg ferrous sulfate/day, 12 weeks): significant ADHD symptom reduction (p<0.008). Mechanism: iron is cofactor for tyrosine hydroxylase — the rate-limiting enzyme in dopamine synthesis. Omega-3 EPA (Chang 2018, King's College London, meta-analysis, n=534): ADHD youth have lower EPA (g=−0.38). High-dose EPA 1.2g/day (RCT, n=92): improved focused attention — but ONLY in youth with lowest baseline EPA. Zinc: Bilici 2004 (n=400): benefits for hyperactivity, but Arnold 2011 (n=52 American children) FAILED to replicate — likely because US children have adequate zinc vs endemic deficiency in Middle Eastern populations.
ADHD in Women: 4 Million Undiagnosed and the Hormonal Connection
An estimated 4 million US women remain undiagnosed (Ellen Littman). The childhood diagnostic ratio of 2.4–4:1 boys-to-girls narrows substantially in adulthood. Girls present predominantly with inattentive symptoms and internalising patterns (anxiety, depression), developing sophisticated masking strategies that hide symptoms until demands exceed capacity. The hormonal mechanism: estrogen stimulates dopamine production, reduces reuptake, and inhibits degradation (Del Río 2018). Jacobs & D'Esposito (2011, Journal of Neuroscience, n=32): estradiol status impacts working memory via cortical dopamine modulation. ADHD symptoms worsen in the late luteal phase when estrogen drops. Perimenopause produces "ADHD squared" — exponential effect of declining estrogen on an already dopamine-deficient system. Patricia Quinn recommends tracking menstrual cycles alongside ADHD symptoms and adjusting stimulant doses accordingly.
ADHD and Sleep: 80% Have Sleep Disruption — and It Makes Everything Worse
Up to 80% of adults with ADHD have insomnia or sleep disturbances, and 73–78% have delayed sleep-wake cycles (Van Veen 2010). Dim-light melatonin onset is delayed by ~45 minutes in children and ~90 minutes in adults with ADHD. Van Andel et al. (2021 RCT, n=51 adults with ADHD and delayed sleep phase): melatonin 0.5mg/day advanced circadian timing by 1 hour 28 minutes and reduced ADHD symptoms by 14%. Combined with bright light therapy: advance reached nearly 2 hours. The bidirectional nature is critical: sleep deprivation produces symptoms functionally indistinguishable from ADHD. Lunsford-Avery et al. (2018) proposed that some late-onset ADHD may actually represent circadian misalignment. Protocol: low-dose melatonin (0.5–1mg) 3–4 hours before desired sleep, morning bright light (10,000 lux for 30 min), consistent wake time, screen curfew 2 hours before bed.
The ADHD Elimination Diet: 64% Responded in the Lancet Trial
The INCA elimination diet study (Pelsser et al. 2011, The Lancet): 64% of ADHD children on a restricted elimination diet showed ≥40% symptom improvement. The diet removed common trigger foods and reintroduced systematically. However, Phase 1 was open-label, and IgG blood testing did NOT predict which foods triggered relapse — meaning you cannot shortcut the elimination process with a blood test. Magnesium deficiency was found in 72% of ADHD children (El Baza Egyptian study), with Mg-B6 supplementation improving hyperactivity and school attention (Mousain-Bosc 2004, 2006). Magnesium L-threonate crosses the blood-brain barrier most effectively. Protein timing matters: front-loading protein at breakfast stabilises dopamine precursor delivery throughout the morning. The gut-brain axis in ADHD is emerging — altered Bifidobacterium with increased cyclohexadienyl dehydratase (phenylalanine synthesis enzyme) in ADHD microbiomes.
Cognitive Decline Is Not Inevitable: What Actually Works
Exercise produces the most robust evidence. Erickson et al. (2011, PNAS, n=120 adults 55–80): moderate-intensity aerobic walking 3x/week for one year produced a 2% increase in anterior hippocampal volume — reversing 1–2 years of age-related loss, with correlated increases in serum BDNF and spatial memory. VITACOG study (Smith 2010, n=168 adults >70 with MCI): high-dose B vitamins (folic acid 0.8mg + B12 0.5mg + B6 20mg daily) reduced brain atrophy rate by 29.6%. In those with elevated homocysteine (>13 µmol/L): 53% reduction. Douaud 2013 (PNAS): 7-fold reduction in grey matter atrophy in Alzheimer's-vulnerable regions. Critical interaction: Jernerén 2015 showed B vitamin effects were ONLY observed in subjects with high baseline omega-3 levels — the synergy is essential. DHA 900mg/day improved visuospatial memory equivalent to ~3 years younger (MIDAS, Yurko-Mauro 2010, n=485).
Sarcopenia: Losing 3–8% Muscle Per Decade — and How to Fight It
Muscle loss progresses at 3–8% per decade after age 30, accelerating sharply between 65–80, affecting 10–20% of those over 60 and up to 50% over 80. The RDA of 0.8g/kg/day is inadequate — PROT-AGE study group recommends 1.0–1.3g/kg/day for older adults, with 25–30g protein per meal. The leucine threshold is critical: elderly adults require ~2.5–3g leucine per meal to trigger muscle protein synthesis due to age-related "anabolic resistance." Wall et al. (2013): adding 2.5g free leucine to 20g casein restores the MPS response in elderly. Creatine monohydrate (3–5g/day) combined with resistance training improves lean mass and strength — but without exercise, creatine alone does not improve outcomes (Oliveira 2020). HMB (3g/day): anti-catabolic effects during disuse/bed rest. For the professional extending their career past 50 or 60: resistance training 2–3x/week is non-negotiable, not optional.
Joint Preservation After 50: What the Evidence Supports
The GAIT trial (Clegg 2006, NEJM, n=1,583): glucosamine HCl showed NO benefit over placebo in the overall cohort. Only the moderate-to-severe pain subgroup (n=354) showed benefit with combination glucosamine + chondroitin. The trial used glucosamine HCl — glucosamine sulfate has stronger European evidence. Hydrolysed collagen (10g/day): significant joint pain improvement in athletes (Clark 2008, n=147). UC-II (undenatured type II collagen, 40mg/day) outperformed glucosamine + chondroitin in Lugo et al. (2016, n=191). Bioavailable curcumin (1,500mg/day) matched ibuprofen for knee OA in Kuptniratsaikul (2014, n=367). The hierarchy of evidence for joint preservation: resistance training to strengthen surrounding musculature first, then collagen peptides, UC-II, and curcumin. Glucosamine only if moderate-to-severe and combined with chondroitin.
Vision Preservation: AREDS2, Lutein, and the Screen-Dependent Professional
AREDS2 (Chew 2013, n=4,203): lutein 10mg + zeaxanthin 2mg safely substitutes for beta-carotene in AMD prevention, with 18% further reduction in progression. These carotenoids form the macular pigment — a physical blue-light filter that declines with age, smoking, and obesity. Astaxanthin (6mg/day) shows modest benefits for eye strain and accommodative fatigue in Japanese studies (Nitta 2005, n=40): significant improvement across three visual parameters at 6mg/day, establishing the optimum dose for computer-related eye fatigue. For screen-dependent professionals: lutein 10mg + zeaxanthin 2mg + astaxanthin 6mg is the evidence-based stack. Blue-light filtering glasses remain controversial — the largest meta-analysis found limited evidence of benefit. The 20-20-20 rule (every 20 minutes, look 20 feet away, for 20 seconds) has more clinical support for digital eye strain than any supplement.
NAD+ Decline: The Central Driver of Ageing — and What We Can't Yet Prove
NAD+ levels fall to approximately half of youthful levels by middle age. Camacho-Pereira et al. (2016, Cell Metabolism, Eduardo Chini at Mayo Clinic): CD38 is the main enzyme responsible, with expression increasing 2.5–6× across tissues during ageing. CD38 also degrades NMN, potentially limiting precursor supplementation. NR (nicotinamide riboside) at 1,000mg/day raises blood NAD+ by ~60% (NIAGEN trial). NMN at 250mg/day improved muscle insulin sensitivity in Yoshino et al. (2021, Science, n=25 postmenopausal women with prediabetes). However: short-term human trials show minimal functional improvements in cognition, vascular function, or muscle. The translational gap remains wide. The honest assessment: raising NAD+ is easy to prove biochemically and extremely difficult to prove functionally in humans. Apigenin (CD38 inhibitor) may be more effective than precursor supplementation alone.
Resistance Training Reduces All-Cause Mortality by 15–21%
Momma et al. (2022, British Journal of Sports Medicine, 16 prospective cohort studies): 10–17% lower risk of all-cause mortality, CVD, cancer, and diabetes. Optimal dose: 30–60 minutes per week. Combined with aerobic exercise: 40% lower all-cause mortality and 46% lower cardiovascular mortality. Shailendra et al. (2022, American Journal of Preventive Medicine, 10 studies): 15% lower all-cause mortality, 19% lower CVD mortality, 14% lower cancer mortality. For depression: Gordon 2018 (JAMA Psychiatry, 33 RCTs, 1,877 participants) — moderate effect regardless of health status. Updated 2025 meta-analysis (29 RCTs, n=2,036): effect size −0.94 — nearly a full standard deviation. Maria Fiatarone Singh (JAMA 1990) demonstrated dramatic strength gains in nonagenarians. Age is never a contraindication. If resistance training were a drug, it would be the most prescribed medication in history.
Lactoferrin: Iron Regulation Through Inflammation, Not Just Supplementation
An 80 kDa iron-binding glycoprotein with ~30% iron saturation capacity. The pivotal insight from Paesano et al. (2010, two clinical trials): bovine lactoferrin (bLf) 100mg twice daily vs ferrous sulfate 520mg/day — bLf increased all haematological parameters (p<0.0001) while DECREASING serum IL-6 (p<0.0001) and increasing prohepcidin (p=0.0007). Ferrous sulfate did the opposite — it INCREASED IL-6 and decreased prohepcidin. This reveals lactoferrin's unique mechanism: it establishes iron homeostasis by modulating the IL-6/hepcidin axis, not merely supplying iron. Nappi 2009 (double-blind RCT, n=100 pregnant women): similar efficacy with significantly fewer GI side effects. Lactoferrin enhances NK cell activity via IL-18 and type I interferon production (Kuhara 2006). Shows in vitro activity against SARS-CoV-2 by blocking heparan sulfate proteoglycan attachment (Campione 2020). 200–600mg/day bovine lactoferrin, on empty stomach.
Colloidal Silver: The Evidence Supports Extreme Caution
The FDA's 1999 final ruling classified colloidal silver in OTC products as "not generally recognised as safe and effective." The critical distinction: silver demonstrates antimicrobial activity in test tubes but NO controlled clinical trials validate oral colloidal silver for treating any human condition. In vivo, protein binding, absorption limitations, and biological fluid inactivation prevent therapeutic tissue concentrations. Argyria (permanent blue-grey skin discolouration) requires a total oral dose of ~6g and is IRREVERSIBLE — not amenable to chelation. Case reports document renal failure (GFR 12 mL/min after 8 years of use), peripheral neuropathy, and serum silver levels 20–100× reference range. Most commercial products at maximum recommended doses exceed the EPA reference dose of 5µg/kg/day. The only legitimate applications — silver sulfadiazine wound dressings and silver-coated catheters — are FDA-regulated devices with entirely different evidence bases from oral supplements.
Astaxanthin: The Only Antioxidant That Spans the Entire Cell Membrane
Unique molecular structure: polar hydroxyl groups anchor in both hydrophilic membrane layers while the lipophilic polyene chain sits within the hydrophobic core — enabling simultaneous ROS scavenging across the ENTIRE cell membrane, unlike vitamin E (inner only) or vitamin C (outer only). Nishida 2007: singlet oxygen quenching 6,000× stronger than vitamin C, 800× stronger than CoQ10, 110× stronger than vitamin E. Clinical evidence: eyes — Nitta 2005 (n=40, 6mg/day for 4 weeks): significant improvement across three visual parameters. Skin — 16-week study (n=65 females, 6 or 12mg/day): maintained wrinkle parameters and moisture vs placebo deterioration. At 2mg/day for 8 weeks: plasma 8-OHdG (DNA damage marker) decreased 35.29%, CRP decreased 33.56%. Natural astaxanthin from Haematococcus pluvialis is 50× stronger in singlet oxygen quenching vs synthetic. Dosing: 4mg wellness, 6mg eyes/skin, 8–12mg performance.
Shilajit: Mitochondrial Electron Shuttle and Testosterone Enhancement
Primary bioactive: fulvic acid (40–85% by weight), acting as an electron shuttle that stimulates mitochondrial energy transfer. Dibenzo-α-pyrones (DBPs) stabilise CoQ10 in its active ubiquinol form — when co-administered with CoQ10, tissue levels exceeded CoQ10 supplementation alone (Ghosal et al.). Pandit et al. (2016, Andrologia, double-blind RCT, PrimaVie 500mg/day for 90 days): total testosterone increased 20.45%, free testosterone 19.14%, DHEAS 31.35% in healthy men aged 45–55 — with LH and FSH maintained (not suppressive). Biswas et al. (2010, n=28 oligospermic men, 200mg/day for 90 days): +61.4% total sperm count, +37.6% spermia, +23.5% testosterone (all p<0.001). Critical safety note: raw shilajit carries heavy metal contamination risk. Only purified, standardised extracts (≥50% fulvic acid, ≥0.3% DBPs) should be used. PrimaVie is the most-studied standardised form.
Spirulina and Chlorella: Legitimate Nutrient Density, Overstated Detox Claims
Spirulina has robust allergic rhinitis evidence: Cingi et al. (2008, double-blind RCT, n=150, 2,000mg/day for 6 months): significant improvement in all nasal symptoms vs placebo (p<0.001). Mao 2005: 32% reduction in cytokine IL-4. Nutrient density is genuine: 57–70% protein with complete amino acid profile, phycocyanin (unique anti-inflammatory pigment), GLA. For heavy metals: 58 preclinical studies demonstrate alleviative effects, but only 5 human clinical studies exist — all for arsenic exposure in Bangladesh. Chlorella binds heavy metals via its unique cell wall and intracellular metallothioneins. However, chlorella functions primarily as an intestinal binder preventing metal reabsorption — NOT an active systemic chelator. Important distinction from "detoxification" claims. Cracked cell wall form essential. Both carry contamination risks from open ponds and may stimulate immune function problematically in autoimmune conditions.
Apigenin: Preserves NAD+ by Inhibiting Its Primary Destroyer
The mechanistic case centres on CD38 inhibition. Escande & Chini et al. (2013, Diabetes): apigenin inhibits the NAD+ase CD38, with treated obese mice showing higher intracellular NAD+, improved glucose homeostasis. Camacho-Pereira et al. (2016): CD38 is responsible for 97% of NAD+ degradation and its expression increases 2.5–6× with ageing. A mouse study showed apigenin treatment nearly doubled liver NAD+ levels. Because CD38 also degrades NMN, apigenin may be more effective at raising NAD+ than precursor supplementation alone — it stops the drain rather than just filling the bath. For sleep: binds the benzodiazepine-binding site on GABA_A receptors, producing anxiolysis without sedation, tolerance, or dependency. The standard supplement dose of 50mg before bed is empirical, popularised by the longevity community rather than derived from clinical trials. The comprehensive Kramer & Johnson review (2024) noted long-term clinical trials are urgently needed. Bioavailability limited by poor water solubility.
Zone 2 Cardio: The Foundation of Metabolic Health
Exercise at or just below the first lactate threshold (blood lactate ~2 mmol/L), primarily recruiting Type I slow-twitch fibres. San-Millán & Brooks (2018, Sports Medicine): blood lactate accumulation is negatively correlated with fat oxidation and positively correlated with carbohydrate oxidation — establishing lactate as an indirect marker of mitochondrial function and metabolic flexibility. The 2022 follow-up: chronic lactate exposure decreases mitochondrial function by inhibiting fatty acid uptake, increasing ROS (p<0.001), and decreasing ATP production (p<0.05). Mechanism: PGC-1α activation — the master regulator of mitochondrial biogenesis — producing increased mitochondrial number and size, enhanced oxidative enzyme activity. Peter Attia prescribes 3–4 hours per week across 3–4 sessions, minimum 45–60 minutes each. Identification: lactate testing (gold standard), talk test (conversational but slightly laboured), or Maffetone's MAF method (heart rate = 180 − age).
Fascia: A Sensory Organ With 6–10× More Receptors Than Muscle
Robert Schleip's research at Ulm University established that fascia contains 6–10× more mechanoreceptors than muscle tissue. His 2003 paper (Journal of Bodywork and Movement Therapies) proposed that immediate tissue release during myofascial manipulation is neurologically mediated — stimulating intrafascial mechanoreceptors altering proprioceptive input — not purely mechanical. Foam rolling meta-analyses (Wilke 2020, 32 studies): large effect on range of motion (d=0.76) with no detrimental performance effects, though mechanisms remain debated. The fascia system functions as a body-wide sensory network communicating mechanical state to the nervous system. Fascial adhesions develop from immobility, repetitive strain, and inflammation — explaining why "tight" muscles often fail to respond to stretching alone. Tools: foam rolling, instrument-assisted soft tissue mobilisation, active release techniques. The distinction between mobilising fascia and stretching muscle is clinically meaningful.
Falls Kill More Seniors Than Car Accidents — These Interventions Prevent Them
Falls affect one-third of adults over 65 annually — leading cause of injury death in older adults. Tai Chi: Huang 2017 (meta-analysis, 10 trials, 2,850 participants): 30% reduced risk (OR 0.70). Chen 2023: 24-form simplified Tai Chi produced a 41% reduction (RR 0.59). The Otago Exercise Programme (17 strength and balance exercises, 3×/week): 35–40% fall reduction in frail older adults across 4 RCTs, deployed in 29+ countries. The most promising approach: perturbation-based reactive balance training — deliberately exposing people to unexpected balance challenges — shows 50–75% reductions in laboratory settings. The clinical hierarchy: resistance training (builds the strength to recover from stumbles), proprioception training (teaches the nervous system to detect instability earlier), and reactive training (practises the actual recovery response). For professionals wanting to extend their careers: fall prevention starts at 50, not 75.
Mobility vs Flexibility: Why Usable Range of Motion Matters More
The distinction is clinically meaningful. Flexibility: passive range of motion achieved through external forces. Mobility: usable, actively controlled ROM. Dr. Andreo Spina's Functional Range Conditioning (FRC) operationalises this through CARs (Controlled Articular Rotations), PAILs (Progressive Angular Isometric Loading), and RAILs (Regressive Angular Isometric Loading) — training the nervous system to produce force in lengthened positions while simultaneously adapting connective tissue. The Alexander Technique ATEAM trial (Little 2008, BMJ, n=579 chronic back pain): 24 lessons reduced pain days from 21 to just 3 per month, with 6 lessons plus exercise achieving ~70% of this effect. Static stretching under 60 seconds produces only trivial performance impairments (Behm 2016). The shift from passive flexibility to active mobility represents the future of joint preservation: if you can't control it, you can't protect it.
Facing surgery? Get the evidence package before you commit.
Published outcomes. Complication rates. Alternative approaches. The questions that reveal whether your surgeon is the right one. From £2,000.
Autoimmune Disease Requires Three Things — Remove One and the Process May Halt
Alessio Fasano's 2012 model (Clinical Reviews in Allergy & Immunology): autoimmunity requires (1) genetic predisposition, (2) environmental trigger, and (3) intestinal permeability. Remove the permeability and the antigenic load reaching the immune system drops below threshold. Zonulin — the only known physiological regulator of intestinal tight junctions — is upregulated by gliadin exposure in ALL humans, not just coeliacs (Drago et al., 2006, Scandinavian Journal of Gastroenterology). Molecular mimicry: Vojdani (2015, Autoimmunity Reviews) documented that wheat gliadin shares amino acid sequences with cerebellar peptides (Hashimoto's/neurological autoimmunity), aquaporin-4 (neuromyelitis optica), and synapsin (neurological dysfunction). Bystander activation, epitope spreading, and cross-reactivity expand the attack beyond the initial trigger. The question isn't whether gut permeability matters in autoimmunity — it's why most rheumatologists still ignore it.
Histamine Intolerance: When Fermented Foods Make Everything Worse
Estimated 1–3% of the population (Maintz & Novak, 2007, American Journal of Clinical Nutrition). Diamine oxidase (DAO) is the primary enzyme degrading ingested histamine in the gut. Genetic polymorphisms in AOC1 (the DAO gene) reduce activity. Competitive inhibitors: alcohol, certain medications (NSAIDs, some antibiotics, antidepressants), and gut dysbiosis all suppress DAO. Symptoms mimic allergy without true IgE activation: migraine, flushing, urticaria, tachycardia, nasal congestion, GI distress, anxiety. High-histamine foods: aged cheese, wine, fermented vegetables, cured meats, tinned fish, kombucha, bone broth. The trap: health-conscious people load up on "gut-healing" fermented foods and get dramatically worse. Serum DAO activity <10 U/mL suggests deficiency. DAO supplementation (Naturdao/DAOsin, 20,000 HDU before meals) has pilot RCT support (Yacoub 2018, n=28). Methylation status matters — undermethylation impairs histamine clearance via HNMT.
Mast Cell Activation Syndrome: When Your Immune System Won't Stop Firing
Mast cells release >200 mediators: histamine, tryptase, prostaglandins, leukotrienes, cytokines, heparin. In MCAS, mast cells degranulate inappropriately — triggered by heat, cold, stress, foods, chemicals, exercise, vibration. Molderings et al. (2011, PLOS ONE): estimated prevalence up to 17% of the German population for some degree of mast cell mediator release. Diagnosis: elevated serum tryptase (>11.4 ng/mL or >20% above baseline + 2 ng/mL during flare), 24-hour urinary N-methylhistamine, prostaglandin D2, or leukotriene E4. Management hierarchy: H1 + H2 antihistamines (cetirizine + famotidine), mast cell stabilisers (cromolyn sodium 200mg QID, ketotifen 1–2mg BID), leukotriene inhibitors (montelukast 10mg). Natural stabilisers: quercetin 500–1,000mg (Weng 2012: inhibits IL-6 and IL-8 from human mast cells), luteolin (Theoharides 2009: more potent than cromolyn in vitro). MCAS frequently co-occurs with Ehlers-Danlos syndrome and POTS — the triad is increasingly recognised.
Ehlers-Danlos Syndrome: The Condition That Takes a Decade to Diagnose
Mean diagnostic delay: 10–12 years (Tinkle et al., 2017, American Journal of Medical Genetics). Hypermobile EDS (hEDS) is the most common subtype — prevalence estimates revised upward to possibly 1 in 500. Defective collagen processing leads to joint hypermobility, chronic subluxations, tissue fragility, poor wound healing, and chronic pain. The triad: hEDS + MCAS + POTS (postural orthostatic tachycardia syndrome) — Cheung & Vadas (2015). Dysautonomia in hEDS: lax connective tissue fails to support blood vessels → venous pooling → compensatory tachycardia → fatigue, brain fog, exercise intolerance. Beighton score ≥5/9 suggests generalised hypermobility, but the 2017 International Criteria require additional systemic features. Management: physical therapy focused on proprioception and joint stabilisation (NOT stretching), cardiovascular reconditioning, salt/fluid loading for POTS, compression garments. These patients are systematically dismissed as "anxious" — the average patient sees 8+ specialists before diagnosis.
SIBO: When Bacteria Colonise the Wrong Part of Your Gut
Small intestine should contain <10³ CFU/mL — SIBO is defined as >10⁵ CFU/mL. Three types: hydrogen-dominant (diarrhoea-predominant), methane-dominant/IMO (constipation-predominant, now reclassified as intestinal methanogen overgrowth since archaea aren't bacteria), and hydrogen sulphide (recently identified by Pimentel's trio-smart breath test). Lactulose breath test: sensitivity 52–68%, specificity 44–86% — imperfect but best non-invasive option. Root causes: impaired migrating motor complex (MMC — the "cleansing wave" between meals, requires 90–120 minute fasting intervals), hypochlorhydria (PPI use increases SIBO risk 2–8×, Lo & Chan 2013, Clinical Gastroenterology and Hepatology), ileocecal valve dysfunction, post-infectious dysmotility (anti-vinculin/anti-CdtB antibodies). Treatment: rifaximin 550mg TID × 14 days (Target 3 trial: 40.7% vs 31.7% response in IBS-D). Methane: add neomycin or allicin. Herbal alternatives (Johns Hopkins, Chedid 2014): comparable to rifaximin using berberine, oregano, neem.
Long COVID: Microclots, Viral Persistence, and Mitochondrial Damage
Affects 10–30% of non-hospitalised infections (Davis et al., 2023, Nature Reviews Microbiology). Three leading mechanistic hypotheses: (1) Viral persistence — Swank et al. (2023, monocyte reservoir): spike protein detected in blood up to 15 months post-infection. (2) Microclots — Pretorius et al. (2021, Cardiovascular Diabetology): amyloid fibrin(ogen) microclots resistant to fibrinolysis found in long COVID plasma, trapping inflammatory molecules. (3) Mitochondrial dysfunction — Guarnieri et al. (2023): SARS-CoV-2 ORF3a and ORF10 directly inhibit Complex I, reducing oxidative phosphorylation. Overlapping features with ME/CFS suggest shared pathophysiology. Emerging interventions under investigation: triple anticoagulant therapy (Pretorius protocol), low-dose naltrexone (4.5mg, Bonilla 2023 pilot), nattokinase (fibrinolytic), stellate ganglion block for dysautonomia. No large RCTs completed — the RECOVER trial ($1.15B) has been criticised for design limitations. Test: D-dimer, fibrinogen, CRP, complement panels.
ME/CFS: A Mitochondrial and Immune Crisis, Not "Just Tired"
Myalgic encephalomyelitis/chronic fatigue syndrome: prevalence ~0.4–1% (836,000–2.5 million in the US, Bateman et al. 2021). Post-exertional malaise (PEM) — symptom worsening 24–72 hours after minimal exertion — is the cardinal feature distinguishing ME/CFS from depression or deconditioning. Fluge et al. (2016, JCI Insight): impaired pyruvate dehydrogenase function, forcing cells into amino acid catabolism for energy — explaining exercise intolerance at a metabolic level. Naviaux et al. (2016, PNAS): metabolomics revealed a hypometabolic "cell danger response" with >60 biochemical abnormalities — resembling hibernation. The mitochondrial support protocol with most published basis: CoQ10 200–300mg + NADH 10–20mg (Castro-Marrero 2015, n=73: significant reduction in fatigue and cognitive symptoms at 8 weeks), D-ribose 5g TID (Teitelbaum 2006: 61% improvement in energy), plus pacing as the foundation — graded exercise therapy was harmful enough that NICE removed it from UK guidelines in 2021.
Mould Illness and Mycotoxins: Legitimate Science Buried Under Controversy
25% of buildings have water damage. Mycotoxins — aflatoxins, ochratoxin A, trichothecenes, gliotoxin — are well-established toxicants in agriculture and occupational medicine. Ochratoxin A: classified as Group 2B carcinogen (IARC), nephrotoxic, immunosuppressive, crosses the blood-brain barrier. The controversy isn't whether mycotoxins are harmful (they demonstrably are) — it's whether indoor exposure at typical levels causes the chronic symptom pattern described as CIRS (Chronic Inflammatory Response Syndrome). Shoemaker's protocol (VCS testing, HLA-DR typing, C4a, TGF-β1, MMP-9, MSH) lacks large-scale validation but individual biomarkers are well-characterised. What IS well-established: urinary mycotoxin testing (RealTime Labs, Great Plains) has 85–90% analytical reliability. Binders: cholestyramine (Shoemaker's primary intervention), activated charcoal, bentonite clay, Saccharomyces boulardii. Remove exposure first — no binder protocol works if you're still living in the source.
Insulin Resistance: The Upstream Driver of Nearly Everything
Hyperinsulinaemia precedes type 2 diabetes by 10–20 years (Kraft 1975: 14,384 glucose tolerance tests — 75% of "normal" fasting glucose patients were hyperinsulinaemic when insulin was measured). Fasting glucose is the LAST biomarker to move. HOMA-IR (fasting insulin × fasting glucose ÷ 22.5): optimal <1.0, insulin resistant >2.5. Fasting insulin alone: optimal <5 mIU/L, concerning >8. Insulin resistance drives: PCOS (hyperandrogenism), NAFLD, cardiovascular disease (insulin damages endothelium directly), Alzheimer's ("type 3 diabetes" — de la Monte 2008), certain cancers (insulin/IGF-1 promote cell proliferation). CGM data from Levels Health (n=2,000+): "metabolically healthy" individuals spending 15–25% of their day above 140 mg/dL — a threshold that accelerates glycation, oxidative stress, and endothelial dysfunction. Test fasting insulin, not just glucose. The £15 test your GP won't order is the most important metabolic marker you have.
LDL Cholesterol Is a Poor Predictor — Here's What Actually Matters
Standard LDL-C measures cholesterol MASS, not particle NUMBER. Two people with identical LDL of 130 mg/dL can have wildly different cardiovascular risk depending on particle count and size. ApoB (one molecule per atherogenic lipoprotein) is the superior predictor — Sniderman et al. (2019, JAMA Cardiology meta-analysis, n=233,455): ApoB outperformed LDL-C and non-HDL-C for predicting cardiovascular events. Optimal: <80 mg/dL, ideal <60. Lp(a) — the genetic risk factor affecting 20% of the population — is an LDL particle with apolipoprotein(a) covalently bonded, making it pro-thrombotic AND atherogenic. Levels are 90% genetically determined — diet and statins don't significantly lower it. PCSK9 inhibitors reduce Lp(a) ~25%. The landmark Lp(a)HORIZON trial (pelacarsen antisense oligonucleotide) is ongoing. Triglyceride:HDL ratio <2.0 is a proxy for insulin sensitivity. Request: ApoB, Lp(a), fasting insulin, hsCRP. Standard lipid panels miss the most dangerous patterns.
Nitric Oxide Declines 75% by Age 70 — and Your Arteries Pay the Price
NO is the master vasodilator — produced by endothelial NOS (eNOS) from L-arginine, requiring BH4, FAD, and oxygen as cofactors. Production declines ~10–12% per decade from age 30. Taddei et al. (2001, Hypertension): endothelium-dependent vasodilation impaired by age 40 in men, accelerating post-menopause in women. Two production pathways: (1) L-arginine → NOS → NO (enzyme-dependent, impaired by oxidative stress/insulin resistance), (2) dietary nitrate → nitrite → NO (bacteria-dependent, occurs in mouth and stomach — mouthwash use disrupts this pathway, Kapil et al. 2013, Free Radical Biology & Medicine). Beetroot juice (500mL, ~6.4 mmol nitrate): Webb et al. (2008): reduced blood pressure by ~10/8 mmHg at 3 hours. Citrulline (3–6g/day) raises arginine more effectively than arginine itself (bypasses first-pass hepatic metabolism). Sunlight exposure triggers dermal NO release from nitrite stores (Oplander 2009) — one mechanism linking sun exposure to cardiovascular benefit independent of vitamin D.
Homocysteine: The Methylation Marker Linking Heart Disease, Dementia, and Depression
Homocysteine is a metabolic intermediate requiring B12, folate, and B6 to recycle. Elevated levels (>10 µmol/L) independently predict cardiovascular disease, stroke, dementia, and depression. Wald et al. (2002, BMJ meta-analysis): each 5 µmol/L increase → 32% higher IHD risk, 59% higher stroke risk. MTHFR C677T polymorphism (heterozygous: 40–50% of population; homozygous: 10–15%): reduces methylenetetrahydrofolate reductase activity 30–70%, impairing folate metabolism. Methylfolate (5-MTHF) bypasses the enzyme deficiency. The VITACOG trial (Smith 2010): high-dose B vitamins reduced brain atrophy 29.6% in MCI — but ONLY in those with elevated homocysteine AND adequate omega-3 status (Jernerén 2015). The interaction is critical: B vitamins without omega-3s showed minimal benefit. Target: homocysteine <8 µmol/L. Protocol: methylfolate 400–800µg, methylcobalamin 1,000µg, P5P (B6) 25–50mg, trimethylglycine (TMG) 500–1,000mg if still elevated.
Fasting Protocols: What the Evidence Supports at Each Duration
Time-restricted eating (TRE, 16:8): Wilkinson et al. (2020, Cell Metabolism, n=19 metabolic syndrome patients, 10-hour window): reduced body weight, waist circumference, blood pressure, and atherogenic lipids — maintained at 16-month follow-up. BUT the largest RCT (Lowe 2020, JAMA Internal Medicine, n=116): 16:8 TRE produced NO significant difference in weight loss vs control, with a concerning trend toward lean mass loss. Prolonged fasting (48–72h): autophagy activation peaks at 48–72 hours (Alirezaei 2010, Autophagy — measured in mouse neurons, human data extrapolated). Growth hormone surges 300–500% by day 2 (Ho 1988, JCEM). Valter Longo's Fasting-Mimicking Diet (FMD, 5 days at ~750 kcal/day monthly): Wei et al. (2017, Science Translational Medicine, n=100, 3 cycles): reduced BMI, blood pressure, fasting glucose, IGF-1, triglycerides, CRP. mTOR suppression begins at ~16–24 hours — the switch from growth to repair. Contraindicated: underweight, pregnant, type 1 diabetic, history of eating disorders.
The Seed Oil Debate: What the Evidence Actually Shows
Linoleic acid (LA, omega-6) consumption increased from ~2% to ~8% of calories over the 20th century — a 4× increase driven by soybean, corn, canola, and cottonseed oils. The biochemistry: LA is incorporated into cell membranes and oxidises readily, producing 4-HNE and other reactive aldehydes. Ramsden et al. (2016, BMJ, recovered data from the Minnesota Coronary Experiment, n=9,423): replacing saturated fat with LA-rich corn oil LOWERED cholesterol but showed no reduction in mortality — each 30 mg/dL decrease in cholesterol was associated with 22% HIGHER risk of death. The Sydney Diet Heart Study recovery (Ramsden 2013): same pattern — LA intervention group had higher all-cause and cardiovascular mortality. Counterpoint: Hooper 2020 Cochrane review (15 RCTs, 59,000 participants) found reducing saturated fat DID lower cardiovascular events by 17%. The nuance: it may not be omega-6 per se but the OXIDATION of industrial seed oils during high-heat processing that drives harm. Cook with: tallow, ghee, coconut oil, olive oil (low-medium heat). Avoid: deep-fried restaurant food where oils are reheated repeatedly.
HPA Axis Dysregulation: What "Adrenal Fatigue" Actually Is
"Adrenal fatigue" isn't a recognised diagnosis — but HPA axis dysregulation absolutely is. The hypothalamic-pituitary-adrenal axis can become maladapted through chronic stress: initially hypercortisolaemic (elevated cortisol, Cushing's-like pattern), then progressing to a blunted cortisol response. Fries et al. (2009, Psychoneuroendocrinology review): chronic stress produces a flattened diurnal cortisol slope — associated with higher inflammation, mortality, and metabolic dysfunction. The cortisol awakening response (CAR) — the 50–100% surge within 30 minutes of waking — is a reliable marker: blunted CAR predicts burnout, PTSD, and chronic fatigue. DUTCH test (dried urine) measures free cortisol, cortisone, and their metabolites across the diurnal curve — more informative than a single morning serum cortisol. The pregnenolone steal hypothesis (stress diverts pregnenolone toward cortisol at the expense of sex hormones) is mechanistically plausible but not definitively proven in humans. Interventions: phosphatidylserine 400–800mg (Monteleone 2004: blunted cortisol response to exercise stress), ashwagandha KSM-66 600mg (Salve 2019, n=58: significant cortisol reduction).
Glutathione: Your Body's Master Antioxidant — and How to Actually Raise It
The most abundant intracellular antioxidant (1–10 mM). Declines 8–12% per decade after age 20. Functions: Phase II conjugation of toxins, regeneration of vitamins C and E, immune cell proliferation (T-cell function requires adequate GSH), mitochondrial protection. Oral glutathione: Richie et al. (2015, European Journal of Nutrition, n=54, 6 months, 250–1,000mg/day): dose-dependent increases in blood GSH up to 35% — contradicting the old claim that oral glutathione is destroyed by digestion. Liposomal form: Sinha et al. (2018): raised body stores 40% over 30 days. N-acetylcysteine (NAC, 600–1,800mg/day): provides the rate-limiting cysteine for GSH synthesis. GlyNAC (glycine + NAC) — Sekhar et al. (2021, Clinical and Translational Medicine, RCT, n=24 older adults, 8 weeks): corrected glutathione deficiency, reduced oxidative stress, improved mitochondrial function, insulin resistance, endothelial function, inflammation, genomic damage, muscle strength, gait speed, exercise capacity, body composition, and waist circumference. The most comprehensively beneficial intervention in a single ageing RCT.
Sulforaphane: The Most Potent Natural NRF2 Activator Known
An isothiocyanate produced when glucoraphanin (in broccoli seeds/sprouts) contacts myrosinase (released by chewing/crushing). NRF2 activation upregulates >200 cytoprotective genes including glutathione synthesis, NAD(P)H:quinone oxidoreductase, and heme oxygenase-1. Shapiro et al. (2006, Cancer Epidemiology Biomarkers): broccoli sprouts contain 10–100× more glucoraphanin than mature broccoli. Egner et al. (2014, Cancer Prevention Research, n=291, Qidong China): broccoli sprout beverage increased urinary excretion of benzene by 61% and acrolein by 23% — demonstrating enhanced Phase II detoxification of airborne pollutants. Singh et al. (2014, PNAS): sulforaphane reversed behavioural abnormalities in autism models by inducing heat-shock proteins. The human RCT (Singh 2014, n=44 young men with ASD): significant improvements in social interaction and aberrant behaviour at 18 weeks, reversing after discontinuation. Dosing: 3-day-old broccoli sprouts (30g) or standardised supplement delivering 35–60mg sulforaphane. Mustard seed powder (myrosinase source) increases yield from supplements by 3–4×.
Quercetin: Senolytic, Mast Cell Stabiliser, and Zinc Ionophore
Triple mechanism of interest: (1) Senolytic — Zhu et al. (2015, Aging Cell): dasatinib + quercetin selectively cleared senescent cells in aged mice, improving cardiovascular function and extending healthspan. The first human senolytic trial (Hickson 2019, n=9 diabetic kidney disease): D+Q reduced senescent cell burden. (2) Mast cell stabilisation — Weng et al. (2012, PLOS ONE): quercetin inhibited IL-6 and IL-8 release from human mast cells at physiologically achievable concentrations. (3) Zinc ionophore — Dabbagh-Bazarbachi et al. (2014, Journal of Agricultural and Food Chemistry): quercetin transports zinc across lipid membranes into cells, raising intracellular zinc (relevant for immune function and viral replication inhibition). Bioavailability is quercetin's Achilles heel — 2–5% oral absorption. Phytosome form (Quercefit): 20× greater absorption (Riva 2019). Dosing: 500–1,000mg/day phytosome, or 1,000–2,000mg standard with fat. For senolytic protocols: intermittent pulsing (2–3 days/month) rather than daily.
Spermidine: The Autophagy Inducer Linked to 5-Year Mortality Reduction
A natural polyamine that declines with age. Eisenberg et al. (2009, Nature Cell Biology): spermidine induced autophagy and extended lifespan in yeast, flies, worms, and human immune cells. The Bruneck Study (Kiechl et al. 2018, American Journal of Clinical Nutrition, n=829, 20-year follow-up): highest tertile of dietary spermidine intake associated with significantly lower all-cause mortality — equivalent to a 5-year mortality reduction. The difference between top and bottom tertile: ~12mg vs ~8mg daily. Madeo et al. (2019, Science): spermidine supplementation in aged mice improved cardiac function and reduced cardiac hypertrophy, extended lifespan ~10%, and enhanced memory. The SmartAge trial (Wirth 2018, Cortex, n=30 older adults with subjective cognitive decline): spermidine 1.2mg/day for 3 months improved memory performance. Food sources: wheat germ (24mg/100g — richest source), aged cheese, mushrooms, soy products, legumes. Supplemental: 1–6mg/day. Mechanism: inhibits EP300 acetyltransferase, inducing autophagy through the same pathway as caloric restriction. One of the most promising longevity compounds with epidemiological, mechanistic, and early clinical support.
Taurine Deficiency as a Driver of Ageing: 10% Lifespan Extension in Mice
Singh et al. (2023, Science — one of the highest-impact longevity papers in years): taurine levels decline with age across species. Supplementation in middle-aged mice extended median lifespan by 10–12%, improved muscle strength, reduced cellular senescence, suppressed inflammation, increased bone mass, improved immune function, and reduced body fat. In monkeys: 6 months of supplementation improved bone density, fasting glucose, liver function, and immune markers. The epidemiological arm: lower taurine, hypotaurine, and N-acetyltaurine levels in humans were associated with higher BMI, hypertension, inflammation, and type 2 diabetes markers. Taurine is the most abundant free amino acid in the body (heart, retina, brain, muscle). Functions: bile acid conjugation, osmoregulation, calcium signalling, mitochondrial function, antioxidant defence. Conditional essentiality increases with age as biosynthesis from cysteine decreases. Dosing in mouse studies extrapolates to ~3–6g/day in humans — within the range used in energy drinks and clinical trials without adverse effects. Human longevity RCTs are needed, but the mechanistic breadth is remarkable.
Magnesium: Seven Forms, Vastly Different Applications
48–60% of adults are deficient (King 2005). Serum magnesium reflects <1% of total body stores — a normal serum level means nothing. RBC magnesium is slightly better; ionised magnesium or the magnesium loading test are most accurate. The forms: Threonate (Magtein) — the only form demonstrated to raise brain magnesium in animal studies (Slutsky et al. 2010, Neuron): enhanced learning, working memory, and short/long-term memory in aged rats by increasing synaptic density and NMDA receptor signalling. Dose: 1,000–2,000mg magnesium L-threonate (144–288mg elemental). Glycinate — high bioavailability, calming, minimal GI effects; 400–600mg elemental for sleep/anxiety. Taurate — cardiovascular preference; taurine and magnesium both support cardiac function. Citrate — decent absorption, osmotic laxative effect; useful for constipation. Malate — Krebs cycle intermediate, theoretical preference for fatigue/fibromyalgia. Oxide — 4% absorption, essentially an osmotic laxative, yet still the most-prescribed form. Orotate — European cardiology tradition, limited evidence. Never take one form for everything — stack based on target.
Glycine: The Amino Acid You're Almost Certainly Deficient In
Meléndez-Hevia et al. (2009, Annals of the New York Academy of Sciences): human biosynthesis of glycine falls ~10g/day short of metabolic demand. This deficit accelerates with age as collagen turnover increases and endogenous synthesis declines. Three distinct applications: (1) Sleep — Bannai et al. (2012, Sleep and Biological Rhythms, n=15, 3g before bed): improved subjective sleep quality, reduced sleep onset latency, and IMPROVED next-day cognitive performance without sedation. Mechanism: glycine lowers core body temperature by promoting vasodilation via NMDA receptors in the suprachiasmatic nucleus. (2) Collagen synthesis — glycine constitutes 33% of collagen (every third amino acid). Shaw et al. (2017, American Journal of Clinical Nutrition): 15g gelatin + vitamin C 60 minutes before exercise doubled collagen synthesis rate (measured by PINP biomarker). (3) Glutathione — glycine is one of three amino acids in glutathione; Sekhar's GlyNAC studies show glycine deficiency may be the limiting factor in age-related glutathione decline. Dosing: 3g for sleep, 10–15g for collagen/glutathione support.
Boron: The Forgotten Mineral That Modulates Hormones, Bones, and Inflammation
Naghii et al. (2011, Journal of Trace Elements in Medicine and Biology, n=8 healthy men, 10mg/day for 7 days): free testosterone increased 28.3%, free estradiol decreased 39%, DHEA increased, CRP decreased 50%, TNF-α decreased. Meacham et al. (1994, Environmental Health Perspectives review): boron supplementation prevented calcium and magnesium urinary losses in postmenopausal women, improved vitamin D metabolism, and enhanced cognitive function (reaction time, manual dexterity). The vitamin D connection: boron inhibits 24-hydroxylase (the enzyme that inactivates 25(OH)D), effectively extending vitamin D half-life. Hegsted et al. (1991): boron-deprived postmenopausal women excreted 44% more calcium and 30% more magnesium than supplemented women. This means: if you're supplementing D3, calcium, and magnesium but not boron, you may be losing what you're taking in. Dietary sources: raisins, prunes, avocados, nuts. Supplemental: 3–10mg/day as boron glycinate or calcium fructoborate. Upper tolerable limit: 20mg/day. Possibly the most underappreciated trace mineral in clinical nutrition.
Low-Dose Lithium: Neuroprotection at a Fraction of Psychiatric Doses
Psychiatric lithium: 600–1,800mg lithium carbonate daily (serum levels 0.6–1.2 mmol/L). Nutritional lithium: 5–20mg lithium orotate daily (no measurable serum impact). The ecological evidence is striking: Schrauzer & Shrestha (1990, Biological Trace Element Research): Texas counties with higher lithium in drinking water had significantly lower suicide, homicide, and rape rates. Replicated in Japan (Ohgami 2009, British Journal of Psychiatry, n=18 municipalities): inverse correlation between tap water lithium and suicide rates. Nunes et al. (2013): systematic review of 9 ecological studies — consistent inverse association. Mechanism: lithium inhibits GSK-3β (glycogen synthase kinase-3), a pro-apoptotic enzyme. This increases BDNF, promotes neurogenesis, and preserves grey matter volume. Forlenza et al. (2011, British Journal of Psychiatry, RCT, n=45 MCI patients, lithium 150µg/day for 15 months): stabilised cognitive decline and reduced CSF phospho-tau vs placebo. 5mg lithium orotate provides ~0.4mg elemental lithium — ~1/300th of a psychiatric dose. No monitoring required at nutritional doses.
Sauna Use: 40% Reduction in All-Cause Mortality at 4–7 Sessions/Week
The KIHD study (Laukkanen et al. 2015, JAMA Internal Medicine, n=2,315 Finnish men, 20-year follow-up): 4–7 sauna sessions/week vs 1 session → 40% lower all-cause mortality, 50% lower cardiovascular mortality, 65% lower risk of sudden cardiac death. Dose-response: more sessions, longer duration (>19 minutes), and higher temperature (>80°C) all independently predicted benefit. Mechanism: heat shock proteins (HSP70, HSP90) — Krause et al. (2015): 30 minutes at 73°C increased HSP72 by 49%. HSPs function as molecular chaperones, refolding damaged proteins and enhancing immune surveillance. Hannuksela & Ellahham (2001): sauna produces haemodynamic changes equivalent to moderate exercise — heart rate 100–150 BPM, cardiac output increases 60–70%. Infrared sauna: Beever (2009, Canadian Journal of Diabetes, n=9 T2DM): improved endothelial function. Hussain & Cohen (2018): infrared sauna improved exercise tolerance and reduced pain in chronic pain patients. Protocol: 20–30 minutes at 80–100°C (traditional) or 45–60 minutes at 55–65°C (infrared), 3–7× per week.
Cold Exposure: Dopamine, Brown Fat, and What the Research Supports
Srámek et al. (2000, European Journal of Applied Physiology): 1 hour of cold water immersion at 14°C increased plasma norepinephrine by 530% and dopamine by 250%. Unlike caffeine, the dopamine elevation from cold exposure is gradual, sustained (lasting 2–3 hours), and does not produce a crash. The Søberg protocol (Dr. Susanna Søberg, Cell Reports Medicine 2022): cold exposure totalling 11 minutes per week across 2–3 sessions increased brown adipose tissue activation and metabolic rate. End on cold — not hot — to maintain the thermogenic afterburn. Brown fat: metabolically active tissue that burns glucose and fatty acids to generate heat. PET-CT studies show cold-exposed adults can activate 50–100g of brown fat, increasing resting energy expenditure by 80–400 kcal/day. The Wim Hof Method adds hyperventilation breathing — Kox et al. (2014, PNAS, n=24): trained subjects showed attenuated immune response to endotoxin challenge, demonstrating voluntary influence over the innate immune system. Protocol: 1–3 minutes at 10–15°C, 2–4×/week. Cold after resistance training may blunt hypertrophy (Roberts 2015) — separate by 6+ hours.
Red Light Therapy: Photobiomodulation With Genuine Mechanistic Basis
Mechanism: photons at 630–670nm (red) and 810–850nm (near-infrared) are absorbed by cytochrome c oxidase (Complex IV) in the mitochondrial electron transport chain, displacing nitric oxide that inhibits the enzyme → increased electron flow → increased ATP production → reduced oxidative stress. Hamblin (2017, BBA Clinical comprehensive review): >4,000 published papers documenting effects on wound healing, pain reduction, inflammation, and neurodegeneration. Specific evidence: thyroid — Höfling et al. (2013, n=43 Hashimoto's patients): LLLT reduced TPO antibodies significantly, with 47% of patients able to discontinue levothyroxine at 9-month follow-up. Joints — Bjordal et al. (2003, Australian Journal of Physiotherapy, meta-analysis): significant reduction in joint pain and morning stiffness in RA. Skin — Wunsch & Matuschka (2014, RCT, n=136): 633nm significantly improved wrinkle severity, skin roughness, and collagen density at 30 sessions. Hair — Lanzafame et al. (2013, RCT, n=44): 655nm LED produced 39% increase in hair growth vs sham. Parameters matter enormously: 3–50 J/cm² dose, 5–20 minute sessions, device distance critical. Biphasic dose response — too much inhibits rather than stimulates.
Vagal Tone: Measuring and Improving Your Parasympathetic Capacity
The vagus nerve carries 80% of parasympathetic signalling. Low vagal tone (measured by heart rate variability, HRV) predicts cardiovascular events, inflammatory conditions, depression, and all-cause mortality. Thayer & Lane (2007, Neuroscience & Biobehavioral Reviews): HRV reflects prefrontal cortical regulation of subcortical threat responses — low HRV indicates the brain is stuck in "threat detection" mode. Tracey (2002, Nature): the "inflammatory reflex" — vagal efferents inhibit TNF-α production via the cholinergic anti-inflammatory pathway, reduced by 75% in animal models of sepsis. Interventions with published support: slow breathing (5.5 breaths/minute, Bernardi 2001): maximises respiratory sinus arrhythmia, improving HRV within a single session. Cold face immersion: triggers the diving reflex, acutely increasing vagal tone (Khurana & Wu 2006). Gargling/singing: mechanically stimulate the pharyngeal branch. Transcutaneous vagus nerve stimulation (taVNS, tragus of ear): Stavrakis et al. (2020, JACC, n=53 atrial fibrillation): reduced AF burden significantly. HRV biofeedback: Lehrer (2013, Applied Psychophysiology and Biofeedback): meta-analysis supports efficacy for anxiety, depression, insomnia, and chronic pain.
Breathwork: CO₂ Tolerance, Nasal Breathing, and the Bohr Effect
The Bohr effect (1904): haemoglobin releases oxygen to tissues in proportion to local CO₂ concentration. Chronic hyperventilation (overbreathing) lowers CO₂ → haemoglobin holds oxygen more tightly → tissues become relatively hypoxic despite normal SpO₂. Buteyko's control pause test: comfortable breath-hold after normal exhalation — <25 seconds suggests chronic hyperventilation. Normal: 40+ seconds. Nasal breathing: Patrick McKeown (The Oxygen Advantage) and James Nestor (Breath): nasal breathing produces nitric oxide (humming increases NO 15-fold, Weitzberg & Lundberg 2002), filters and humidifies air, provides 50% more airflow resistance (training respiratory muscles), and activates the parasympathetic system. Mouth taping at night: Sano et al. (2022, pilot): reduced AHI scores in mild OSA. Wim Hof/Tummo breathing (cyclic hyperventilation + breath holds): temporarily suppresses the immune response — Kox et al. 2014 demonstrated this rigorously. Box breathing (4-4-4-4): widely used by military for acute stress management. CO₂ tolerance training: extend exhale holds progressively to improve chemo-receptor sensitivity and reduce baseline respiratory rate.
Grounding: Plausible Mechanism, Preliminary Evidence, No Large Trials
The hypothesis: direct physical contact with the Earth's surface transfers free electrons into the body, neutralising reactive oxygen species. The Earth's surface carries a net negative charge (~−100V relative to the ionosphere). Oschman et al. (2015, Journal of Inflammation Research review): outlined the electron transfer mechanism and anti-inflammatory potential. Published evidence: Ghaly & Teplitz (2004): grounded sleep normalised cortisol profiles and improved sleep quality (n=12, unblinded). Chevalier et al. (2013, Journal of Alternative and Complementary Medicine): 2 hours of grounding reduced blood viscosity (zeta potential) — a cardiovascular risk factor. Brown et al. (2015): grounding decreased RBC aggregation. Sinatra et al. (2017): pilot showed grounding improved HRV. The honest assessment: the mechanism (electron transfer reducing oxidative free radicals) is physically sound. The clinical evidence is uniformly small-sample, often unblinded, frequently authored by the same group, and there are no large RCTs. It costs nothing — walk barefoot on grass for 20–30 minutes. But the therapeutic claims currently outpace the evidence by a wide margin.
Molecular Hydrogen: Selective Antioxidant or Expensive Water?
Ohsawa et al. (2007, Nature Medicine): molecular hydrogen (H₂) selectively neutralised hydroxyl radicals (the most damaging ROS) and peroxynitrite without scavenging superoxide or hydrogen peroxide (which serve signalling functions). This selectivity is the theoretical advantage over conventional antioxidants. Since 2007: >2,000 published papers and >100 human clinical studies across diverse conditions. Sim et al. (2020, n=60 healthy adults): H₂-rich water reduced 8-OHdG (DNA damage marker) and improved antioxidant capacity. Kajiyama et al. (2008, n=30 T2DM patients): improved lipid and glucose metabolism. Ishibashi et al. (2012, n=20 RA patients): 4 weeks of H₂-rich water (4–5 ppm) improved DAS28 disease activity scores significantly. Mechanism likely extends beyond direct antioxidant action: H₂ activates NRF2, modulates NF-κB, and influences cell signalling at concentrations too low for stoichiometric radical scavenging. Delivery: hydrogen tablets (most practical, 1–3 ppm), hydrogen inhalation (2–4% H₂ gas, used clinically in Japan), or electrolytic generators. The evidence base is growing but most studies remain small and short-duration.
Conventional vs Optimal Lab Ranges: Why "Normal" Isn't Normal
Lab reference ranges are statistical constructs — typically the middle 95% of the tested population. If the population is unhealthy, "normal" includes pathology. Examples: TSH reference range typically 0.5–4.5 mIU/L. But Wartofsky & Dickey (2005, JCEM): argued for an upper limit of 2.5 based on NHANES III data excluding thyroid-antibody-positive individuals. Ferritin "normal" range: 12–300 ng/mL for men — a range wide enough to include both iron deficiency and haemochromatosis. Optimal: 50–150. Fasting insulin: most labs don't flag until >25 mIU/L (frank insulin resistance). Optimal: <5 mIU/L. Vitamin D: "sufficient" at 30 ng/mL, but Holick (2007) and Heaney (2003) argue 40–60 ng/mL optimises calcium absorption and parathyroid suppression. HbA1c: "normal" at <5.7%, but continuous glucose monitoring reveals that 5.5% already involves significant glycaemic variability. The functional medicine approach: narrow the ranges based on outcome data, not population statistics. The essential panel nobody orders together: fasting insulin, ApoB, Lp(a), hsCRP, ferritin, homocysteine, full thyroid (TSH/fT3/fT4/rT3/antibodies), RBC magnesium, omega-3 index, vitamin D.
Natural Testosterone Optimisation: What Works Beyond the Supplement Hype
Foundation first: Leproult & Van Cauter (2011, JAMA): 1 week of 5 hours/night sleep reduced testosterone 10–15% — equivalent to 10–15 years of ageing. Pilz et al. (2011, Hormone and Metabolic Research): vitamin D supplementation (3,332 IU/day for 1 year) increased testosterone by 25% in deficient men. Resistance training acutely elevates testosterone — heavy compound movements (squat, deadlift) at 70–85% 1RM produce the largest response (Kraemer & Ratamess 2005). Body composition: every 1-point BMI increase above normal is associated with 2% decrease in testosterone (MacDonald 2010). Tongkat Ali (Eurycoma longifolia): Talbott 2013 (n=63, 200mg/day for 4 weeks) — cortisol decreased 16%, testosterone increased 37% in stressed adults. Fadogia agrestis: widely promoted but based on a SINGLE rat study (Yakubu 2005, n=6 per group) showing testicular toxicity at the highest dose — the lack of human evidence and potential for organ toxicity makes current recommendations irresponsible. Ashwagandha KSM-66 (600mg/day, Lopresti 2019, n=57): 15% increase in testosterone, 18% increase in DHEA-S. Priority order: sleep, body composition, resistance training, vitamin D/zinc repletion — THEN consider botanicals.
Estrogen Dominance: Real Pattern, Misleading Name
The term is imprecise but the physiology is real. Estrogen dominance refers to the RATIO of estrogen to progesterone, not absolute estrogen levels. Causes: anovulatory cycles (no corpus luteum → no progesterone), perimenopause (progesterone declines first), xenoestrogen exposure (BPA, phthalates, parabens), impaired hepatic estrogen clearance, gut dysbiosis (beta-glucuronidase-producing bacteria deconjugate estrogen in the gut, allowing reabsorption — the "estrobolome," Baker 2017). Clinical presentation: heavy periods, breast tenderness, fibroids, endometriosis, PMS, weight gain at hips/thighs, mood instability, insomnia in the luteal phase. Assessment: Day 19–21 serum progesterone (should be >10 ng/mL to confirm ovulation), DUTCH test for estrogen metabolites (2-OH:16α-OH ratio — higher 2-OH is protective). Interventions: DIM 100–200mg (shifts metabolism toward 2-hydroxylation), calcium D-glucarate 1,500–3,000mg (inhibits beta-glucuronidase), sulforaphane (enhances Phase II conjugation), vitex/chasteberry 20–40mg (Schellenberg 2001, BMJ RCT, n=170: superior to placebo for PMS). Address the source: liver support, gut health, xenoestrogen avoidance.
PCOS: An Insulin Problem Disguised as a Hormonal One
Affects 8–13% of reproductive-age women — the most common endocrine disorder. 2023 International Evidence-Based Guidelines: PCOS is now diagnosed with 2 of 3 Rotterdam criteria (oligo/anovulation, hyperandrogenism, polycystic ovarian morphology on ultrasound) — but AMH >5.0 ng/mL can replace ultrasound for diagnosis. The insulin connection: 50–80% of women with PCOS have insulin resistance regardless of BMI (Dunaif 1997). Hyperinsulinaemia stimulates ovarian theca cells to produce excess androgens AND reduces SHBG, amplifying free testosterone. Metformin 1,500–2,000mg/day: reduces fasting insulin ~25%, improves ovulation — but GI side effects limit compliance. Myo-inositol 4g/day + D-chiro-inositol 0.1g (40:1 ratio): Facchinetti 2015 meta-analysis — improved insulin sensitivity, reduced androgens, restored ovulation, comparable to metformin with fewer side effects. Berberine 500mg TID: Wei 2012 (n=89 PCOS) — comparable to metformin for insulin resistance, superior for lipid reduction. Spearmint tea: reduces androgens (Grant 2010). Ovasitol is the most-studied commercial inositol product. Address insulin FIRST — the hormonal cascade follows.
Endometriosis: A Systemic Inflammatory Disease, Not "Just Bad Periods"
Affects ~10% of reproductive-age women — 190 million globally. Mean diagnostic delay: 7–10 years (Ballard 2006, Fertility and Sterility). Endometriosis is NOT simply endometrial tissue outside the uterus — lesions contain distinct tissue with their own estrogen synthesis (local aromatase expression), immune dysfunction, and neuroangiogenic properties. Sampson's retrograde menstruation theory explains access but not why — 90% of women have retrograde menstruation, yet only 10% develop endometriosis. The immune surveillance failure is the distinguishing factor. Revised ASRM classification (2021): stages I–IV, but staging correlates POORLY with pain severity — Stage I disease can cause more pain than Stage IV. Gold standard treatment: excision surgery by a specialist — not ablation (which burns the surface leaving disease at depth). Rizk et al. (2021): excision reduces pain recurrence by 50% compared to ablation. Anti-inflammatory management: NAC (1,200mg/day, Porpora 2013, n=92: reduced endometrioma size), omega-3 (Missmer 2010, n=70,709 Nurses' Health Study: highest omega-3 intake = 22% lower risk), resveratrol (inhibits aromatase and NF-κB in endometriotic stromal cells in vitro). The contraceptive pill suppresses but does not treat — disease progresses silently.
Prostate Health: What Every Man Over 40 Should Actually Know
BPH (benign prostatic hyperplasia) affects 50% of men by age 50 and 80% by age 80. The mechanism: intraprostatic DHT conversion by 5α-reductase type 2 drives stromal and epithelial proliferation. PSA: a screening tool, not a diagnosis — elevated PSA has a 75% false-positive rate for cancer (US Preventive Services Task Force). PSA velocity (rate of change) is more informative than absolute level. Finasteride/dutasteride: reduce prostate volume 20–30% but carry sexual side effects in 3–16% of users. "Post-finasteride syndrome" is reported but not universally accepted. Saw palmetto (Serenoa repens, 320mg/day): the STEP trial (Bent 2006, NEJM, n=225) found NO benefit over placebo — contradicting earlier positive European studies. Beta-sitosterol (130mg/day): Wilt 1999 Cochrane review — improved urinary symptom scores and flow rates. Lycopene (15mg/day): Chen 2015 meta-analysis (17 studies): 12% reduced risk of prostate cancer. Zinc concentrates in prostate tissue at 10× serum levels — chronic deficiency increases BPH risk. Pygeum (Prunus africana, 100mg/day): Ishani 2000 meta-analysis — moderate improvements in urinary symptoms.
Oral Health Drives Systemic Disease — The Evidence Is Now Overwhelming
Periodontitis affects 47% of adults over 30 (Eke 2012, CDC). The mouth houses 700+ bacterial species in the second most diverse microbiome after the gut. Periodontal bacteria enter the bloodstream daily — Forner et al. (2006): 23% of subjects had bacteraemia after simply chewing food. Porphyromonas gingivalis: Dominy et al. (2019, Science Advances): found in 96% of Alzheimer's brain samples, along with its toxic proteases (gingipains). P. gingivalis gingipain inhibitor (COR388/atuzaginstat): entered Phase 2/3 clinical trial for Alzheimer's. Cardiovascular: Sanz et al. (2020, Journal of Clinical Periodontology): periodontal treatment reduced hsCRP by 0.50 mg/L — comparable to statin anti-inflammatory effects. Meta-analysis (Humphrey 2008): periodontitis increased CHD risk by 24–35%. Mercury amalgam fillings: Richardson et al. (2011): 67% of mercury body burden in amalgam bearers from dental sources — but FDA and WHO maintain safety at current exposure levels. The oral microbiome influences: nitric oxide production (critical for blood pressure), nutrient absorption, immune education, and systemic inflammation. Antiseptic mouthwash destroys beneficial nitrate-reducing bacteria — Kapil 2013: chlorhexidine mouthwash INCREASED blood pressure.
Lyme Disease: The Controversy Over Chronic Infection and Persistent Symptoms
Borrelia burgdorferi (US) and B. afzelii/garinii (Europe) transmitted via Ixodes tick bites. The bull's-eye rash (erythema migrans) occurs in only 70–80% of confirmed cases — its absence does not exclude infection. Two-tier testing (ELISA + Western Blot): sensitivity as low as 29–40% in early infection (Wormser 2008). The medical divide: IDSA (Infectious Diseases Society of America) maintains that 2–4 weeks of doxycycline eradicates infection, with subsequent symptoms being "post-treatment Lyme disease syndrome" (autoimmune). ILADS (International Lyme and Associated Diseases Society) cites evidence of persistent infection: Embers et al. (2012, PLOS ONE): intact spirochetes found in primates 12 months after antibiotic treatment. Hodzic et al. (2008): Borrelia DNA persisted in mice after aggressive antibiotic therapy. Biofilm formation: Sapi et al. (2012): Borrelia forms biofilms in vitro that are 1,000× more resistant to doxycycline than planktonic forms. Coinfections (Babesia, Bartonella, Ehrlichia, Anaplasma) confound treatment — test for these independently. The reality: both extremes are likely wrong. Persistent symptoms are real, and oversimplified treatment guidelines fail complex patients.
Electrolytes: Why Low-Carb and Active People Are Chronically Depleted
Insulin promotes renal sodium retention. When insulin drops (low-carb, fasting, or simply not eating frequently), the kidneys excrete sodium — taking water, potassium, and magnesium with it. Volek & Phinney: the "keto flu" is largely electrolyte depletion, not carbohydrate withdrawal. Exercise compounds losses: Montain 2007 — sweat sodium concentration ranges 200–1,600 mg/L depending on fitness, acclimatisation, and genetics. Hyponatraemia (overhydration with plain water) kills ~14 marathon runners annually — more than dehydration. The fear of sodium is based on population-level data (DASH-Sodium trial) that may not apply to metabolically healthy, active individuals. Mente et al. (2018, Lancet, n=95,767, PURE study): cardiovascular risk was J-shaped — lowest risk at 3–5g sodium/day (equivalent to 7.5–12.5g salt), with risk INCREASING below 3g/day. Potassium: 97% of Americans don't meet the 4,700mg/day adequate intake. Magnesium: discussed separately. Protocol for active/low-carb: 4,000–6,000mg sodium, 3,500–4,700mg potassium, 400–600mg magnesium daily. LMNT, Drip Drop, or DIY (½ tsp salt + ¼ tsp potassium chloride per litre).
BPC-157: The Gut-Derived Peptide With Extraordinary Healing Data — All From Rodents
A 15-amino-acid peptide derived from human gastric juice. Sikiric et al. (>100 published papers from University of Zagreb): demonstrated accelerated healing of tendons, ligaments, muscles, bones, skin, corneas, intestinal anastomoses, and fistulas — in rats. Mechanism: upregulates VEGF, EGF, and NO production, promoting angiogenesis and granulation tissue formation. The GI evidence: reversed NSAID-induced gut damage, alcohol-induced lesions, IBD models, and fistulas. Chang et al. (2011): protected against cytokine-mediated intestinal damage. The critical caveat: NO human clinical trials exist. All evidence is preclinical. The peptide community uses 250–500µg once or twice daily (subcutaneous or oral) based on animal dose extrapolation. Oral bioavailability (BPC-157 is acid-stable, unlike most peptides) makes it unique — the gastric juice origin means it naturally survives stomach acid. The FDA issued warning letters to companies selling it in 2023, classifying it as an unapproved drug. Biologically compelling. Clinically unproven in humans. Use at your own risk with full awareness of the evidence gap.
GHK-Cu: The Copper Peptide That Modulates 4,000+ Genes
A naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) with high copper affinity. Circulating levels decline from ~200 ng/mL at age 20 to ~80 ng/mL by age 60 (Pickart 2008). The gene expression data is extraordinary: Hong et al. (2010, Gene Expression Omnibus): GHK-Cu modulated 4,048 genes — 31.2% of the human genome — resetting gene expression patterns toward a healthier profile. Specifically: upregulated collagen synthesis, DNA repair enzymes, antioxidant genes, ubiquitin/proteasome system; downregulated inflammatory mediators, fibrinogen, and insulin signalling disruptions. Topical evidence: Leyden et al. (2002, n=71): GHK-Cu cream significantly improved skin laxity, clarity, and firmness vs vitamin C and retinoic acid. Finkley et al. (2005): increased collagen in photoaged skin. Wound healing: Mulder et al. (1994, Archives of Facial Plastic Surgery): accelerated diabetic wound closure. Subcutaneous/injectable use: explored for systemic anti-ageing effects but human trials limited to topical. The breadth of gene modulation suggests GHK-Cu is less a "skin peptide" and more a fundamental tissue-maintenance signal that declines with age.
Thymosin Alpha-1: The Immune Modulator Approved in 35 Countries
A 28-amino-acid peptide originally isolated from thymic tissue. Approved as Zadaxin in 35+ countries for hepatitis B, hepatitis C, and as an immune adjunct in cancer (NOT approved in US/UK). Mechanism: activates dendritic cells via TLR9, enhances NK cell cytotoxicity, promotes T-cell maturation and differentiation (particularly CD4+/CD8+ T-cells), and modulates cytokine balance. Garaci et al. (2003, International Journal of Immunopharmacology): comprehensive review of clinical trials — improved immune response in HBV, HCV, HIV, and cancer immunotherapy. Li et al. (2021, meta-analysis): Tα1 combined with standard treatment improved overall survival in hepatocellular carcinoma. Dosing in clinical trials: 1.6mg subcutaneous twice weekly. The immune modulation — NOT stimulation — distinction matters: Tα1 upregulates suppressed immune function without triggering autoimmune activation in clinical observations. COVID-19: retrospective studies (Liu 2020, n=76 critical patients): Tα1 reduced mortality from 30% to 11%, increased CD8+ and CD4+ counts. Available from compounding pharmacies in the US/UK (as a research peptide). One of the most well-characterised immune peptides with a genuine regulatory approval history.
Resveratrol: From Red Wine Hype to Clinical Disappointment — What Remains
The poster child for longevity hype and scientific recalibration. Howitz et al. (2003, Nature): resveratrol activated SIRT1 in vitro, extending yeast lifespan by 70%. Baur et al. (2006, Nature): protected mice on high-fat diets from metabolic disease and extended lifespan. Then reality: Pacholec et al. (2010, JBC): the original SIRT1 activation was an artefact of the fluorescent assay — resveratrol didn't directly activate SIRT1 in vivo at achievable concentrations. Bioavailability: oral resveratrol undergoes extensive first-pass metabolism — peak plasma levels of free resveratrol reach only 1–5% of ingested dose (Walle 2011). Human trials: mixed. Timmers et al. (2011, n=11 obese men, 150mg/day for 30 days): improved mitochondrial function and metabolic profile. But larger trials (Poulsen 2013, n=24 obese men, 500mg/day): no significant effects on insulin sensitivity or inflammation. What remains: modest anti-inflammatory effects, potential cardiovascular benefits at 150–500mg/day, and combination benefits (resveratrol enhances NMN efficacy in mouse models). Pterostilbene: a methylated analogue with 4× greater bioavailability and longer half-life — may be the more practical choice.
Telomeres and Epigenetic Clocks: Two Ways to Measure Biological Age
Telomeres: repetitive DNA caps (TTAGGG)n that shorten with each cell division. When critically short (~5 kb), cells enter senescence or apoptosis. Blackburn, Greider & Szostak (Nobel 2009) discovered telomerase — the enzyme that can rebuild telomeres. Lifestyle factors: Ornish et al. (2008, Lancet Oncology, n=30): comprehensive lifestyle intervention (plant-based diet, exercise, stress management, social support) increased telomerase activity 29% in 3 months. Epstein et al. (2009, Biological Psychiatry): perceived stress inversely correlated with telomere length — equivalent to ~10 years of additional ageing in the most stressed women. TA-65 (cycloastragenol, astragalus extract): Harley et al. (2011, Rejuvenation Research): increased telomere length in CMV+ CD8+ T-cells over 12 months. However, epigenetic clocks (Horvath 2013, Genome Biology) may be more accurate predictors of biological age than telomere length. The Horvath clock measures methylation at 353 CpG sites and predicts mortality independently of chronological age. GrimAge (2019): the most predictive epigenetic clock, incorporating smoking history, inflammation, and plasma protein surrogates. Tests: telomere length (LifeLength, RepeatDx) — £200–400; epigenetic age (TruDiagnostic, Elysium) — £200–500.
Neuroplasticity Doesn't End at 25 — and Here's What Drives It
The "brain is fixed after 25" myth persists despite Eriksson et al. (1998, Nature Medicine): first definitive evidence of adult human neurogenesis in the hippocampus. BDNF (brain-derived neurotrophic factor) is the master growth factor for neuroplasticity — promoting synaptogenesis, dendritic branching, and long-term potentiation. Strongest BDNF elevators: Exercise — Szuhany et al. (2015, meta-analysis): single exercise bouts increase peripheral BDNF acutely; regular exercise raises resting BDNF levels chronically. High-intensity intervals produce larger acute spikes than moderate exercise. Learning novel skills: Draganski et al. (2004, Nature): juggling for 3 months produced measurable grey matter increases in visual-motion areas. Meditation: Luders et al. (2009, NeuroImage): long-term meditators had larger hippocampal and frontal grey matter volumes. Sleep: BDNF consolidation requires sleep — Schmitt et al. (2016): sleep deprivation reduced serum BDNF 27%. Omega-3 DHA: essential structural component of synaptic membranes, facilitates BDNF signalling. Lion's mane: hericenones and erinacines stimulate NGF synthesis (Mori 2009). The protocol: exercise (especially high-intensity), sleep, novel learning, social engagement, omega-3s, and targeted nootropics. Neuroplasticity is not lost — it's neglected.
Fibromyalgia: Central Sensitisation With a Mitochondrial Component
Affects 2–8% of the population — 80% female. The central mechanism: augmented central nervous system pain processing (central sensitisation). Harris et al. (2007, Journal of Neuroscience, PET study): fibromyalgia patients had reduced mu-opioid receptor availability in pain-processing regions, explaining why opioids are ineffective. Clauw (2014, JAMA review): elevated substance P in CSF (3× normal), reduced serotonin and norepinephrine in descending inhibitory pathways, altered functional connectivity on fMRI. The mitochondrial component: Cordero et al. (2010, Clinical Biochemistry): CoQ10 levels were significantly lower in fibromyalgia patients, correlating with symptom severity. Cordero (2014, PLOS ONE, n=20): CoQ10 300mg/day for 40 days improved pain, fatigue, morning tiredness, and tender points. D-ribose (15g/day, Teitelbaum 2012, n=41): 61% improvement in energy, sleep, mental clarity, pain intensity. LDN (4.5mg/day, Younger 2013, n=31): reduced pain 29% vs placebo, with reduced plasma levels of inflammatory cytokines. Approved medications (pregabalin, duloxetine, milnacipran): effective in ~30–40% of patients with modest benefit. Fibromyalgia is not psychosomatic — it is a disorder of central pain processing with identifiable neurochemical and mitochondrial abnormalities.
Parasitic Infection: More Common Than You Think, Harder to Detect Than You'd Hope
CDC estimates >60 million Americans carry Toxoplasma gondii alone. Standard O&P (ova and parasite) stool testing: sensitivity as low as 50–60% for many organisms — single samples miss intermittent shedding. Three-sample collection improves to ~85%. GI-MAP (PCR-based) detects DNA of specific organisms with higher sensitivity than microscopy. Common presentations: Blastocystis hominis (found in 5–15% of stool samples in developed countries, pathogenic potential debated — symptomatic in some, commensal in others), Dientamoeba fragilis (associated with IBS-like symptoms, especially in children), Giardia (infects 2% of adults in developed countries, causes post-infectious IBS in 30–40%). Pharmaceutical treatment: metronidazole, nitazoxanide (Alinia), ivermectin — organism-specific. Herbal protocols (used in naturopathic practice, limited RCT evidence): artemisinin (wormwood extract), berberine, oregano oil, black walnut hull. Biofilm disruption (NAC, bismuth thiol complexes, enzymes) theoretically improves antimicrobial penetration. The functional medicine approach: test (GI-MAP or comprehensive parasitology ×3), treat targeted organism, re-test to confirm clearance, repair gut lining. Most important: don't treat blind — identify the organism first.
Carnivore, Keto, and AIP: When Extreme Diets Are Therapeutically Justified
The carnivore diet lacks RCTs — but the mechanistic case as an ELIMINATION diet has merit. Harvard survey (Lennerz 2021, Current Developments in Nutrition, n=2,029 self-reported carnivore dieters): 93% improved or resolved obesity/excess weight, 98% improved diabetes, 97% improved GI symptoms. These are self-selected, uncontrolled data — but the effect sizes warrant investigation. The mechanism: removing ALL plant compounds simultaneously eliminates lectins, oxalates, phytates, salicylates, histamine, and FODMAPs — useful for identifying severe food sensitivities. Ketogenic diet: established therapeutic use in drug-resistant epilepsy since 1921. Neal 2008 (Lancet Neurology, RCT, n=145 children): 38% achieved >50% seizure reduction. Emerging evidence in bipolar disorder (Danan 2022, pilot), depression, and neurodegenerative conditions — shared mechanism of improved brain energy metabolism via ketone bodies. AIP (Autoimmune Protocol): Konijeti 2017 (n=15 IBD patients): 73% achieved clinical remission by week 6. The principle: use restrictive diets as DIAGNOSTIC tools and therapeutic interventions, not permanent lifestyles unless symptoms demand it. Reintroduce systematically.
Oxalates: When "Healthy" Foods Are Causing Your Symptoms
Oxalic acid binds calcium to form calcium oxalate crystals — responsible for 80% of kidney stones AND increasingly implicated in joint pain, vulvodynia, thyroid nodules, and breast tissue calcifications. High-oxalate foods: spinach (750mg/100g — extraordinarily high), rhubarb, beets, almonds, sweet potatoes, dark chocolate, Swiss chard. Mitchell et al. (2019, Urolithiasis review): genetic hyperoxaluria accounts for 1–2% of cases, but dietary hyperoxaluria combined with gut dysbiosis (reduced Oxalobacter formigenes colonisation, which normally degrades oxalate) produces clinically significant oxalate loading. The gut permeability connection: Liebman & Al-Wahsh (2011): increased intestinal permeability allows greater oxalate absorption — explaining why oxalate symptoms worsen with gut dysfunction. Diagnosis: 24-hour urinary oxalate >40mg suggests hyperexcretion. Plasma oxalate testing available but less standardised. Don't reduce oxalates abruptly — rapid mobilisation from tissue stores can temporarily worsen symptoms ("oxalate dumping"). Reduce by 10–15% per week. Pair high-oxalate foods with calcium (binds oxalate in the gut, reducing absorption). Citrate (lemon juice) inhibits crystal formation.
Autism Spectrum: The Gut-Brain Axis, Nutritional Interventions, and What Parents Need to Know
Prevalence: 1 in 36 children (CDC 2023, up from 1 in 150 in 2000). GI comorbidity: 46–84% of children with ASD have GI symptoms (McElhanon 2014, Pediatrics, meta-analysis). Sharon et al. (2019, Cell): germ-free mice colonised with gut microbiota from ASD children developed ASD-like behaviours — direct causal evidence for microbiome involvement. Kang et al. (2017, Microbiome, n=18 ASD children): Microbiota Transfer Therapy (modified FMT) improved GI symptoms by 80% AND ASD symptoms by 22% at 8 weeks, with benefits persisting at 2-year follow-up (2019). Nutritional: Adams et al. (2011, BMC Pediatrics, RCT, n=141): comprehensive supplement protocol (multivitamin, essential fatty acids, digestive enzymes) improved nutritional status AND autism rating scores. Vitamin D: Saad et al. (2018, RCT, n=109 ASD children, 300 IU/kg/day for 4 months): significant improvements in autism scales. Sulforaphane: Singh 2014 (PNAS, n=44): significant improvements in social interaction and aberrant behaviour at 18 weeks, reversed after stopping. Methyl B12: James 2009 (n=40): improved methylation capacity and glutathione status. Interventions should complement — not replace — behavioural therapy, speech therapy, and OT.
Screen Time: The Dose-Dependent Neurodevelopmental Impact
Hutton et al. (2020, JAMA Pediatrics, n=47 children 3–5 years, DTI brain imaging): greater screen use was significantly associated with lower microstructural integrity of white matter tracts supporting language and literacy — poorer myelination in children who had more screen exposure. Madigan et al. (2019, JAMA Pediatrics, longitudinal, n=2,441): greater screen time at 24 months predicted poorer developmental screening at 36 months — the effect was directional (screens→development, not development→screens). Myopia: Lanca & Saw (2020, British Journal of Ophthalmology review): near-work and screen time are independent risk factors for myopia progression, while outdoor time is protective (mechanism: dopamine release from bright light exposure inhibits axial elongation). Sleep: Hale & Guan (2015, meta-analysis): screen-based media use was consistently associated with shorter sleep duration and delayed sleep onset in children — blue light suppresses melatonin, but arousing content is equally disruptive. AAP recommendations: no screens under 18 months (except video calling), 1 hour/day age 2–5, consistent limits thereafter. The 2023 Surgeon General's Advisory specifically flagged social media's impact on adolescent mental health as a public health crisis.
Chronic Insomnia: CBT-I Works Better Than Sleeping Pills — and Lasts
Mitchell et al. (2012, Annals of Internal Medicine, meta-analysis): CBT-I (cognitive behavioural therapy for insomnia) was effective for sleep onset, sleep efficiency, and wake after sleep onset — with effects PERSISTING at 12-month follow-up, unlike medications which lose efficacy after 4–8 weeks. Trauer et al. (2015, Annals of Internal Medicine, 20 RCTs, n=1,162): CBT-I improved sleep onset latency by 19 minutes, WASO by 26 minutes, and sleep efficiency by 9.9%. Medications: Z-drugs (zopiclone, zolpidem) suppress slow-wave sleep, creating dependence within 2–4 weeks (Holbrook 2000). Suvorexant (orexin antagonist): preserves sleep architecture better than GABAergic drugs but costs significantly more. The compound stack with evidence: magnesium glycinate 400mg (Abbasi 2012, n=46 elderly: improved sleep quality, melatonin, cortisol), glycine 3g (Bannai 2012: improved subjective quality without sedation), L-theanine 200mg (Kim 2011, n=98 boys with ADHD: improved sleep quality), apigenin 50mg (GABA-A binding, anxiolytic). Tart cherry juice: Howatson 2012 (n=20): raised melatonin, improved time in bed, sleep efficiency, and total sleep. Address circadian timing, sleep hygiene, and anxiety before adding compounds.
Circadian Biology: Light Is the Most Powerful Drug You're Ignoring
The suprachiasmatic nucleus (SCN) — your master clock — is primarily entrained by light via intrinsically photosensitive retinal ganglion cells (ipRGCs) containing melanopsin, most sensitive to ~480nm blue light. Morning light exposure: Terman et al. (1989, Neuropsychopharmacology): 30 minutes of 10,000 lux within 1 hour of waking is the gold standard for circadian entrainment. Outdoor light on a cloudy day: ~10,000 lux. Indoor office lighting: 100–500 lux — woefully insufficient. Huberman's protocol: get outside within 30–60 minutes of waking for 10–30 minutes (longer on cloudy days). Evening light: even 50 lux of room lighting suppresses melatonin onset by 50% if experienced after sunset (Gooley 2011, JCEM). Shift work: meta-analysis (Vyas 2012, BMJ, n=2,011,935): shift workers had 23% higher risk of MI, 5% higher risk of ischaemic stroke, 24% higher all-cause mortality. Short-wavelength filtering glasses (amber/orange) after sunset: Burkhart & Phelps (2009): wearing blue-blocking glasses 3 hours before bedtime improved sleep quality and mood. Peripheral clocks in liver, gut, muscle, and fat have their own circadian rhythms — disrupted by meal timing independent of the SCN.
EMF Exposure: What the Research Shows Beyond the Conspiracy Theories
The NTP study (National Toxicology Program, 2018, $30M, 10 years, 3,000 rodents): "clear evidence" of carcinogenic activity — schwannomas and gliomas in male rats exposed to GSM/CDMA-modulated RF-EMF at SAR levels achievable by phones. The Ramazzini Institute (Falcioni 2018): replicated schwannoma findings at lower, environmental-level exposures. Hardell & Carlberg (2009, International Journal of Oncology): >25 years of mobile phone use associated with OR 3.0 for ipsilateral glioma. WHO/IARC: classified RF-EMF as "Group 2B — possibly carcinogenic" in 2011. Pall (2018, Journal of Chemical Neuroanatomy): proposed mechanism via voltage-gated calcium channels (VGCCs) — EMF activates VGCCs, producing intracellular calcium influx, oxidative stress, and downstream inflammation. Counter-evidence: UK Million Women Study (2022, n=776,000): no overall increase in brain tumours with mobile phone use. The precautionary principle: use speakerphone/wired headphones (inverse square law — doubling distance reduces exposure 75%), phone on airplane mode at night, router on timer, laptop off lap. Avoid catastrophising — the absolute risk, if real, is small. But cumulative low-level exposure across decades warrants rational minimisation.
Vitamin K2: The Missing Link Between Calcium, Arteries, and Bones
K2 activates two critical proteins by carboxylation: osteocalcin (directs calcium INTO bones) and matrix Gla protein (MGP — prevents calcium deposition IN arteries). Without sufficient K2, you get the "calcium paradox" — calcium leaves bones and enters arteries. The Rotterdam Study (Geleijnse 2004, n=4,807, 10-year follow-up): highest dietary K2 intake associated with 50% lower coronary heart disease mortality and 25% lower all-cause mortality. K2 had NO effect on these outcomes. Two main forms: MK-4 (short-acting, requires 45mg TID, mostly found in animal fats) and MK-7 (long-acting, effective at 100–200µg/day, primarily from natto fermentation). Knapen et al. (2013, Osteoporosis International, RCT, n=244 postmenopausal women, MK-7 180µg/day for 3 years): significantly decreased BMD decline at lumbar spine and femoral neck, improved bone strength indices. Knapen 2015 (n=244): MK-7 180µg/day significantly reduced arterial stiffness. Anyone supplementing D3 and/or calcium WITHOUT K2 is potentially accelerating vascular calcification while failing to optimally build bone. MK-7 180–200µg/day, taken with a fat-containing meal. Contraindication: warfarin (vitamin K antagonist) — discuss with prescriber.
Vitamin A: Retinol vs Beta-Carotene — The Conversion Problem Nobody Mentions
Preformed vitamin A (retinol, retinyl palmitate) from animal sources is directly bioavailable. Beta-carotene from plants requires conversion by BCMO1 enzyme — and genetic polymorphisms in BCMO1 reduce conversion by 32–69% (Leung 2009, FASEB Journal). An estimated 45% of the population carries at least one variant. This means nearly half the population CANNOT efficiently obtain vitamin A from plant sources alone. Functions: retinol is essential for immune cell differentiation (T-cell and IgA production), thyroid hormone receptor activation (T3 binding requires retinoid X receptor), skin integrity (regulates keratinocyte differentiation), and visual cycle (rhodopsin synthesis). Deficiency symptoms: frequent infections, dry skin, poor night vision, thyroid resistance despite normal labs, follicular hyperkeratosis. Vitamin A and D work synergistically — they share the RXR receptor. Excess without adequate D increases toxicity risk. Liver consumption (3,000–10,000 IU preformed retinol per serving) is the most bioavailable food source. Supplemental: 3,000–10,000 IU retinyl palmitate daily is generally safe; toxicity concerns begin >25,000 IU/day chronically. Contraindicated in pregnancy above 10,000 IU/day (teratogenic).
The Copper-Zinc Axis: A Critical Ratio Most Practitioners Ignore
Copper and zinc are metabolic antagonists — they compete for absorption at metallothionein binding sites. Excessive zinc supplementation (>40mg/day long-term) depletes copper — causing copper deficiency anaemia, neutropaenia, and irreversible neurological damage mimicking B12 deficiency (Jaiser & Winston 2010, Journal of Neurology). Conversely, copper excess (relative to zinc) drives oxidative stress, anxiety, racing thoughts, and estrogen dominance (copper and estrogen upregulate each other). Ceruloplasmin: the copper transport protein — when low, "free" unbound copper increases, generating hydroxyl radicals via Fenton chemistry. Copper's essential functions: ceruloplasmin (ferroxidase activity — needed to load iron onto transferrin), cytochrome c oxidase (Complex IV — mitochondrial respiration), superoxide dismutase (Cu/Zn-SOD — primary intracellular antioxidant), dopamine beta-hydroxylase (converts dopamine to norepinephrine), lysyl oxidase (collagen/elastin crosslinking). Optimal serum copper:zinc ratio: approximately 0.7–1.0. Test both together, always. If supplementing zinc >15mg/day, add 1–2mg copper. Zinc carnosine (75mg twice daily) is the best-studied form for GI applications (Mahmood 2007: protection against NSAID gut damage).
Biofilms: Why Antimicrobials Fail and Chronic Infections Persist
Biofilms are structured communities of microorganisms encased in a self-produced extracellular polymeric substance (EPS) matrix — a fortress of polysaccharides, proteins, and extracellular DNA. NIH estimates 80% of chronic infections involve biofilms. Organisms within biofilms are 100–1,000× more resistant to antibiotics than planktonic (free-floating) forms (Stewart & Costerton 2001, Lancet). Biofilm-associated conditions: chronic sinusitis (Foreman 2009: biofilms found in 70% of surgically treated cases), prosthetic joint infections, chronic wound infections, SIBO (Sapi 2012: Borrelia forms biofilms), chronic UTI, and dental plaque (the original biofilm model). Disruption strategies: NAC (N-acetylcysteine) — Zhao & Liu (2010): disrupts EPS matrix at 2–20mg/mL, effective against Staphylococcus, Pseudomonas, and candida biofilms. Bismuth thiol compounds: synergistic with antibiotics by 10–1,000× (Domenico 2001). Enzymes: nattokinase, serrapeptase, and lumbrokinase theoretically degrade fibrin components of the matrix. EDTA chelates calcium and magnesium that stabilise biofilm structure. Phase-based approach: disrupt matrix (NAC, enzymes, EDTA) → apply antimicrobial (pharmaceutical or herbal) → prevent reformation (probiotics, immune support).
Stem Cells and Exosomes: Separating Clinical Evidence from Clinic Marketing
Mesenchymal stromal cells (MSCs — renamed from "stem cells" because most don't actually differentiate into new tissue in vivo): primary mechanism is PARACRINE — they secrete anti-inflammatory cytokines, growth factors, and exosomes that modulate the local environment. Exosomes: 30–150nm extracellular vesicles carrying mRNA, microRNA, and proteins. The marketing claims far exceed the evidence for most applications. What IS evidence-based: PRP (platelet-rich plasma) for knee osteoarthritis — Dai 2017 (meta-analysis, 10 RCTs, 1,069 knees): significantly superior to hyaluronic acid for pain and function at 12 months. Bone marrow concentrate for knee OA: Shapiro 2017 (n=25, RCT vs saline): significant improvements at 6 months. What is NOT proven: IV stem cell infusions for "anti-ageing" (no large RCTs), exosome injections for systemic rejuvenation (mechanistically plausible, clinically unproven), stem cells for neurodegeneration (early-phase trials only). Red flags at clinics: guaranteeing outcomes, treating multiple conditions with the same protocol, lacking published outcomes data, "stem cell" counts without viability testing. The Regenerative Medicine Due Diligence package exists specifically because this space has a massive evidence-to-marketing gap.
DIM: Estrogen Metabolism Modulator — Mechanisms, Dosing, and Caveats
DIM (3,3'-diindolylmethane) is the primary bioactive metabolite of indole-3-carbinol (I3C) from cruciferous vegetables. After oral I3C, only DIM is detectable in circulation — I3C itself is entirely converted in gastric acid (Reed 2006, Cancer Epidemiology Biomarkers). DIM's primary action: shifts estrogen metabolism from 16α-hydroxylation (produces 16α-OHE1, a proliferative metabolite associated with breast and endometrial cancer risk) toward 2-hydroxylation (produces 2-OHE1, a metabolite with anti-proliferative properties). Dalessandri 2004 (Cancer Epidemiology Biomarkers, n=19 postmenopausal women with history of breast cancer): absorption-enhanced DIM (108mg/day) significantly increased the 2:16α ratio. Thomson et al. (2017, Breast Cancer Research and Treatment, n=130 postmenopausal women): BioResponse DIM 300mg/day for 12 months increased 2-OHE1:16α-OHE1 by 47%. Dosing: 100–200mg/day (absorption-enhanced form — BioResponse DIM is the most studied). Higher doses (>300mg) may suppress estrogen excessively in some women — monitor symptoms. Men: used to manage estrogen in testosterone optimisation protocols. Test: DUTCH test provides complete estrogen metabolite profile including 2-OH, 4-OH, and 16α-OH pathways plus methylation markers.
The Lymphatic System: Your Body's Drainage Network Has No Pump
The lymphatic system transports 2–3 litres of fluid daily, carrying immune cells, waste products, and absorbed dietary fats. Unlike the cardiovascular system, it has NO central pump — lymph moves via skeletal muscle contraction, respiratory pressure changes, and one-way valves. Stagnation → oedema, immune compromise, and waste accumulation. Xie et al. (2013, Science): discovered the glymphatic system — the brain's waste clearance pathway operating primarily during deep (NREM) sleep, dependent on aquaporin-4 channels on astrocyte endfeet. Amyloid-beta clearance is 2× more efficient during sleep than waking. Iliff et al. (2012, Science Translational Medicine): glymphatic flow reduced 40% with ageing. Movement is the primary driver of peripheral lymph flow: exercise increases lymphatic flow 10–30× (Olszewski 1977). Manual lymphatic drainage (Vodder technique): Cochrane reviews support efficacy for lymphoedema post-cancer surgery. Dry brushing: no published clinical trials despite widespread recommendation — theoretically stimulates superficial lymph flow via mechanical pressure. Rebounding (mini-trampoline): frequently cited but primary evidence base is NASA's 1980 biomechanical study on acceleration forces, not lymphatic flow specifically. Deep breathing exercises: the thoracic duct drains into the left subclavian vein — respiratory excursion directly pumps central lymph.
Iodine: Essential for Far More Than Thyroid — But Dosing Is Everything
Iodine concentrates in thyroid, breast, ovary, prostate, and gastric mucosa. RDA: 150µg — set to prevent goitre, not to optimise tissue-level function. Japanese dietary intake: 1,000–3,000µg/day with lower rates of breast, endometrial, and ovarian cancer. Abraham's "iodine project": proposed 12.5mg/day (Iodoral/Lugol's) — 83× the RDA. The Wolff-Chaikoff effect: acute iodine loading temporarily inhibits thyroid hormone synthesis (a protective mechanism). Most healthy thyroids "escape" within 24–48 hours. Risk: Hashimoto's patients may experience thyroid flare with iodine loading — the relationship is complex. Markou et al. (2001): iodine excess triggers thyroiditis in genetically susceptible individuals via increased thyroid peroxidase (TPO) exposure. Halide competition: iodine competes with fluoride, bromide, and chloride for the sodium-iodide symporter (NIS) — environmental halide exposure may contribute to relative iodine deficiency. Selenium (200µg as selenomethionine) should ALWAYS precede or accompany iodine supplementation — it supports glutathione peroxidase which protects thyroid from H₂O₂ generated during iodination. Start low: 225–500µg, titrate by symptoms and thyroid function tests.
Thyroid: Why TSH Alone Misses the Diagnosis in 30–40% of Cases
Standard practice: test TSH. If "normal" (0.5–4.5), case closed. The problem: TSH reflects pituitary perception of thyroid hormone, not peripheral tissue availability. Bianco & Kim (2006): local deiodinase activity in different tissues means T3 levels vary organ-by-organ — a single blood test cannot capture this. The full panel: TSH, free T4, free T3, reverse T3, TPO antibodies, thyroglobulin antibodies. Reverse T3 (rT3): the inactive metabolite of T4 — elevated by stress, inflammation, caloric restriction, iron deficiency, and illness. A high rT3:fT3 ratio suggests impaired T4→T3 conversion despite "normal" TSH. Selenium: required for deiodinase enzymes (DIO1, DIO2) that convert T4→T3. Rayman 2012: selenium supplementation (200µg/day) reduced TPO antibodies in Hashimoto's. Iron: also required for thyroid peroxidase — ferritin <50–70 impairs thyroid function regardless of TSH. NDT (natural desiccated thyroid — Armour, NP Thyroid): contains T4 AND T3 in porcine-derived ratio. Hoang et al. (2013, JCEM, n=70, crossover): 49% of patients preferred NDT over levothyroxine, with greater weight loss and no difference in adverse effects. Functional targets: TSH 0.5–2.0, fT3 upper third of range, rT3 <15 ng/dL, TPO-Ab <35.
Bovine Colostrum: Immunoglobulins, Growth Factors, and Gut Barrier Repair
First milk produced 24–48 hours post-birth, containing IgG (20–30% by weight), lactoferrin, growth factors (IGF-1, TGF-β, EGF), and proline-rich polypeptides (PRPs). Playford et al. (2001, Gut, n=7, RCT): bovine colostrum prevented the 3-fold increase in gut permeability caused by indomethacin — ibuprofen users take note. Marchbank et al. (2011, American Journal of Physiology): colostrum reduced exercise-induced gut permeability by 80% vs placebo in athletes at 20g/day. Immunoglobulins survive gastric digestion (IgG is acid-stable) and bind pathogens/toxins in the intestinal lumen. Huppertz et al. (2023, Frontiers in Nutrition): hyperimmune bovine colostrum contains specific antibodies against human pathogens including C. difficile, E. coli, and rotavirus. Jones et al. (2015, n=160 adults): colostrum supplementation reduced the incidence of upper respiratory infections by 33% compared to placebo over 12 weeks. Dosing: 10–20g/day powder or 2–4g concentrated capsules. Source quality matters — first-milking, grass-fed, minimally processed. Contraindication: dairy allergy (casein content).
Heavy Metal Testing: What's Reliable, What's Not, and When to Chelate
Blood testing: reliable for ACUTE/RECENT exposure (lead, mercury). Whole blood mercury reflects recent fish consumption; blood lead reflects exposure within 30 days. Hair mineral analysis: reflects 2–3 month exposure, useful for methylmercury and arsenic, but contamination and variable growth rates limit reliability. Provoked urine testing (DMSA/DMPS challenge): controversial — Ruha et al. (2013, Clinical Toxicology, ACMT position statement): challenged urine should NEVER be compared to unprovoked reference ranges, as the chelator mobilises stored metals producing artificially elevated readings. Unprovoked 24-hour urine: more interpretable, reflects ongoing excretion. Environmental sources: mercury (amalgam fillings, large predatory fish), lead (pre-1978 paint, contaminated water, imported spices/cosmetics), cadmium (tobacco, rice, chocolate, batteries), arsenic (rice, groundwater, pressure-treated wood). Treatment hierarchy: (1) remove ongoing exposure, (2) support endogenous detox (glutathione, selenium, NAC, fibre for enterohepatic recirculation), (3) pharmaceutical chelation (DMSA, DMPS, IV EDTA) ONLY under medical supervision with documented toxicity. Chlorella and cilantro extract are promoted as "natural chelators" — chlorella binds metals in the gut (preventing reabsorption) but does NOT mobilise tissue-stored metals.
Loneliness Kills as Effectively as 15 Cigarettes a Day
Holt-Lunstad et al. (2010, PLOS Medicine, meta-analysis, 148 studies, n=308,849): strong social relationships increased survival odds by 50% — effect size comparable to quitting smoking, exceeding physical inactivity and obesity. The 2015 follow-up (70 studies, n=3.4 million): social isolation, loneliness, and living alone each predicted premature mortality by 26–32%. Mechanism: loneliness upregulates the conserved transcriptional response to adversity (CTRA) — Cole et al. (2007, Genome Biology): lonely individuals showed increased expression of pro-inflammatory genes (NF-κB pathway) and decreased expression of antiviral/antibody genes. Chronic inflammation without infectious cause. Blue Zone research (Buettner): all five zones share strong social integration — Okinawa's "moai" (social support groups), Sardinia's multi-generational households, Loma Linda's faith community. The UK Surgeon General's 2023 advisory: loneliness as a public health epidemic. This is not self-help advice. Social connection is the most powerful modifiable determinant of longevity, outperforming every supplement, drug, and protocol on this entire page.
Hearing Loss Prevention: The Modifiable Risk Factor for Dementia Nobody Addresses
Lancet Commission on Dementia (2020): hearing loss is the LARGEST modifiable risk factor for dementia — contributing 8.2% of population-attributable fraction, more than smoking, depression, or physical inactivity. Lin et al. (2011, Archives of Internal Medicine, n=639): mild hearing loss doubled dementia risk, moderate tripled it, severe quintupled it. Mechanism: social isolation, cognitive load diverting resources from memory encoding, and direct neurodegeneration from auditory deprivation. Noise-induced hearing loss (NIHL) is cumulative and irreversible — cochlear hair cells do not regenerate. 85 dB for 8 hours damages hair cells; 100 dB (concerts, power tools) causes damage in 15 minutes. Protective compounds: NAC (Kopke 2007, military RCT, n=566): significantly reduced temporary threshold shift when taken before noise exposure. Magnesium: Attias et al. (1994, American Journal of Otolaryngology, n=300 military recruits): 167mg/day for 2 months significantly reduced permanent noise-induced hearing loss. Combined NAC + magnesium: synergistic in animal models. Ototoxic medications: aminoglycosides, loop diuretics, cisplatin, high-dose aspirin — monitor audiometry during treatment. Custom-fit musician's earplugs (15–25 dB reduction with flat frequency response) preserve sound quality while protecting hair cells.
Senolytics: Clearing Zombie Cells — The Most Promising Anti-Ageing Strategy?
Senescent cells: metabolically active but permanently growth-arrested, accumulating with age. They secrete the SASP (senescence-associated secretory phenotype) — a cocktail of inflammatory cytokines, matrix metalloproteinases, and growth factors that damages neighbouring cells. Baker et al. (2011, Nature): genetic clearance of senescent cells in progeroid mice delayed age-related pathology in every organ system tested. Baker 2016 (Nature): clearance in naturally aged mice extended median lifespan 25%. Pharmacological approach: dasatinib (tyrosine kinase inhibitor) + quercetin (flavonoid). Zhu et al. (2015, Aging Cell): D+Q selectively killed senescent cells in vitro and in vivo. Hickson et al. (2019, EBioMedicine, n=9 diabetic kidney disease): 3 days of D+Q reduced senescent cell markers, decreased circulating SASP factors. Fisetin (Yousefzadeh 2018, EBioMedicine): more potent senolytic than quercetin in mouse models, reduced age-related pathology. Human fisetin trial (AFFIRM, Mayo Clinic) ongoing. Protocol from published trials: intermittent dosing (3 consecutive days per month) — senolytics are hit-and-run drugs, not daily supplements. The goal is clearance, not chronic exposure.
Growth Hormone: Declines 14% Per Decade — Secretagogues vs Exogenous HGH
GH secretion peaks during adolescence and declines ~14% per decade thereafter. By age 60, 24-hour GH secretion is 25–50% of youthful levels. Rudman et al. (1990, NEJM, landmark study, n=21 men 61–81): 6 months of exogenous HGH increased lean mass 8.8%, decreased adipose 14.4%, increased lumbar spine BMD 1.6%. But: carpal tunnel syndrome, gynecomastia, arthralgias, and insulin resistance were common side effects. Exogenous HGH: £500–2,000/month, requires injection, potential cancer risk from sustained IGF-1 elevation (Renehan 2004: elevated IGF-1 associated with increased colorectal, breast, and prostate cancer risk). Secretagogue approach (stimulates endogenous pulsatile release): MK-677 (ibutamoren, oral): Chapman 1996 (n=9): increased GH and IGF-1 to young adult levels. But raises cortisol, prolactin, fasting glucose. Not without metabolic cost. CJC-1295/Ipamorelin (peptide combination): stimulates GHRH receptor + ghrelin receptor — produces pulsatile GH release mimicking natural physiology. Administered subcutaneously before bed. Free strategies that significantly boost GH: deep sleep (GH pulse occurs in first SWS cycle), high-intensity exercise, fasting (Ho 1988: GH increased 300–500% during 2-day fast). Optimise these before considering peptides.
The Omega-3 Index: The Blood Test That Predicts Heart and Brain Health
The Omega-3 Index (Harris & Von Schacky 2004): EPA + DHA as a percentage of total erythrocyte fatty acids. Optimal: 8–12%. Average Western population: 4–5%. <4% = high cardiovascular risk zone. Harris et al. (2017, Journal of Clinical Lipidology): Omega-3 Index of 8% associated with 35% lower risk of CHD death vs 4%. Kleber et al. (2016, n=3,259 angiography patients, 10-year follow-up): each 1% increase in Omega-3 Index reduced sudden cardiac death risk by 9%. Brain: Tan et al. (2012, Neurology, n=1,575 Framingham offspring): lowest quartile of DHA had significantly smaller brain volume and lower cognitive scores — equivalent to 2 years of accelerated brain ageing. The Jernerén 2015 interaction: B vitamins only reduced brain atrophy when Omega-3 Index was >8% — below this threshold, B vitamin supplementation was ineffective. To raise the index from 4% to 8%: typically requires 2–3g combined EPA+DHA daily for 3–4 months. Algal DHA for vegetarians/vegans is an option but raises DHA preferentially over EPA. Test through OmegaQuant (developed by Harris) or as part of comprehensive fatty acid profiles. Cost: £50–80. This single test informs both cardiovascular and neurological risk more reliably than standard cholesterol panels.
Nattokinase: The Fibrinolytic Enzyme With Legitimate Cardiovascular Data
A serine protease from Bacillus subtilis natto, isolated by Sumi et al. (1987, Experientia). Unlike pharmaceutical thrombolytics (tPA, streptokinase), nattokinase has both direct fibrinolytic activity AND enhances endogenous fibrinolysis by converting pro-urokinase to urokinase and inactivating PAI-1 (plasminogen activator inhibitor-1). Kim et al. (2008, Hypertension Research, RCT, n=86 hypertensive patients): 2,000 FU/day for 8 weeks significantly reduced systolic and diastolic blood pressure. Ren et al. (2017, Atherosclerosis, n=76 statin-naïve patients): 6,000 FU/day for 26 weeks reduced atherosclerotic plaque size by 36.6% as measured by carotid ultrasound — a remarkable finding if replicated. Kurosawa et al. (1995, Acta Haematologica): oral nattokinase enhanced fibrinolysis for 8+ hours and completely dissolved arterial thrombi in animal models. Safety: theoretically contraindicated with anticoagulants (warfarin, DOACs) due to additive fibrinolytic effect — though clinical bleeding events are not documented. Dosing: 2,000–4,000 FU (fibrinolytic units) daily, taken on empty stomach. The enzyme is destroyed by gastric acid in some individuals — enteric-coated capsules preferred.
Just received a diagnosis? Within 72 hours, I give you the complete picture your consultant can't.
Evidence. Treatment pathways. Specialist recommendations. The questions that change the conversation. Don't spend weeks Googling in fear. From £1,500.
PTSD Rewires Three Brain Regions — Understanding This Changes Everything About Treatment
PTSD is not a psychological weakness — it is a measurable neurobiological injury. Three structures are consistently altered on fMRI and PET: (1) Amygdala hyperactivation — Rauch et al. (2000, Biological Psychiatry): the brain's threat-detection centre fires at stimuli that are no longer dangerous, producing hypervigilance, exaggerated startle, and flashbacks. (2) Prefrontal cortex hypoactivation — Shin et al. (2005, Annals of the New York Academy of Sciences): the medial PFC (which normally inhibits the amygdala) shows reduced activity, meaning the "brake pedal" on fear responses fails. (3) Hippocampal volume reduction — Bremner et al. (1995, American Journal of Psychiatry): Vietnam veterans with PTSD had 8% smaller right hippocampi — the structure responsible for contextualising memories in time and place. When the hippocampus underperforms, traumatic memories aren't filed as "past events" — they're experienced as happening NOW. Chronically elevated norepinephrine drives the hyperarousal cluster. Cortisol is paradoxically LOW in many PTSD patients (Yehuda 2002), unlike depression where it's elevated — this distinguishes PTSD neurochemistry. Only two FDA-approved medications (sertraline, paroxetine) with remission rates of just 20–30%. The field is desperate for better options.
EMDR: The Gold-Standard Trauma Therapy That Nobody Fully Understands
Developed by Francine Shapiro (1989) after observing that bilateral eye movements reduced the distress of disturbing thoughts. The Adaptive Information Processing model proposes that trauma memories are stored in isolated neural networks — EMDR's bilateral stimulation (eye movements, tapping, or auditory tones) facilitates integration with existing memory networks, transforming raw traumatic experience into processed narrative memory. WHO (2013), NICE (2018), APA (2017), and VA/DoD (2023): all recommend EMDR as a first-line trauma treatment. Chen et al. (2015, Journal of Nervous and Mental Disease, meta-analysis): EMDR was as effective as trauma-focused CBT for PTSD, with some evidence of faster symptom reduction. Ironside et al. (2022, Frontiers in Psychology, n=10 RCTs): EMDR showed large effect sizes (d=1.01–2.96) for PTSD symptom reduction. The mechanism debate continues: de Jongh et al. (2013) argue bilateral stimulation taxes working memory during recall, reducing the vividness and emotionality of traumatic images (dual-attention hypothesis). Typically 6–12 sessions for single-event trauma; complex PTSD requires longer. Intensives (daily sessions over 1–2 weeks) increasingly popular — de Jongh 2020: intensive EMDR produced equivalent outcomes to standard-spaced protocols.
Somatic Experiencing and Polyvagal Theory: Trauma Lives in the Body, Not Just the Mind
Peter Levine's Somatic Experiencing (SE) is based on the observation that animals in the wild rarely develop PTSD despite constant threat — because they discharge survival energy through trembling, shaking, and completing thwarted fight/flight responses. Humans suppress these discharge responses, trapping activation in the nervous system. SE works through "titration" (approaching traumatic material in small doses) and "pendulation" (oscillating between activation and resource states) to gradually complete interrupted defensive responses. Brom et al. (2017, Journal of Traumatic Stress, RCT, n=63 PTSD patients): SE significantly reduced PTSD symptoms and depression, with effects maintained at 15-month follow-up. Stephen Porges' Polyvagal Theory (1994): the autonomic nervous system has three hierarchical states — ventral vagal (social engagement/safety), sympathetic (fight/flight), and dorsal vagal (freeze/collapse/dissociation). PTSD patients often cycle between sympathetic hyperactivation and dorsal vagal shutdown. Treatment aims to expand the "window of tolerance" — the range of arousal within which a person can process experience without being overwhelmed or shutting down. Van der Kolk (2014, "The Body Keeps the Score"): argued that body-based therapies are essential for developmental and complex trauma where talking therapies alone are insufficient.
Ketamine for PTSD: Rapid Relief Through NMDA Blockade and Memory Reconsolidation
Ketamine is an NMDA glutamate receptor antagonist that at subanesthetic doses (0.5 mg/kg IV over 40 minutes) produces rapid antidepressant and anti-PTSD effects within hours — compared to weeks for SSRIs. Feder et al. (2014, JAMA Psychiatry, RCT, n=41 chronic PTSD): single ketamine infusion produced significant reduction in PTSD symptoms within 24 hours, with effects lasting a median of 7 days. Feder et al. (2021, American Journal of Psychiatry, n=30): repeated ketamine infusions (6 over 2 weeks) produced sustained improvement. Sicignano et al. (2024, systematic review): confirmed significant PTSD score reductions and increased time to relapse vs control. Mechanism: ketamine increases BDNF, promotes synaptogenesis (restoration of stress-damaged synaptic connections in the PFC and hippocampus), reduces default mode network hyperconnectivity, and may facilitate memory reconsolidation — the process by which reactivated traumatic memories become labile and modifiable. Esketamine (Spravato, nasal spray): FDA-approved for treatment-resistant depression (not PTSD specifically). Ketamine-Assisted EMDR: emerging protocol combining low-dose ketamine's anxiolytic/empathogenic properties with trauma reprocessing — retrospective data (2024) shows enhanced EMDR outcomes when ketamine widens the window of tolerance for traumatic material. Limitation: effects are transient without ongoing therapy; risk of dependence with frequent use.
MDMA-Assisted Therapy: 71% No Longer Met PTSD Criteria — Then the FDA Said No
MDMA (3,4-methylenedioxymethamphetamine) is an entactogen that simultaneously increases serotonin, dopamine, norepinephrine, and oxytocin while reducing amygdala reactivity — creating a state where patients can revisit traumatic memories without being overwhelmed by fear. The MAPP1 trial (Mitchell 2021, Nature Medicine, n=90): 67% of MDMA participants no longer met PTSD diagnostic criteria at study end vs 32% placebo. MAPP2 (confirmatory, n=104): 71% vs 48%. Effect size: Cohen's d=0.91 — among the largest ever reported for a psychiatric intervention. No serious drug-related adverse events in either trial. Three sessions of MDMA (80–120mg) with trained therapists over 12 weeks. In August 2024, the FDA declined approval, citing: (1) difficulty blinding (participants know they received MDMA), (2) inability to regulate the psychotherapy component, (3) ethical misconduct at one Phase 2 trial site, (4) standards that shifted after trials were completed under an agreed Special Protocol Assessment. The advisory committee voted 2–9 against efficacy, 1–10 against risk-benefit. MAPS called it "moving the goalposts." MDMA remains Schedule I. Lykos Therapeutics continues negotiations for an additional Phase 3 trial. For the 13 million Americans with PTSD, the most effective treatment ever tested remains unavailable — trapped in a regulatory paradox where the drug's psychoactive effects, which ARE the mechanism, make conventional blinding impossible.
Psilocybin: Resetting the Brain's Default Mode Network in Depression, Addiction, and Trauma
Psilocybin (from Psilocybe mushrooms) is converted to psilocin, a 5-HT2A serotonin receptor agonist. The key neuroimaging finding: Carhart-Harris et al. (2012, PNAS): psilocybin DECREASES activity in the default mode network (DMN) — the brain's "narrator" responsible for self-referential thinking, rumination, and ego maintenance. In depression and PTSD, the DMN is hyperactive and rigid. Psilocybin temporarily dissolves these rigid patterns, allowing new neural connections. Depression: Davis et al. (2021, JAMA Psychiatry, Johns Hopkins, n=27 MDD): two psilocybin sessions produced effect sizes of d=2.2–2.3 — four times larger than standard antidepressants. 71% showed >50% reduction in depression scores at 4 weeks, with 54% in remission. Carhart-Harris et al. (2021, NEJM, n=59): psilocybin (two 25mg sessions) vs escitalopram (6-week course) — psilocybin showed comparable efficacy with faster onset and greater improvements in connectedness, emotional breakthrough, and meaning. PTSD-specific trials: now recruiting at Johns Hopkins and multiple sites (NCT06407635). Smoking cessation: Johnson et al. (2014, Journal of Psychopharmacology): 80% abstinence at 6 months — unprecedented for any intervention. Mechanism: the "mystical experience" (oceanic boundlessness, unity, transcendence) during the session predicts long-term therapeutic outcome. This is not pharmacology in the traditional sense — it is pharmacologically-facilitated psychological transformation.
Stellate Ganglion Block: Resetting the Sympathetic Nervous System in 30 Minutes
The stellate ganglion is a bundle of sympathetic nerves at C6-C7 in the neck — part of the system driving the "fight or flight" response. In PTSD, this system is chronically overactivated. SGB involves injecting local anaesthetic (typically 0.5% ropivacaine) under ultrasound guidance to temporarily block sympathetic outflow. Mulvaney et al. (2014, Military Medicine, n=166 active-duty soldiers): 79% response rate within one week, 82% at 1–2 months, 74% at 3–6 months after a single SGB. The Dual Sympathetic Reset (DSR) protocol: right-sided C6 + left-sided injection within two weeks. Mechanism: Lipov's theory — PTSD increases nerve growth factor in the stellate ganglion, causing sympathetic sprouting (new nerve growth) that maintains hyperactivation. SGB may prune this overgrowth and "reset" the sympathetic set-point. SGB is now available at Walter Reed, Tripler Army Medical Center, multiple VA facilities, and private clinics. The procedure takes 30 minutes, is minimally invasive, and side effects are typically limited to temporary drooping eyelid, hoarse voice, and warmth in the arm — resolving within hours. Not a standalone cure — optimal results come when combined with trauma-focused therapy (EMDR, CPT) after the sympathetic system is calmed. Israel data (Stella Center): prospective PCL-5 scores showed significant sustained reduction at 3 months post-SGB.
Neurofeedback for PTSD: Training the Brain to Regulate Itself
Neurofeedback uses real-time EEG to train brainwave patterns. The brain receives visual/auditory feedback when it produces desired patterns, gradually learning self-regulation. Van der Kolk et al. (2016, PLOS ONE, RCT, n=52 chronic PTSD, 24 sessions): neurofeedback produced significant reductions in PTSD symptoms comparable to trauma-focused therapy, with 73% of the neurofeedback group no longer meeting PTSD criteria at 3-month follow-up — vs 32% of the waitlist control. Alpha-theta training: the traditional protocol for trauma — trains the brain to produce alpha (8–12 Hz, calm alertness) and theta (4–8 Hz, deep relaxation/integrative states) waves. Peniston & Kulkosky (1991): 30 sessions of alpha-theta training in combat veterans — 12 of 15 showed significant improvement, maintained at 30-month follow-up. Infra-low frequency (ILF) neurofeedback: targets the slowest brain oscillations (<0.1 Hz) thought to regulate autonomic and emotional stability — early clinical reports are promising but controlled trials are limited. LORETA (Low Resolution Electromagnetic Tomography) neurofeedback: targets specific deep brain structures including the anterior cingulate cortex. qEEG-guided neurofeedback personalises protocols based on individual brainwave mapping. Typically 20–40 sessions required. Non-invasive, no medication side effects. Best evidence is for PTSD and ADHD.
Ibogaine: The Most Powerful — and Most Dangerous — Psychedelic for Addiction and PTSD
Ibogaine is an alkaloid from the West African shrub Tabernanthe iboga, used ceremonially by the Bwiti tradition for centuries. Unique mechanism: simultaneously acts on opioid receptors (kappa, mu, delta), NMDA receptors, serotonin transporters, nicotinic receptors, and sigma-2 receptors — no other compound touches this many systems at once. A single dose can eliminate opioid withdrawal symptoms within hours and reduce cravings for weeks to months. Noller et al. (2018, American Journal of Drug and Alcohol Abuse, n=14 opioid-dependent patients): significant reductions in withdrawal scores, with 50% remaining opioid-free at 12 months. The Stanford/VETS study (Kiraga 2024, Nature Medicine, n=30 special operations veterans): single ibogaine treatment combined with magnesium produced dramatic reductions in PTSD symptoms (mean PCL-5 reduction of 60%), depression, anxiety, and suicidality — sustained at 1 month. Disability scores improved from 30.2 to 5.1. The critical caveat: ibogaine carries genuine cardiac risk — it prolongs QT interval, and at least 33 deaths have been reported, mostly in unscreened patients or unsupervised settings. Mandatory cardiac screening (ECG, electrolytes, echocardiogram) is essential. Illegal in the US/UK. Available in Mexico, New Zealand, Brazil, and some European clinics. Currently the most dramatic single-session results for treatment-resistant PTSD and opioid addiction in the published literature.
Ayahuasca: Ancient Plant Medicine With Modern Neuroplasticity Data
A brew of Banisteriopsis caapi (containing harmine/harmaline, MAO inhibitors) and Psychotria viridis (containing DMT, a potent 5-HT2A agonist). The MAO inhibitors make DMT orally active — without them, gut enzymes destroy DMT before it reaches the brain. Used ceremonially in Amazonian traditions for thousands of years. Palhano-Fontes et al. (2019, Psychological Medicine, RCT, n=29 treatment-resistant depression): single ayahuasca session produced rapid antidepressant effects significantly superior to placebo at 7 days — the first RCT of ayahuasca for depression. Riba et al. (2006, Psychopharmacology): ayahuasca reduced neural activity in the DMN and increased activity in regions associated with autobiographical memory and emotional processing. Neuroplasticity: Morales-Garcia et al. (2017, Translational Psychiatry): harmine and tetrahydroharmine stimulated neurogenesis and BDNF expression in human neural progenitor cells in vitro. Trauma processing: Domínguez-Clavé et al. (2016, Current Neuropharmacology review): ayahuasca enhances emotional processing and autobiographical memory recall — mechanistically relevant for trauma. The Takiwasi Centre (Peru): 20+ years combining ayahuasca ceremonies with psychotherapy for addiction — published observational data shows significant reductions in addiction severity. Adverse effects: intense nausea/purging (considered therapeutically important by traditions), serotonin syndrome risk with SSRIs (ABSOLUTE contraindication), psychological distress in unprepared individuals.
LSD Microdosing: Sub-Perceptual Dosing — Massive Hype, Limited Hard Evidence
Microdosing: 5–20µg LSD (1/10th to 1/20th of a "trip" dose) every 3rd day. Fadiman protocol: dose day 1, off days 2–3, repeat. Stamets stack: psilocybin microdose + lion's mane + niacin. Self-reported benefits (Polito & Stevenson 2019, PLOS ONE, n=98, 6-week daily tracking): improved mood, focus, creativity, reduced mind-wandering. BUT: Szigeti et al. (2021, eLife, n=191, citizen science RCT with innovative self-blinding): microdosing showed NO significant difference from placebo on any measure when participants were properly blinded. ALL improvements were accounted for by expectation effects. The problem: when people KNOW they're microdosing, they report benefits. When they don't know, the benefits vanish. Full-dose LSD: Gasser et al. (2014, Journal of Nervous and Mental Disease, n=12 life-threatening illness): 200µg LSD-assisted psychotherapy significantly reduced anxiety, with effects sustained at 12-month follow-up. Krebs & Johansen (2012, PLOS ONE, meta-analysis of 6 RCTs from the 1960s–70s, n=536): single dose of LSD had a beneficial effect on alcohol misuse, maintained at 6 months. Neuroimaging: Carhart-Harris et al. (2016, PNAS): LSD increased global brain connectivity and reduced DMN integrity — similar to psilocybin but with longer duration (8–12 hours vs 4–6). The honest assessment: full-dose psychedelic therapy has strong evidence. Microdosing may be a powerful placebo.
Transcranial Magnetic Stimulation: FDA-Approved Brain Stimulation for Depression and PTSD
TMS uses magnetic pulses to stimulate or inhibit specific brain regions non-invasively. FDA-cleared for depression (2008), OCD (2018), and smoking cessation (2020). For PTSD: not yet FDA-approved but accumulating evidence. Kozel et al. (2018, Brain Stimulation, RCT, n=103 veterans): rTMS to the right dorsolateral PFC showed improvement but did not reach statistical significance for the primary outcome. However, Isserles et al. (2013, Brain Stimulation, n=30): deep TMS combined with trauma script exposure produced significant PTSD symptom reduction vs sham. Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT/SNT): Cole et al. (2020, American Journal of Psychiatry): compressed 5-day protocol delivering 50 theta burst sessions (normally 6 weeks of daily TMS) achieved 79% remission rate in treatment-resistant depression — one of the highest ever reported. Mechanism: stimulating the left DLPFC increases top-down inhibitory control over the amygdala (addressing the PFC hypoactivation seen in PTSD). Standard protocol: 30–36 sessions over 6 weeks. Accelerated protocols: 5–10 days. Side effects: headache, scalp discomfort, <0.1% seizure risk. Contraindicated with metallic implants near the head. Deep TMS (H-coil) reaches structures up to 6cm deep vs 2cm for standard figure-8 coils — potentially accessing limbic regions directly relevant to PTSD.
Hyperbaric Oxygen Therapy: Neuroplasticity at 2 Atmospheres
HBOT: breathing 100% oxygen at 1.5–2.4 ATA (atmospheres absolute) in a pressurised chamber. Mechanism: hyperoxia stimulates angiogenesis (new blood vessel growth), mobilises stem cells from bone marrow (Thom et al. 2006, American Journal of Physiology: 8-fold increase in circulating stem/progenitor cells after single HBOT session), reduces neuroinflammation, and upregulates hypoxia-inducible factor (HIF) and VEGF during the intermittent protocol. Efrati et al. (Tel Aviv, 2013, PLOS ONE, n=74 post-stroke patients): 40 HBOT sessions significantly improved neurological function and brain metabolism even years after stroke — challenging the assumption that brain injury is permanent. The TBI/PTSD veteran studies: Harch et al. (2012, Journal of Neurotrauma, n=16 military blast-TBI): 40 HBOT sessions at 1.5 ATA improved cognitive function, PTSD symptoms, headache, sleep, and quality of life. SPECT imaging showed increased blood flow to previously hypoperfused brain regions. Bryan Johnson's HBOT protocol: 60 sessions, 5×/week, 90 minutes at 2 ATA — he reported hsCRP falling below detectable levels and telomere length increasing 2.6%. Hadanny et al. (2020, Aging, n=35): 60 HBOT sessions in healthy elderly improved cerebral blood flow, cognitive performance, and telomere length by 20% while reducing senescent cell populations by 37%. Protocols typically 40–60 sessions. Costs £100–250 per session. Established for wound healing, decompression sickness, carbon monoxide poisoning; experimental for TBI/PTSD/longevity.
Flotation REST: Sensory Deprivation Tanks for Anxiety, PTSD, and Interoceptive Awareness
Restricted Environmental Stimulation Technique (REST): floating in 25cm of Epsom salt-saturated water (500kg MgSO₄) at skin temperature (35.5°C) in total darkness and silence. The environment eliminates 90%+ of sensory input, reducing sympathetic nervous system activity and shifting the brain into theta-dominant states. Feinstein et al. (2018, PLOS ONE, n=50 anxiety/stress-related disorders including PTSD): single 60-minute float session produced significant reductions in anxiety, stress, muscle tension, and pain, with concurrent increases in serenity — effects were LARGEST in the most anxious participants. Feinstein (Laureate Institute for Brain Research, 2022 follow-up): 8 weekly float sessions in anorexia patients improved interoceptive awareness — the ability to perceive internal body signals, which is disrupted in both eating disorders and PTSD. Jonsson & Kjellgren (2016, BMC Complementary Medicine, n=46 stress-related conditions): 12 float sessions over 7 weeks significantly reduced stress, depression, anxiety, and pain, with improvements in sleep and optimism maintained at 4-month follow-up. Magnesium absorption: transdermal magnesium uptake through float tank exposure is debated — Waring (2004, Epsom Salt Council report) showed plasma magnesium increases after Epsom salt bathing, but the study wasn't peer-reviewed. Mechanistically compelling, well-tolerated, evidence base growing from excellent research groups.
Psychedelic Integration: Why the Session Is Only Half the Therapeutic Work
The clinical evidence for psychedelics consistently shows that PREPARATION and INTEGRATION predict outcomes as much as the drug itself. Griffiths et al. (2006, Psychopharmacology, Johns Hopkins): the "mystical experience" (measured by the Mystical Experience Questionnaire) during psilocybin sessions predicted long-term positive outcomes — and this was heavily influenced by preparation, setting, and therapeutic relationship. The three phases: (1) Preparation (1–3 sessions): establishing therapeutic alliance, setting intentions, psychoeducation about what to expect, screening for contraindications (personal/family history of psychosis, bipolar I, current SSRI use). (2) The session: set (mindset) and setting (physical/social environment) are more determinative of experience quality than dose. Trained therapists provide "non-directive support" — being present without interpreting or guiding. (3) Integration (weeks to months): the session generates insight and emotional material; integration therapy helps translate this into lasting behavioural change. Without integration, psychedelic experiences can fragment or become unprocessed — potentially worsening outcomes. Challenging experiences ("bad trips"): Carbonaro et al. (2016, Journal of Psychopharmacology): 84% of those who had challenging psilocybin experiences rated them among the most meaningful of their lives, with 34% calling them THE most meaningful. Difficulty is not synonymous with harm — but supervision matters.
PTSD Pharmacology Beyond SSRIs: Prazosin, Propranolol, and Memory Reconsolidation
Only two FDA-approved PTSD medications (sertraline, paroxetine) — both with modest efficacy and 20–30% remission rates. The off-label options with stronger emerging evidence: Prazosin (alpha-1 adrenergic blocker): Raskind et al. (2013, American Journal of Psychiatry, n=304 veterans): prazosin significantly reduced trauma nightmares and improved sleep quality. However, the larger RASKIND trial (2018, NEJM, n=304) showed no significant difference from placebo — raising questions about earlier positive results. Clinical experience: many PTSD specialists still use it for nightmares based on individual response. Propranolol (memory reconsolidation interference): Brunet et al. (2008, Journal of Clinical Psychopharmacology): propranolol 40mg given DURING traumatic memory reactivation (within the 6-hour reconsolidation window) reduced physiological responses to the trauma memory one week later. Brunet et al. (2018, American Journal of Psychiatry, n=60): 6 sessions of propranolol-assisted memory reconsolidation reduced PTSD symptoms, maintained at 6-month follow-up. The key: propranolol must be taken DURING memory reactivation, not chronically. Nabilone (synthetic cannabinoid, CB1 agonist): Jetly et al. (2015, Psychoneuroendocrinology, n=10 military PTSD): significantly reduced nightmares. Topiramate, gabapentin, and low-dose quetiapine all have limited evidence for specific PTSD symptom clusters.
Investing in longevity? Is anyone actually reviewing whether your protocol is backed by evidence?
NAD+, senolytics, peptides, HRT, supplements — I pressure-test every element against published research. No sales agenda. From £2,000.
Bryan Johnson's Blueprint: $2M/Year, 100+ Interventions — What the Science Actually Supports
Bryan Johnson (founder of Braintree, sold to PayPal for $800M in 2013) spends ~$2M/year on Project Blueprint — the most comprehensive documented longevity protocol. Reported results: biological age testing younger than chronological age across multiple organ systems, carotid artery elasticity equivalent to age 18–26, zero atherosclerotic plaque. The protocol layers ~100+ interventions simultaneously — making it impossible to attribute results to any specific one. The American Council on Science and Health (2025): "Despite Johnson presenting the project as science-backed, it is anecdotal evidence — at best a case study, the lowest level of scientific evidence." What IS evidence-based in his protocol: sleep optimisation (his #1 stated priority — extensive data supports this), 6 hours/week exercise, calorie-controlled whole-food nutrition, comprehensive blood testing. What is SPECULATIVE: follistatin gene therapy (one study in mice), young plasma transfusions (he discontinued these — no measurable benefit), growth hormone for thymus regeneration (discontinued due to side effects including elevated glucose and intracranial pressure). Blueprint raised $60M in October 2025, with investors including Kim Kardashian and Naval Ravikant. Johnson stepped back as CEO to focus on the philosophical movement "Don't Die." The core insight: 80% of Blueprint's benefit likely comes from sleep, exercise, nutrition, and stress management — available to anyone for near-zero cost.
The Blueprint Supplement Stack: What Johnson Takes and What the Evidence Says
Johnson categorises interventions into three tiers: "for everyone," personal biomarker-driven, and experimental. The core stack includes: Nicotinamide Riboside (NR) — alternated with NMN 6×/week for NAD+ optimisation. His intracellular NAD+ tested at 54.6µM (optimal range 40–100µM). Clinical evidence: NR raises NAD+ levels in humans but functional improvements remain modest in completed trials. CA-AKG (Calcium Alpha-Ketoglutarate) — Demidenko et al. (2021, Cell Metabolism): AKG extended mouse lifespan ~12%. One human trial (Rejuvant, n=42): reduced biological age by 8 years on average over 7 months using TruAge clock. Promising but very early. Creatine — the most evidence-backed supplement in his stack. Extensive data for muscle, brain (Rae 2003: improved working memory), and potential neuroprotection. NAC, ashwagandha KSM-66, curcumin, red yeast rice (natural statin alternative), glucosamine — all have reasonable evidence bases individually. Prescription medications: Metformin 500mg (TAME trial still ongoing, no longevity data in non-diabetics yet), Acarbose 200mg (strong mouse data, ITP study: 22% lifespan extension in male mice), Jardiance/empagliflozin 10mg (SGLT-2 inhibitor — cardiovascular protection proven, longevity data only in animal models), Rapamycin (the only drug consistently extending lifespan across multiple species — Johnson has trialled it periodically). The uncomfortable truth: no human has proven ANY supplement extends human lifespan.
Follistatin Gene Therapy: Johnson's Most Experimental Intervention — and Why It Matters
In October 2023, Johnson received his first longevity gene therapy via Minicircle: a follistatin transgene delivered to increase endogenous follistatin production. Follistatin inhibits myostatin (the protein that limits muscle growth) and activin A (involved in inflammation and fibrosis). Results: 160% increase in follistatin levels, reaching target. The mouse precedent: follistatin gene therapy ranks 7th among lifespan-extending interventions in mouse studies, extending lifespan by ~30%. In humans: zero longevity data. The risks: insertional mutagenesis (where the transgene integrates into the genome and disrupts tumour suppressor genes), immune response to the viral vector, and unintended downstream effects of chronically elevated follistatin — including potential impacts on reproductive hormones, bone morphogenetic proteins, and TGF-β signalling. This is a genuinely frontier intervention. Johnson is paying to be a test subject for something that won't have safety data for years. His monitoring includes: epigenetic age tracking, 12+ organ function panels, and MRI surveillance. Other gene therapies entering the longevity space: telomerase (Liz Parrish, BioViva — self-experimented in 2015, controversial), klotho overexpression (cognitive benefits in mice), and VEGF for angiogenesis. Gene therapy may ultimately be the most powerful longevity tool — but right now, human evidence is essentially n=1 case reports from wealthy self-experimenters.
Rapamycin: The Only Drug That Extends Lifespan in Every Species Tested
Discovered on Easter Island (Rapa Nui) in 1972. Originally an antifungal, then immunosuppressant for transplant patients, now the most replicated longevity drug in history. NIA Interventions Testing Program (ITP): rapamycin extended mouse lifespan by 9–14%, even when started at age 600 days (equivalent to ~60 human years) — Harrison et al. (2009, Nature). Extended lifespan in yeast, worms, flies, and mice across multiple labs. Mechanism: inhibits mTORC1 (mechanistic target of rapamycin complex 1), the master nutrient-sensing kinase that drives growth and proliferation. mTOR inhibition activates autophagy, reduces senescent cell burden, improves stem cell function, and shifts metabolism from growth to maintenance. The Dog Aging Project (TRIAD study): rapamycin in companion dogs is ongoing — the first large-scale mammalian longevity trial. Mannick et al. (2014, Science Translational Medicine): low-dose mTOR inhibitor (everolimus) improved immune function in elderly humans by 20% — the OPPOSITE of immunosuppression at low doses. Human longevity trials: PEARL trial (rapamycin in healthy adults) recruiting. Dosing in longevity context: 3–6mg weekly (pulsed, not daily — mimicking intermittent mTOR inhibition rather than chronic suppression). Side effects at clinical doses: mouth ulcers, hyperlipidaemia, impaired wound healing. The risk-benefit calculation for healthy adults remains the central debate — is a proven lifespan extender in every animal worth the uncertain risk profile in humans?
Metformin for Longevity: The TAME Trial Will Answer What Decades of Observational Data Cannot
Metformin (1957, biguanide from French lilac) is the most prescribed diabetes drug globally. The longevity interest: Bannister et al. (2014, Diabetes, Obesity and Metabolism, n=180,000): type 2 diabetics on metformin lived LONGER than non-diabetic controls — despite having a disease that typically shortens lifespan. Mechanism: activates AMPK (the cellular energy sensor), inhibits mitochondrial Complex I, reduces hepatic glucose production, improves insulin sensitivity, activates autophagy, reduces inflammation (NF-κB), and may reduce cancer incidence (Gandini 2014 meta-analysis: 31% reduced cancer risk in diabetics on metformin). The TAME trial (Targeting Aging with Metformin, PI: Nir Barzilai): the first FDA-recognised trial testing a drug specifically for "ageing" as a treatable condition — 3,000 adults aged 65–79, randomised to metformin 1,500mg/day vs placebo, tracking composite age-related outcomes over 6 years. If positive, it establishes "ageing" as a regulatory indication — opening the door for all longevity drugs. The counter-evidence: Long et al. (2017, Aging Cell): metformin blunted exercise-induced improvements in mitochondrial function and cardiorespiratory fitness in older adults — suggesting it may counteract some benefits of exercise. This is a real concern for active individuals. Johnson takes 500mg daily. Most longevity physicians who prescribe it use 500–1,000mg in non-diabetics.
Young Blood and Plasma Exchange: From Parabiosis Studies to Johnson's Abandoned Experiment
The spark: Conboy et al. (2005, Nature): heterochronic parabiosis (surgically joining old and young mice circulatory systems) rejuvenated old muscle, liver, and brain tissue. Initially attributed to "youthful factors" in young blood. The plot twist: Conboy et al. (2020, Aging): diluting old blood (replacing half of plasma with saline and albumin) was sufficient to rejuvenate tissues — suggesting the benefit comes from REMOVING age-related pro-inflammatory factors, not from adding youthful ones. Therapeutic plasma exchange (TPE): Kiprov et al. (2022, GeroScience): 5 monthly plasma exchanges in healthy older adults reduced biological age markers. Johnson's experience: he received multiple plasma transfusions from his 17-year-old son Talmage (generating massive media attention). After 6 exchanges, he reported NO measurable benefit and discontinued the intervention. He acknowledged it was unclear whether any improvement came from his son's "super plasma" or simply from removing his own aged plasma. The science supports the Conboy model: it's dilution of harmful factors, not transfusion of magical ones. Ambrosia (the "young blood" startup charging $8,000/litre): FDA issued a warning in 2019 that there was no clinical evidence supporting the use of young donor plasma for ageing. Albumin-based plasma exchange is being investigated more rigorously as a potential intervention — without needing young donors at all.
Caloric Restriction: The Only Proven Lifespan Extender — and Why Hardly Anyone Can Do It
Caloric restriction (CR, 20–40% below ad libitum intake without malnutrition) extends lifespan in every organism tested: yeast, worms, flies, mice, rats, dogs, and likely primates. The primate data: Wisconsin study (Colman 2009, 2014, Science): 30% CR reduced age-related disease by 50% and mortality by 30% in rhesus monkeys over 20 years. NIA study (Mattison 2012, Nature): no significant lifespan extension, but improved metabolic health — the discrepancy likely explained by different control group diets. CALERIE trial (Ravussin 2015, JAMA Internal Medicine, n=218 healthy non-obese humans): 25% caloric restriction for 2 years. Results: reduced blood pressure, cholesterol, insulin resistance, inflammation (CRP decreased 40%), and oxidative stress markers. Belsky et al. (2017, biomarkers analysis): pace of biological ageing slowed by 2–3% per year of CR. The problem: chronic 25% restriction is psychologically unsustainable for most humans. Compliance in CALERIE averaged only 12% restriction (not 25%). This is why CR mimetics (rapamycin, metformin, spermidine, NAD+ precursors, fasting-mimicking diets) are pursued — to capture the molecular benefits without the hunger. Johnson's Blueprint nutrition is essentially a precisely calibrated CR-adjacent diet (~1,977 kcal/day, 130g protein, high-nutrient-density whole foods). The principle: every calorie must "fight for its life."
Medical Cannabis for PTSD and Chronic Pain: Navigating Ideology and Actual Evidence
The endocannabinoid system (ECS): CB1 receptors (densest in brain — hippocampus, amygdala, prefrontal cortex, basal ganglia) and CB2 receptors (primarily immune cells). Endocannabinoids anandamide and 2-AG regulate fear extinction, pain modulation, inflammation, and stress response. PTSD: Neumeister et al. (2013, Molecular Psychiatry): PTSD patients had elevated CB1 receptor availability and reduced anandamide — suggesting endocannabinoid DEFICIENCY as a pathophysiological feature. Jetly et al. (2015, Psychoneuroendocrinology, n=10 military PTSD): nabilone (synthetic THC analogue) significantly reduced nightmare frequency and improved overall wellbeing. Observational data (Bonn-Miller 2020, n=150 PTSD): cannabis users showed greater symptom reduction over 1 year than non-users. BUT: no large, well-controlled RCTs of whole-plant cannabis for PTSD exist. The FDA has not approved cannabis for PTSD. Chronic pain: Whiting et al. (2015, JAMA, systematic review, 79 trials): moderate evidence for cannabinoids reducing chronic pain, with NNT (number needed to treat) of ~11. CBD specifically: Shannon et al. (2019, The Permanente Journal, n=72): 300mg/day reduced anxiety in 79.2% and improved sleep in 66.7%. Anti-inflammatory: CB2 activation reduces TNF-α and IL-6. The honest assessment: the ECS is clearly relevant to PTSD and pain. Cannabis has therapeutic potential. But the evidence base is weaker than advocates claim and stronger than opponents acknowledge.
Complex PTSD: When Trauma Is Repeated, Relational, and Developmental
CPTSD was formally recognised in ICD-11 (2022) as distinct from PTSD. It arises from prolonged, repeated trauma — typically childhood abuse, neglect, domestic violence, captivity, or trafficking — where the victim cannot escape. Three additional symptom clusters beyond PTSD: (1) affect dysregulation (explosive or suppressed emotions, chronic emptiness), (2) negative self-concept (shame, worthlessness, self-blame), (3) disturbed relationships (avoidance, inability to trust, re-enactment patterns). Felitti's ACE Study (1998, American Journal of Preventive Medicine, n=17,421): Adverse Childhood Experiences showed a dose-response relationship — 4+ ACEs increased depression risk 4.6×, suicide attempt 12.2×, heart disease 2.2×, cancer 1.9×. The mechanism: developmental trauma disrupts the HPA axis during critical periods, alters epigenetic expression (Yehuda 2014: trauma-related methylation changes transmit intergenerationally), and impairs prefrontal cortex development. Standard trauma-focused CBT has higher dropout rates in CPTSD (Cloitre et al. 2010). The phase-based approach (Herman 1992, "Trauma and Recovery"): (1) stabilisation and safety, (2) trauma processing, (3) reconnection. Body-based therapies (SE, sensorimotor psychotherapy), parts-based therapies (IFS — Internal Family Systems), and attachment-focused EMDR show particular promise for complex presentations.
Trauma-Sensitive Yoga: Van der Kolk's RCT and the Return to the Body
Van der Kolk et al. (2014, Journal of Clinical Psychiatry, RCT, n=64 treatment-resistant PTSD women): 10 weeks of trauma-sensitive yoga significantly reduced PTSD symptoms, with 52% of yoga participants no longer meeting PTSD criteria at study end — compared to 21% in the supportive health education control. Effect size comparable to established psychotherapies. Mechanism: trauma disconnects people from their bodies. PTSD sufferers often have impaired interoception (awareness of internal states) and a chronic sense that their body is not safe. Yoga restores interoceptive awareness and teaches that bodily sensations can be tolerated without catastrophe. Trauma-sensitive yoga (TSY) differs from standard yoga: no hands-on adjustments, invitational language ("you might try" vs "do this"), emphasis on choice and bodily autonomy, no forced breathing patterns. Meditation: Polusny et al. (2015, JAMA, n=116 veterans): mindfulness-based stress reduction (MBSR) significantly improved PTSD symptom severity at 2 months. But Britton (2019, "Willoughby Britton's meditation adverse effects project"): 25% of regular meditators report unwanted effects including anxiety, depersonalisation, and emotional dysregulation — particularly relevant for trauma populations where silent meditation can trigger dissociative states. Movement-based practices may be safer than seated silent meditation for trauma.
Internal Family Systems: The Parts-Based Therapy Gaining Serious Research Traction
Developed by Richard Schwartz (1990s): the mind naturally contains "parts" — subpersonalities with distinct roles. In trauma, parts become polarised: Managers (controlling, perfectionist, intellectualising — keeping the system functioning), Exiles (carrying the pain, shame, and memories of trauma — locked away to prevent overwhelm), and Firefighters (reactive, impulsive — addictions, self-harm, rage — activated when exiles threaten to surface). The "Self" (capital S) is the core — characterised by curiosity, compassion, clarity, calm, courage, connectedness, creativity, and confidence. Therapy: help parts unblend from Self, negotiate new roles, and "unburden" the beliefs and emotions they carry from trauma. NREPP (SAMHSA's National Registry of Evidence-Based Programs and Practices): listed IFS as an evidence-based practice. Hodgdon et al. (2022, Journal of Traumatic Stress, n=25 women with CPTSD): IFS produced significant reductions in PTSD symptoms, depression, and emotion dysregulation. Effect sizes comparable to established treatments. Particularly effective for: complex trauma, eating disorders (Brewerton 2019), chronic pain, and conditions where multiple "parts" drive conflicting behaviours. The model gives patients a language for internal conflict that reduces shame: "A part of me wants to drink" is more workable than "I am an alcoholic." Growing integration with psychedelic therapy — psychedelics often naturally produce "parts" experiences.
Psychedelic Safety: Contraindications, Drug Interactions, and Who Should Never Trip
Psychedelics (psilocybin, LSD, DMT, mescaline) are physiologically among the safest psychoactive substances — Nutt et al. (2010, Lancet): LSD and psilocybin ranked near the bottom for overall harm, below alcohol, tobacco, and cannabis. No known lethal dose for classical psychedelics. ZERO deaths from psilocybin toxicity in published literature. But safety ≠ risk-free. ABSOLUTE contraindications: (1) Personal or first-degree family history of psychotic disorders (schizophrenia, schizoaffective) or bipolar I — psychedelics can trigger first-episode psychosis or manic episodes. (2) Current lithium use — multiple case reports of seizures when combined with psychedelics (Nayak 2021). (3) MAOI + serotonergic psychedelics (especially ayahuasca) — serotonin syndrome risk. Relative contraindications: current SSRI use (reduces psychedelic effect and may increase serotonin-related risks), severe cardiovascular disease (psychedelics increase BP/HR acutely), pregnancy, active suicidality without clinical oversight. HPPD (Hallucinogen Persisting Perception Disorder): rare but real — persistent visual disturbances (trails, halos, geometric patterns) lasting weeks to years post-psychedelic use. Prevalence estimated at <1–4.2% (Orsolini 2017). Risk factors: high doses, frequent use, cannabis co-use, pre-existing anxiety. Set, setting, dose, and screening are not optional luxuries — they are safety fundamentals.
Bryan Johnson's Sleep Protocol: The Intervention He Says Matters More Than Everything Else
Johnson repeatedly states that sleep is the "world's #1 longevity drug." His protocol is perhaps the most replicable part of Blueprint: (1) Fixed sleep/wake times — in bed 8:30 PM, asleep within 3 minutes, wake without alarm. Non-negotiable consistency, even socially. (2) Wind-down routine — no screens, messages, or stimulating content after ~7 PM. Warm shower, skincare routine (his is elaborate), journaling or light reading. (3) Room environment — complete darkness (blackout curtains + eye mask), temperature 18–19°C (supported by Haskell et al. 2013: cool ambient temperature improves SWS), Eight Sleep mattress for temperature regulation. (4) No food within 3+ hours of bed — late eating impairs melatonin secretion and HRV during sleep. (5) No caffeine after early morning — Johnson reportedly avoids caffeine entirely. (6) No fluids after 4 PM — eliminates nocturnal bathroom trips. (7) Zero alcohol — even moderate alcohol devastates sleep architecture (Ebrahim 2013: reduced REM by 20–40%). The data supports EVERY element: Walker (2017, "Why We Sleep"): sleeping 6 hours or less is associated with a 4.2× increase in catching a cold, 70% reduction in NK cell activity after one night, and a 20% increase in S100-B (brain injury marker). Johnson measures: HRV, time in bed, sleep efficiency, and deep sleep duration. His consistently excellent scores (~8 hours, >95% efficiency) likely account for a substantial portion of his biological age results. Cost of replicating this: approximately £0.
NAD+ Supplementation: The Gap Between Mechanistic Promise and Human Clinical Evidence
NAD+ declines 40–50% between ages 40 and 60. This decline impairs sirtuin function, mitochondrial health, DNA repair (PARP enzymes require NAD+), and cellular energy production. Two main precursors compete: NMN (nicotinamide mononucleotide) — popularised by David Sinclair; NR (nicotinamide riboside) — Elysium/ChromaDex, the only form with multiple published human RCTs. NR human evidence: Martens et al. (2018, Nature Communications, n=24 older adults, 1,000mg/day × 6 weeks): raised NAD+ by 60%, reduced aortic stiffness, reduced systolic blood pressure by 8 mmHg — the most clinically meaningful result in any NAD+ precursor trial. NMN: Yoshino et al. (2021, Science, n=25 prediabetic postmenopausal women, 250mg/day × 10 weeks): improved skeletal muscle insulin sensitivity. But: did not improve other metabolic markers. The honest assessment: both NR and NMN reliably RAISE NAD+ levels in humans. What they have NOT yet demonstrated in published RCTs: lifespan extension, significant cognitive improvement, or dramatic functional rejuvenation. The mouse data is compelling. The human data shows biochemical improvement without clear functional translation — yet. The CD38 connection: Camacho-Pereira et al. (2016): CD38 enzyme is responsible for 97% of age-related NAD+ degradation. Inhibiting CD38 (apigenin, quercetin) may be as important as providing more precursor. Johnson alternates NR and NMN — a reasonable hedging strategy given the uncertainty.
Vagus Nerve Stimulation: From Epilepsy to PTSD — Turning Down Inflammation and Hyperarousal
Implanted VNS: FDA-approved for epilepsy (1997) and treatment-resistant depression (2005). A pulse generator in the chest sends electrical impulses to the left vagus nerve via a lead wrapped around it in the neck. George et al. (2005, Biological Psychiatry): VNS produced sustained improvement in TRD over 2 years in patients who had failed multiple medications and ECT. Transcutaneous VNS (tVNS/taVNS): non-invasive stimulation of the auricular branch of the vagus nerve at the tragus of the ear — no surgery required. Devices: gammaCore (cervical, FDA-cleared for migraine and cluster headache), Nurosym, Pulsetto. Stavrakis et al. (2020, JACC, n=53): taVNS reduced atrial fibrillation burden. For PTSD specifically: Lamb et al. (2017, Journal of Traumatic Stress): cervical tVNS paired with traumatic memory exposure reduced physiological startle responses in PTSD patients. The mechanism: vagal afferents project to the nucleus tractus solitarius → locus coeruleus → amygdala/PFC — directly modulating the noradrenergic hyperactivation central to PTSD. Additionally, the cholinergic anti-inflammatory pathway (Tracey 2002): vagal efferents suppress TNF-α production by up to 75%. PTSD is increasingly recognised as a neuroinflammatory condition — vagal stimulation addresses both the autonomic and inflammatory components. Home devices: 15–30 minutes daily, 25 Hz, 250µs pulse width at the tragus. Cost: £200–500 for consumer devices.
The Longevity Evidence Hierarchy: What Actually Works, Ranked by Strength of Evidence
Cutting through the noise. Tier 1 — PROVEN in humans, large effect sizes, low risk: Sleep (7–9 hours consistently), Exercise (150+ min/week moderate OR 75+ min vigorous, including resistance training), Not smoking, Moderate/no alcohol, Social connection (Holt-Lunstad: 50% mortality reduction), Healthy body composition, Whole-food nutrition. Tier 2 — STRONG evidence, moderate effect sizes: Blood pressure management (<120/80), Glycaemic control (HbA1c <5.5%, fasting insulin <5), Statin therapy for high ApoB (controversial in primary prevention but strong secondary prevention data), Omega-3 sufficiency (index >8%), Vitamin D sufficiency (40–60 ng/mL). Tier 3 — PROMISING but incomplete human evidence: Rapamycin (strongest animal data, human trials ongoing), Metformin (TAME trial pending), Caloric restriction/fasting, Sauna (Finnish data strong but observational), Cold exposure, Senolytics (early human trials). Tier 4 — SPECULATIVE, mechanistically plausible: NAD+ precursors, spermidine, GlyNAC, CA-AKG, sulforaphane, longevity peptides. Tier 5 — EXPERIMENTAL, n≈1: Gene therapy, young plasma exchange, stem cell infusions for anti-ageing, most Bryan Johnson interventions beyond the basics. The uncomfortable truth: Tiers 1 and 2 are free or cheap. Most supplement spending targets Tiers 4–5. The expected return on investment is inverted from where most people spend their money and attention.
Conditions I Research
Not a complete list. If your condition isn't here, it doesn't mean I can't help — it means we should talk.
No insights match that search.
Try broader terms — e.g. "thyroid" instead of "thyroid antibodies," or browse by category above.